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ABSTRACT 
  The Effects of a Gluteus Medius Training Protocol on Muscle Activation and Postural 
  Control 
  Dorpinghaus, ND. Gage, MJ. Dominguese, DJ. Kingsley, JD. Yoder, AW. 
 
Context: Researchers have suggested a weak or dysfunctional gluteus medius (GM) has been 
linked to a number of lower extremity injuries.  Identifying an appropriate intervention to 
prevent or correct GM deficits and determine associated outcomes has become a subject of 
increased interest.  Objective: To determine if GM training changes lower extremity muscle 
activation during a dynamic task.  Design: Controlled laboratory study.  Setting: Biomechanics 
research laboratory.  Participants: Eighteen healthy, physically active participants (7 men, 11 
women; age=21.2±2.01yrs; height=168.39±8.92cm; mass=77.76±16.39kg) volunteered for the 
study.  Each participant served as their own control.  Intervention(s): Muscle activation of 5 
trunk muscles were measured bilaterally before and after the protocol during a single-leg drop 
landing (45cm).  All of the participants completed a six week GM training protocol.  Main 
Outcome Measure(s): Peak and mean muscle activation was measured 400ms pre-and post-
landing (pre-mean, pre-peak, post-mean, post-peak).  Muscle activation data was normalized 
using maximal voluntary contractions.  Results: No significant differences were observed during 
the control period.  Decreased muscle activation was observed in the non-dominant GM [pre-
mean (F1,17=14.301, P=.001), pre-peak (F1,17=9.490, P=.007), post-mean (F1,17=5.373, P=.033), iv 
 
and post-peak (F1,17=4.678, P=.045)].  Increased biceps femoris (BF) mean muscle activation 
was observed on the dominant leg pre-landing (F1,17=4.752, P=.044).  Conclusions: Six weeks 
of GM training was enough time to observe improved neuromuscular efficiency of the GM.  
Increased BF muscle activation prior to landing suggests participants had an increased 
feedforward response in preparation for landing following training.  Therefore, the combination 
of improved neuromuscular efficiency and a greater feedforward response suggest pelvic 
stabilization may be improved during a single-leg drop landing as a result of six weeks of GM 
training.  This study suggests clinicians should incorporate bilateral GM exercises to improve 
lower extremity neuromuscular efficiency and feedforward responses which may improve pelvic 
stabilization.  Key words: Electromyography, lower extremity injury, rehabilitation, 
neuromuscular efficiency, single-leg drop landing.    v 
 
 
 
 
PREFACE 
  Rehabilitation from athletic injuries is as much of an art as a science.  It requires evidence 
based decisions coupled with creative thinking.  From the beginning, I knew that I wanted to 
complete a rehabilitation training protocol for my Master Thesis project.  The clinical 
applications that arise from training studies are what intrigued me the most.  I was advised that 
this project was going to be challenging and require work above and beyond other topics.  
Nevertheless, the project was started in September 2010 and completed in June 2012.  I am 
proud to share my results with you.   vi 
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ABSTRACT 
 
  The Effects of a Gluteus Medius Training Protocol on Muscle Activation and Postural 
  Control 
  Dorpinghaus, ND. Gage, MJ. Dominguese, DJ. Kingsley, JD. Yoder, AW. 
 
  Context: Researchers have suggested a weak or dysfunctional gluteus medius (GM) has 
been linked to a number of lower extremity injuries. Identifying an appropriate intervention to 
prevent or correct GM deficits and determine associated outcomes has become a subject of 
increased interest. Objective: To determine if GM training changes lower extremity muscle 
activation during a dynamic task. Design: Controlled laboratory study. Setting: Biomechanics 
research laboratory. Participants: Eighteen healthy, physically active participants (7 men, 11 
women; age=21.2±2.01yrs; height=168.39±8.92cm; mass=77.76±16.39kg) volunteered for the 
study. Each participant served as their own control. Intervention(s): Muscle activation of 5 
trunk muscles were measured bilaterally before and after the protocol during a single-leg drop 
landing (45cm). All of the participants completed a six week GM training protocol. Main 
Outcome Measure(s): Peak and mean muscle activation was measured 400ms pre-and post-
landing (pre-mean, pre-peak, post-mean, post-peak). Muscle activation data was normalized 
using maximal voluntary contractions. Results: No significant differences were observed during 
the control period. Decreased muscle activation was observed in the non-dominant GM [pre-2 
 
mean (F1,17=14.301, P=.001), pre-peak (F1,17=9.490, P=.007), post-mean (F1,17=5.373, P=.033), 
and post-peak (F1,17=4.678, P=.045)]. Increased biceps femoris (BF) mean muscle activation was 
observed on the dominant leg pre-landing (F1,17=4.752, P=.044). Conclusions: Six weeks of GM 
training was enough time to observe improved neuromuscular efficiency of the GM. Increased 
BF muscle activation prior to landing suggests participants had an increased feedforward 
response in preparation for landing following training. Therefore, the combination of improved 
neuromuscular efficiency and a greater feedforward response suggest pelvic stabilization may be 
improved during a single-leg drop landing as a result of six weeks of GM training. This study 
suggests clinicians should incorporate bilateral GM exercises to improve lower extremity 
neuromuscular efficiency and feedforward responses which may improve pelvic stabilization. 
Key words: Electromyography, lower extremity injury, rehabilitation, neuromuscular efficiency, 
single-leg drop landing.  3 
 
Introduction  
  Injuries to the lower extremities are common in athletics due to the external forces that 
are imposed on the body from anatomical, biomechanical, and environmental factors.
1  Hip 
muscle weakness is one deficit observed that may contribute to lower extremity injury.
2  A weak 
or dysfunctional gluteus medius (GM) has been linked to a number of lower extremity injuries, 
which include patellofemoral pain syndrome (PFPS),
3-6 iliotibial band friction syndrome 
(ITBS),
7 anterior cruciate ligament (ACL) injuries,
8 and chronic ankle instability.
9,10  
  Increasingly, researchers have been assessing joints for weakness or deficits proximal to 
the injury site.  Previous studies have identified hip weakness as a predictor of lower extremity 
injury in athletes.
2,3,5,7  In a prospective study examining hip muscle strength through isometric 
testing athletes that had sustained injuries were shown to have significantly weaker hip abductor 
and external rotator strength compared with uninjured athletes.
2  Ireland et al.
5 observed that 
young active women with PFPS have significantly weaker hip abductors and external rotators 
compared to noninjured, age-matched controls.  Hip weakness has also been observed to occur 
following an injury.
1,9  Strength of hip abductors has been observed to be significantly weaker 
following an inversion ankle sprain on the injured side compared to the uninjured side.
9  The 
previous studies examined hip strength and its relation to lower extremity injury.  Researchers 
are utilizing electromyography (EMG) to examine muscle recruitment patterns at the hip and in 
the lower extremities following injury.  
  Electromyography is an established way to quantify muscle activity.  Delayed hip 
extensor and abductor muscle activation have previously been observed in individuals who have 
sustained lower extremity injuries.
1,3,9-11  Delayed hip muscle activation may predispose 
individuals to lower extremity positions frequently associated with non-contact injuries during  4 
 
functional activities.
12  Hip musculature influences how forces are transferred from the lower 
extremity towards the spine.
5  A lack of muscle activation in the hip may delay muscle activation 
lower in the kinetic chain.
10  In contrast, abnormalities within the lower extremity may cause 
forces to be transmitted abnormally up the kinetic chain to the spine as well.
13  Injury to any one 
of the joints or corresponding structures along the kinetic chain can result in a loss of 
feedback.
9,11,14  Beckman and Buchanan
10 observed a significant delay in muscle activation of 
the GM in individuals with chronic ankle instability.  Bullock-Saxton et al.
11 revealed that 
individuals who have sustained a severe unilateral ankle sprain had a significantly greater delay 
of gluteus maximus activation.  Therefore, clinicians may need to address delayed muscle 
activation further up the kinetic chain to prevent future injuries during a lower extremity 
rehabilitation program.  
  Neuromuscular training of proximal hip muscles is not a new concept.  Multiple studies 
have examined the integration of hip strengthening aimed to increase hip-abductor strength
7,15-17 
and postural control.
18-22  Furthermore, hip strengthening programs seem to be effective in 
allowing athletes to return to pain-free activity.
7,15-17  Leavy et al.
19 suggested that GM 
strengthening may improve dynamic balance more than proprioceptive training alone in healthy, 
active individuals.  Fredericson
7 observed that a 34.9% increase in hip-abductor strength lead to 
a decrease in individuals with iliotibial band friction syndrome.  Similar increases in hip-
abductor strength following a hip strengthening program have been shown to decrease pain for 
runners with PFPS.
15,22  Unfortunately, these studies did not assess EMG measurements to 
determine changes in muscle activation.  A previous study examined GM muscle activation 
following a weight-bearing rehabilitation program.
17  The authors indicated that GM muscle 
activation was not altered after a weight-bearing rehabilitation program on individuals diagnosed  5 
 
with PFPS.  Furthermore, the authors were unable to determine why GM muscle activation did 
not change.
17  Therefore, the purpose of this study is to examine the effects that GM training has 
on muscle activation in healthy participants.  Our hypothesis is that six weeks of GM training 
will increase muscle activation of lumbo-pelvic and lower extremity muscles.  
  METHODS 
Design  
  A six week GM training protocol was the independent variable (pretest, posttest).  The 
dependent variable was muscle activation of 5 separate muscles bilaterally: GM, transversus 
abdominis/internal oblique (TrA/IO), vastus medialis (VM), and biceps femoris (BF).  
Participants  
  Eighteen, physically active participants (7 men, 11 women; age = 21±2 years; height = 
168.39±8.92 cm; mass = 77.76±16.39 kg) volunteered for the study.  Physically active was 
defined as regular participation in an aerobic cardiovascular training regime for a minimum of 30 
minutes, 3 times per week for the past 6 months.
23  All participants were asked to maintain their 
physical activity levels that they were currently engaged in prior to the study.  This was 
confirmed using a weekly log that documented each participant’s physical activity.  
  Participants were screened using a health history questionnaire (HHQ).  Inclusion criteria 
consisted of physically active and between 18 and 30 years of age.  Exclusion criteria consisted 
of history of cardiovascular, neurological, or childbirth/pregnancy within the past year; history of 
abdominal, low back, or lower extremity injury within the past year; restriction from physical 
activity or surgery within the past two years; unresolved lower extremity injury or current pain in 
the spine, abdominal, or lower extremity; and missing two or more training sessions during the  6 
 
training protocol.  All participants read and signed an approved university institutional review 
board informed consent prior to participating in the study.  All 18 participants recruited for the 
study completed the duration training protocol and study.   
Data Collection Sessions  
  Each participant reported to the laboratory for one familiarization session and three data 
collection sessions.  Data collection session 1 (DC1) occurred within two days following a 
familiarization session.  Two weeks following DC1 participants completed data collection 
session 2 (DC2).  During this time participants were instructed to maintain current levels of 
physical activity, and this period was defined as the control period. Following DC2 participants 
completed a GM training protocol (3 times a week for 6 weeks).  Upon completion of the six 
week GM training protocol participants reported for data collection session 3 (DC3).  This time 
period was defined as the intervention period.  A timeline of the study is included in Figure 1.  
Procedures 
  Familiarization Session  
  Participants read and completed a HHQ and informed consent during the familiarization 
session.  Demographic data and leg dominance for each participant was obtained at this time. 
Leg dominance was defined as the plant leg when kicking a ball.
24  Participants then practiced 
performing a single-leg drop landing.  
  Participants practiced performing a single-leg drop landing at two different heights (30 
and 45cm).  They were allowed to practice the single-leg drop landing at the lower height (30cm) 
first.  Participants were required to perform three correct practice trials at 30 cm before moving 
to the testing height of 45cm.  At 45cm, each participant was required to perform three correct 
practice trials prior to the end of the familiarization session.  Correct trials were defined as the 7 
 
participant landing on their dominant leg while maintaining balance for approximately 5 
seconds.  Trials were considered incomplete if a participant exhibited any of the following 
balance errors: hands lifted off iliac crest; step, stumble, or fall; moving hip into >30 degrees of 
abduction; lifting forefoot or heel of the stance leg; remaining out of test position >5 seconds.
25  
Trials were determined incomplete off visual inspection from the primary investigator.  
  Participants were re-familiarized to the single-leg drop landing prior to each data 
collection session.  Data collection was then performed during three single-leg drop landing 
trials.
26-29  During single-leg drop landing trials participants were instructed to place their hands 
on their hips, move their dominant limb in front of the platform and lean forward, place the 
dominant foot over the center of the force platform, and maintain balance on their dominant leg 
while keeping their hands on their hips for approximately five seconds.
30,31  Trials were 
disqualified and repeated after a 3 minute rest period if a participant exhibited any of the balance 
errors previously defined.  
  Instrumentation  
  The Myomonitor IV (Delsys, Boston, MA) surface EMG was used to measure muscle 
activation pre-and post landing during data collection sessions.  Data were collected bilaterally 
from the GM, TrA/IO, VM, and BF.  Electrodes were positioned according to placement 
previously defined in the literature (Table 1).  Electromyography measurements were collected 
using Delsys surface EMG sensors (DE-2.1, Delsys Inc., Boston, MA). To ensure consistency 
with electrode placement, the same investigator positioned all electrodes during each data 
collection session.  The skin was shaved if needed, debrided with fine sand paper, and cleaned 
with alcohol before electrode placement to reduce impedance.  Electrodes were placed over the 8 
 
muscle belly parallel with the muscle fibers.
32  A reference electrode was applied to the lateral 
malleolus of the dominant leg.  
  A force platform (Kistler 9281B11, Amherst, NY) was used to determine the time that 
initial contact during landing occurred for each trial. Mean and peak EMG data were assessed for 
400ms prior to initial contact and 400ms after initial contact during landing.   
  The Myomonitor IV System is a wireless unit.  All wireless systems have a delay in 
signal transmission, which Delsys estimated to be approximately 60ms.  We accounted for the 
60ms delay while we processed muscle activation data.  The raw EMG signal was recorded at a 
sampling rate of 1000 Hz.  The input impedance of the amplifier was >1015 megohm//0.2 pF, 
with a common mode rejection ratio of 90 dB, high and low pass filters of 20 and 450Hz, a 
signal to noise ratio of -92 dB, and a gain of 1000.  
  Maximal voluntary isometric contraction (MVIC) testing was performed to normalize all 
EMG data using manual muscle testing (Table 2).  Each participant completed 3 trials of 
maximal contraction, holding each contraction for 5 seconds, similar to previous studies.
33-37 
Data from the initial 1 second and final 1 second were excluded, and the remaining 3 seconds of 
data were analyzed.  The average root mean square (RMS) of the 3 trials was used to determine 
the MVIC of each muscle.  The normalized muscle activity was expressed as a percentage of the 
MVIC.  A 60-second rest period was taken between each repetition, with a 2-minute rest 
between each different muscle group.
34,36,38  Rest periods were timed using the software program 
provided by the EMG Works software program (Delsys, Boston, MA).  
  Three correct single-leg drop landing trials were used to determine mean and peak 
normalized muscle activation values. Matlab software (R2008b, The Mathworks, Inc, Natick, 
MA) processed the raw muscle activation data upon completion of data collection.  All muscle 9 
 
activation data were integrated and smoothed using a RMS algorithm with a 50ms moving 
window.  Mean and peak muscle activation data were normalized to reference values.    
  Training Protocol  
  After DC2 all participants completed the prescribed training protocol three times per 
week for six weeks.
23  Participants were required to report to the laboratory for a one exercise 
session per week.  Participants were required to fill out an exercise log for the remaining two 
training sessions completed without supervision.  Additional physical activity was reported each 
week in the participants’ weekly exercise log.  The exercise logs were turned in and reviewed 
weekly during the participants' supervised training session to ensure exercise levels remained 
similar throughout the study.  
  All exercises used in the GM training protocol have demonstrated effective muscle 
activation of the GM.
33-37,39,40  During the training protocol participants were instructed to rest 
for 60 seconds between sets and two minutes between each exercise for the duration of the six 
weeks.
23  All exercises were performed bilaterally throughout the duration of the training 
protocol.  The training protocol is located in Table 3.  
Statistical Analyses  
  Mean and peak values were calculated for each muscle pre- and post-landing (pre-mean, 
pre-peak, post-mean, and post-peak).  Separate repeated measures analyses of variance 
(ANOVA) were used to compare muscle activation across time (DC1, DC2, DC3) by condition 
(pre- and post-training).  If there was a significant interaction, paired t-tests were used to 
determine main effects.  To control for leg dominance during data analyses the stance leg was 
defined as the dominant leg and the non-stance leg was defined as the non-dominant leg.  Data 
were processed with SPSS 9 version 18.0; SPSS Inc, Chicago, IL).  The level of significance for 10 
 
all analyses was set apriori at P=.05.  Based on documentation from the weekly exercise logs 
participants completed 100% of the six week GM training protocol.  
Results  
  No significant differences were discovered between DC1 and DC2 (control period). 
Means and standard deviations for the control period are shown in Table 4. Significant 
differences were noted between DC2 and DC3 (intervention period) in the BF and GM. The GM 
training protocol produced increased mean muscle activation of the dominant BF and decreased 
muscle activation of the non-dominant GM.  Significant differences were observed in the 
dominant BF pre-mean (F1,17=4.752, P=.044, Figure 9).  No other differences were observed in 
the dominant BF pre-peak (F1,17=3.222, P=.090), post-mean (F1,17=1.049, P=.320), and post-
peak (F1,17=1.726, P=.206).  Decreased muscle activation was observed in the non-dominant GM 
pre-mean (F1,17=14.301, P=.001), pre-peak (F1,17=9.490, P=.007), post-mean (F1,17=5.373, 
P=.033), and post-peak (F1,17=4.678, P=.045, Figure 10).  Means and standard deviations for the 
remaining muscles are shown in Table 5 & Table 6.  
Discussion  
  The purpose of the current study was to examine the effects GM training has on muscle 
activation in healthy participants.  To our knowledge this is the first study to specifically 
examine the effects GM training has on muscle activation in healthy participants during a 
dynamic task.  The results of the current study indicate that GM training improves 
neuromuscular efficiency and produces a greater feedforward response suggesting pelvic 
stabilization may be improved during a single-leg drop landing as a result of six weeks of GM 
training.  The main observation in the present study was that GM training changed BF and GM 11 
 
muscle activation.  We hypothesized that six weeks of GM training would increase muscle 
activation of lumbo-pelvic and lower extremity muscles.  
  In support of our hypothesis, we observed an increase in dominant BF muscle activation 
prior to landing.  However, we observed a decrease in non-dominant GM muscle activation. 
Previous research has indicated that decreased gluteal muscle activation associated with 
increased quadriceps activity may contribute to increased risk for injury through increased knee 
valgus angles, specifically ACL injuries.
41,42  Zazulak et al.
41 examined gender differences of hip 
muscle activity during a single-leg landing, and observed that females demonstrated decreased 
gluteus maximus activity and increased rectus femoris activity.  The authors did not observe any 
difference in gluteus medius muscle activation .
41  Therefore, the authors concluded that 
decreased gluteal muscle activity and increased quadriceps activity may be important factors that 
impact noncontact ACL injuries.
41  However, it has been suggested that the timing of GM 
activation during a single-leg drop landing is more important than the level of activation.
31  We 
did not assess the timing of muscle activation in the current study.  The main differences 
between the current training study and previous studies is we incorporated an intervention.  The 
decreased GM muscle activation observed in the current study may be the result of 
neuromuscular adaptations in response to training as opposed to previously existent hip 
weakness or deficits.  
  Similar studies have shown decreased muscle activation following lower extremity 
training programs as a result of increased neuromuscular efficiency.
20,21,43,44  Zebis et al.
21 
observed decreased GM muscle activation during a side cutting maneuver upon completion of an 
18 week ACL injury prevention program.  The authors suggested high neuromuscular activity of 
the GM may not be beneficial to dynamic movements such as side cutting because of the anterior  12 
 
GM role as an internal hip rotator when the hip joint is flexed.
21  Furthermore, the authors 
concluded that the role of the GM during side cutting maneuvers may be different from its role in 
movements involving single-leg drop landings used in the present study.
21  More pertinent, 
Nyland et al.
20 evaluated the efficacy of progressive resistance, whole body, long-axis rotational 
training for improving the lower extremity neuromuscular control of healthy participants during 
a single-leg drop landings.  Similar to the current study, the authors observed decreases in mean 
gluteus maximus (35.7%) and GM (31.7%) muscle activation following 4 weeks of whole body, 
long-axis rotational training.  The authors concluded that the observed decreased muscle 
activation was a result of improved neuromuscular efficiency.  The decreased GM muscle 
activation in the current study supports the conclusion of the previous authors that training 
improves neuromuscular efficiency of the GM.  
  The GM is responsible for preventing the opposite side of the pelvis from dropping 
during the stance phase.
45  If one leg is swinging forward the GM of the non-dominant leg 
contracts to prevent the pelvis from titling laterally.  A contralateral pelvic drop occurs when the 
GM doesn't produce a sufficient internal hip rotation to balance the external hip rotation that 
occurs during a single leg stance.
46  The decreased muscle activation observed in the non-
dominant GM in the current study suggests that participants were able to effectively withstand 
lower extremity loads which may suggest improved neuromuscular efficiency of the non-
dominant GM.  However, it has also been hypothesized that muscles acting directly on the knee 
joint (ie, quadriceps and hamstrings) are more important in limiting knee valgus positions as 
opposed to GM muscle activation.
31  
  Previous studies have specified the importance of hamstring activation during a dynamic 
movement.
21,31,47  One explanation for the increased BF muscle activation observed in the current 13 
 
study may be the particular landing strategy used by participants.  It is reasonable to speculate 
participants may have adopted a hip strategy post-training resulting in a softer landing as 
opposed to using an ankle strategy or stiff landing.  Devita and Skelly
48 characterized a soft 
landing as a more flexed body configuration with flexion occurring at the hip and knee joints. In 
contrast, a stiff landing was defined by a more erect final position with a smaller range of motion 
at each joint compared with a soft landing.  More recently, Shimokochi et al.
30 examined the 
relationship among lower extremity moment productions at the ankle, knee, and hip during a 
single-leg landing, they concluded that leaning forward during landing may reduce quadriceps 
contraction demand while increasing the hamstrings muscle contraction.  This body position 
places the center of mass more anterior and potentially increases the contraction demand for the 
hamstrings.  The increased BF activation observed in the current study during the pre-landing 
phase accompanied by unchanged muscle activity of the VM indicates an important adaptation in 
response to training.  The increased BF muscle activation prior to landing suggests participants 
may have had an increased feedforward response in preparation for landing.  This finding is 
consistent with the need to control lower extremity positions and maintain the center of mass 
within the base of support.  
  Several limitations of the present study are apparent.  First, the current study included a 
small sample size of eighteen participants.  A study with a larger sample size may provide 
additional insight.  Also, a sample including participants from an injured population may reveal 
different results as well.  Thirdly, participants in our study completed a training protocol that has 
not been previously used or validated in the literature.  We made efforts to include exercises in 
the training protocol that have demonstrated through EMG amplitude to effectively activate the 
GM.
33-37,39,40  However, without the implementation of increasing resistance the training protocol 14 
 
may not have been strenuous enough to reveal comprehensive neuromuscular adaptations. 
Another limitation in the current study was the lack of observation at each training session.  
Participants were only observed for one training session per week and instructed to complete the 
remaining two training sessions on their own.  We controlled for this by having participants 
complete a weekly exercise log, which recorded the training protocol and all other additional 
physical activity performed by each participant.  Our assumption is that participants completed 
the weekly exercise log honestly, and completed all three training sessions per week.  In 
addition, our protocol did not include increases in resistance but were completed only with body 
weight.  The idea behind this decision was to choose exercises that could be prescribed as a 
home exercise program or in settings where supplies may be limited.  The 100% completion by 
all participants suggests that the current training protocol is a user friendly program.  
Clinical Application  
  Clinically, the results of this study demonstrate the importance of incorporating exercises 
bilaterally for the GM.  Clinicians should implement GM exercises bilaterally during isolated 
and dynamic exercises to achieve improved neuromuscular efficiency of the non-dominant 
(contralateral) side and facilitate improved pelvic stabilization.  Additionally, adaptations may 
not be limited to the GM when implementing a GM training protocol.  As seen with the current 
study, increased BF muscle activation suggests a greater feedforward response in preparation for 
landing.  Finally, the current training protocol demonstrates that it is challenging enough to 
achieve neuromuscular adaptations, as well as, an easy home exercise program for individuals 
complete on a regular basis.  
Conclusion  15 
 
Gluteus medius training is associated with a combination of improved neuromuscular efficiency 
and a greater feedforward response which suggest pelvic stabilization may be improved during a 
single-leg drop landing as a result of six weeks of GM training.  These observations are relevant 
because no training protocol to our knowledge focused on GM training has examined 
neuromuscular adaptations related to muscle activation of lower extremity muscles.  Future 
research is needed to evaluate how GM training may impact an injured population with regards 
to neuromuscular adaptations.  16 
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Table 1. Electrode Placement 
Muscle  Anatomical landmarks 
Gluteus medius  One third the distance from the iliac crest to the greater trochanter, 
starting from the greater trochanter.
33,34,37,39,49 
Transverse 
abdominis/Internal 
oblique 
Approximately 2 cm medial and inferior to the right anterior superior 
iliac spine.
50 
Vastus medialis  52 mm from the superior medial side of the patella along a line medially 
oriented at an angle of 50° with respect to the anterior superior iliac 
spine.
34-49 
Biceps femoris  One third the distance from the ischial tuberosity to the lateral side of 
the popliteus cavity, starting from the ischial tuberosity.
34,49 
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Table 2. Maximal Voluntary Isometric Contraction Testing 
Muscle  Procedure 
Gluteus medius  Performed in the side-lying position, with the hip in neutral rotation 
and slightly extended and then actively abducted to end range while 
resistance is applied just above the ankle.
51  
 
Internal Oblique/   Supine lying position with knees bent to 90° and hips flexed at 45°.  
Participant will tilt pelvis posterior to flatten low back on the table.
51  
 
Transverse abdominis 
Vastus medialis  Performed in a seated position, with the knee flexed between 45° to 60° 
while resistance is applied just above the ankle.
51  
 
Biceps femoris  Performed in a prone position, with the knee between 50° to 70° of 
flexion.  The thigh and lower leg are both placed into slight lateral 
rotation.  Pressure is applied against the leg, proximal to the ankle in 
the direction of knee extension.
51  
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Table 3. Gluteus Medius Training Protocol 
Exercise  Week 1  Week 2  Week 3  Week 4  Week 5  Week 6 
1. Wall squat  1x10  1x15  1x15  2x10  2x15  3x15 
2. Forward step-up  10  15  15  2x10  2x15  3x15 
3.SL hip abduction  10  15  15  2x10  2x15  3x15 
4. Wall press  20s  30s  30s  2x20s   2x30s   3x20s  
5. Single-leg deadlift  5  8  8  2x5  2x8  3x8 
6. Single-leg squat  -  5  8  2x5  2x8  3x8 
7. Sideways hop  -  -  8  12  2x8  2x12 
Abbreviations: SL indicates side lying 
aAll exercises, sets, and repetitions were performed bilaterally. 
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Table 4. Post-control period normalized muscle activation   
Pre-Mean Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  17.10±11.72  12.66±7.50  2.775  .114 
Dominant GM  61.82±83.78  36.82±38.02  3.680  .072 
Dominant TrA  103.70±96.84  85.61±98.17  .700  .414 
Dominant VM  27.95±14.20  22.16±9.60  1.741  .206 
Non-dominant BF  56.39±39.84  49.67±31.78  2.021  .173 
Non-dominant GM  45.19±47.32  49.87±39.52  .200  .660 
Non-dominant TrA  64.21±116.78  58.14±73.43  .182  .675 
Non-dominant VM  18.49±9.21  55.19±165.90  .882  .361 
         
Pre-Peak Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  41.96±26.79  32.20±21.55  4.285  .054 
Dominant GM  159.85±230.65  86.87±75.61  2.98  .102 
Dominant TrA  275.85±280.07  215.60±270.54  1.304  .269 
Dominant VM  86.02±43.32  67.10±33.96  1.734  .206 
Non-dominant BF  100.19±68.22  82.74±49.84  3.139  .094 
Non-dominant GM  128.38±155.73  128.74±121.33  .000  .992 
Non-dominant TrA  214.38±397.25  215.91±280.88  .001  .981 
Non-dominant VM  31.43±13.97  96.03±294.05  .889  .359 
         
Post-Mean Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  86.86±55.58  95.74±136.16  .154  .699 
Dominant GM  114.16±120.32  87.87±65.03  1.362  .259 
Dominant TrA  226.61±225.83  201.04±202.22  .293  .595 
Dominant VM  120.54±85.72  142.08±153.06  .255  .620 
Non-dominant BF  22.76±21.41  16.39±10.27  2.123  .163 
Non-dominant GM  87.25±79.63  92.17±77.85  .044  .837 
Non-dominant TrA  215.72±309.10  222.50±206.03  .012  .916 
Non-dominant VM  42.65±26.50  73.20±147.93  .707  .412 
         
Post-Peak Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  165.30±125.39  178.54±275.74  .077  .785 
Dominant GM  222.24±258.89  168.53±129.82  .975  .337 
Dominant TrA  428.76±431.69  364.80±370.26  .523  .480 
Dominant VM  230.88±201.63  273.51±351.21  .180  .677 
Non-dominant BF  51.57±58.18  34.49±25.34  1.707  .209 
Non-dominant GM  177.92±167.82  190.24±191.48  .052  .822 
Non-dominant TrA  388.33±563.85  405.13±390.36  .023  .881 
Non-dominant VM  83.76±52.00  160.61±348.98  .851  .369 
Abbreviations: DC1 indicates data collection session 1; DC2 indicates data collection session 2. 
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Table 5. Muscle Activation data pre-landing following training (%) 
  Pre-Mean Muscle Activation  Pre-Peak Muscle Activation 
Muscle  DC2  DC3  DC2  DC3 
Dominant BF
  12.66±7.50  19.35±15.77
b  32.20±21.55  63.10±80.17 
Dominant GM  36.82±38.02  37.55±31.85  86.87±75.61  95.89±90.55 
Dominant TrA  85.61±98.17  103.04±101.74  215.60±270.54  264.77±283.44 
Dominant VM  22.16±9.60  22.11±10.55  67.10±33.96  72.09±35.47 
Non-dominant BF  49.67±31.78  52.99±31.99  82.74±49.84  96.93±74.28 
Non-dominant GM  49.87±39.52  26.93±21.92
c  128.74±121.33  66.80±55.54
d 
Non-dominant TrA  58.14±73.43  78.87±111.14  215.91±280.88  290.43±362.71 
Non-dominant VM  55.19±165.90  17.96±9.56  96.03±294.05  31.50±20.99 
Abbreviations: DC2 indicates data collection session 2; DC3 indicates data collection session 3. 
aValues are presented as means and standard deviations of muscle activation (%). 
bSignificant increase in pre-mean muscle activation pre-landing following training. 
cSignificant decrease in pre-mean muscle activation pre-landing following training. 
dSignificant decrease in pre-peak muscle activation pre-landing following training. 
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Table 6. Muscle Activation data post-landing following training (%) 
  Post-Mean Muscle Activation  Post-Peak Muscle Activation 
Muscle  DC2  DC3  DC2  DC3 
Dominant BF
  95.74±136.16  131.88±167.85  178.54±275.74  292.27±432.99 
Dominant GM  87.87±65.03  89.72±67.78  168.53±129.82  181.33±159.36 
Dominant TrA  201.04±202.22  270.19±336.46  364.80±370.26  567.74±942.08 
Dominant VM  142.08±153.06  113.41±54.41  273.51±351.21  205.35±108.43 
Non-dominant BF  16.39±10.27  17.78±13.74  34.49±25.34  47.99±63.97 
Non-dominant GM  92.17±77.85  53.13±30.27
b  190.24±191.48  101.46±63.50
c 
Non-dominant TrA  222.50±206.03  285.67±283.38  405.13±390.36  470.74±447.15 
Non-dominant VM  73.20±147.93  49.33±27.61  160.61±348.98  101.21±63.18 
Abbreviations: DC2 indicates data collection session 2; DC3 indicates data collection session 3. 
aValues are presented as means and standard deviations of muscle activation (%). 
bSignificant decrease in post-mean muscle activation post-landing following training. 
cSignificant decrease in post-mean muscle activation post-landing following training. 
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Figure 1. Timeline of Study 
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Figure 2. Wall Squat 
The wall squat was performed by having the participant stand with their back against the wall 
while maintaining a single limb stance.  The non-weight bearing leg was placed into full knee 
extension and the hip was flexed so that the foot was not touching the ground.  The participant 
was then instructed to perform a single-leg squat as far as possible or until their thigh was 
parallel to the ground.   
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Figure 3. Forward Step Up 
During the forward step-up the participant placed the weight bearing foot on a step while 
keeping the knee of the non-weight bearing foot in extension.  Participants were allowed to 
lightly touch, but not hold, a wall to remain upright and balanced throughout the procedure. 
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Figure 4. Side-Lying Hip Abduction 
Side-lying hip abduction was performed in a side-lying position with full knee extension and 
neutral hip position.  The hip was slowly abducted while keeping the knee in extension and then 
slowly returned to the starting position.   
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Figure 5. Wall Press 
To perform the wall press participants were position standing next to a wall with the weight 
bearing limb located furthest from the wall.  The non-weight bearing limb was placed in hip and 
knee flexion.  The participants were instructed to maintain this position while isometrically 
pushing their non-weight bearing leg, knee, and ankle against the wall.  
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Figure 6. Single-Leg Deadlift 
The Single-leg deadlift was performed by starting in a single-leg stance.  The participant slowly 
flexed their hip and trunk and touched their contralateral middle finger to the ground beside their 
support foot, and returned to the starting position.  
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Figure 7. Single-Leg Squat 
To perform the single-leg squat participants maintained a single leg stance while squatting down 
as far as possible or until their thigh was parallel with the ground and return to a single-leg 
stance. 
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Figure 8. Sideways Hop (starting and landing position) 
The sideways hop was performed by starting in a standing position with hand on hips.  
Participants then performed a lateral hop landing in a single-leg stance on the opposite foot they 
jumped off, and repeated this maneuver in the opposite direction.  Participants were instructed to 
land "as softly as possible," with their knees flexed. 
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Figure 9. Increase in Muscle Activation of the left BF.  
aIndicates increased mean muscle 
activation of the BF prior to landing after GM training.   
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Figure 10. Decreases in Muscle Activation of the GM.  
aIndicates decreased mean muscle 
activation of the GM pre-landing after GM training.  
bIndicates decreased peak muscle activation 
of the GM pre-landing after GM training.  
cIndicates decreased mean muscle activation of the 
GM post-landing after GM training.  
dIndicates decreased peak muscle activation of the GM 
post-landing after GM training.  
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CHAPTER 1 
 
INTRODUCTION 
  Injuries to the lower extremities are common in athletics due to the external forces that 
are imposed on the body from  anatomical, biomechanical, and environmental factors.
1  Ankle 
sprains are among the most common lower extremity injuries in both athletics and daily life.
2-6  
Whereas, patellofemoral pain syndrome (PPS) is among the most common causes of knee pain, 
with reported incidence rates among athletes greater than 25%.
7,8  Another knee injury with a 
relatively high incidence rate are ACL injuries, with a reported 38,000 ACL injuries occurring in 
girls and women's athletics in the United States annually.
9  Hip muscle weakness is one deficit 
observed that may contribute to lower extremity injury.
10  A weak or dysfunctional gluteus 
medius (GM)  has been linked to a number of lower extremity injuries, which include PPS,
8,11-13 
iliotibial band friction syndrome,
14 anterior cruciate ligament (ACL) injuries,
9 and chronic ankle 
instability.
4,5 Identifying the risk factors for these lower extremity injuries has become a subject 
of increased interest.
1,4,5,8-11,14-22 
  Trunk muscle function has been reported to influence structures from the low back to the 
ankle.
23  For this reason, balance training or multifaceted training programs targeted toward 
trunk stability are thought to influence injury prevention and rehabilitation.
24-26  Improved trunk 
stability may increase force production through co-contraction of major abdominal muscles, 
which has been shown to improve stability of the spine.
27  The stability of the spine is a result of 
trunk stability and the appropriate combination and intensity of muscle activation which 40 
 
generates intra-abdominal pressure.
27  Hodges and Richardson
28 observed trunk muscle 
activation in preparation to movement of the body, which is thought to stiffen the spine, increase 
intra-abdominal pressure, and provide a foundation for functional movements.  In addition, 
anticipatory feed-forward activation of abdominal muscles is thought to play a major role in 
trunk stability and lower extremity function.
29  This theory is supported by the central nervous 
system, which creates a stable foundation for movement of the lower extremities through co-
contraction of the transversus abdominis and multifidus muscles.
28  This suggests that 
anticipatory feed-forward activation of the trunk muscles is required in preparation for 
movement to maintain spinal stability.
28,29  Hip musculature also influences how forces are 
transferred from the lower extremity towards the spine.
8  The GM is used to correct posture and 
keep an individual balanced.
2  A lack of muscle activation in hip musculature may delay muscle 
activation lower in the kinetic chain.
5  In contrast, abnormalities within the lower extremity may 
cause forces to be transmitted abnormally up the kinetic chain to the spine.
30  Injury to any one 
of the joints or corresponding structures along the kinetic chain can result in a loss of 
feedback.
4,15,31  Beckman and Buchanan
5 observed a delayed onset of the GM after an ankle 
sprain.  Delayed hip muscle activation latency may predispose individuals to lower extremity 
positions frequently associated with non-contact injuries during functional activities.
23  
Therefore, clinicians may need to address delayed muscle activation further up the kinetic chain 
to prevent future injuries during a lower extremity rehabilitation program.   
  Current recommendations for rehabilitating a sprained ankle include strength and 
proprioception training at the ankle joint.
3,32 Studies have examined the integration of strength 
and proprioception training at the ankle joint following injury to the lower extremity.
6,33,34  It is 
unknown whether neuromuscular or strength deficits were present distal or proximal to the injury 41 
 
site before the injury.  More recent studies have examined the effects that trunk stability and hip 
training exercises have on dynamic balance and postural control.
2,35  Kahle and Gribble
35 
concluded that participation in a trunk stability training program leads to an improvement in 
dynamic postural control.  While Leavy et al.
2 suggested that GM strengthening may improve 
dynamic balance more than proprioceptive training alone.  One method used to assess dynamic 
postural control during rehabilitation is the Star Excursion Balance Test (SEBT).  The SEBT 
involves balancing on 1 leg and reaching maximally with the other leg in 8 different reach 
directions.
36  High levels of both intratester and intertester reliabilityhave been observed with  
the SEBT .
37 Although another study concluded the SEBT might not be an appropriate test of 
dynamic balance.
38  Therefore, it is important to include more dynamic measurements that reflect 
more typical movements that are normally performed during athletics.  A measure of postural 
control is center of pressure (COP).  Center of Pressure is the center of the distribution of the 
total force applied to the supporting surface.
39  Numerous studies have reviewed and examined 
the measurement of COP on dynamic postural control using force platforms.
39-43  Center of 
Pressure may prove to be a better assessment of balance deficits during a dynamic task.
  Previous studies have examined the effects that training the trunk
35, GM
2, and ankle 
proprioception
2,6,33,34 have on dynamic postural control.  All of these studies implemented the use 
of a single test to determine postural control, including the SEBT, single-plane balance board 
(SPBB), and COP.  The SEBT has not been validated for determining dynamic postural 
control.
38  Also, these studies did not assess electromyography (EMG) measurements to 
determine changes in muscle activation and its relation to enhancement of dynamic postural 
control.  Therefore, the purpose of this study is to examine the effects that GM training has on 42 
 
muscle activation and dynamic postural control using both SEBT and COP measurements in 
healthy participants. 
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Research Questions 
Pre-training Research Questions 
1.  Do the pre-control and post-control periods have similar lumbo-pelvic and lower extremity 
muscle activation prior to training? 
2.  Do the pre-control and post-control periods have similar COP excursion prior to training? 
Post-training Research Questions 
1.  Does 6 weeks of gluteus medius training alter lumbo-pelvic and lower extremity muscle 
activation? 
2.  Does 6 weeks of gluteus medius training decrease COP excursion? 
 
Hypotheses 
Pre-training  
1.  The control and training periods will have similar lumbo-pelvic and lower extremity muscle 
activation  prior to training. 
2.  The control and training periods will have similar center of pressure excursion prior to 
training. 
Post-training 
3.  Six weeks of gluteus medius training will increase muscle activation of lumbo-pelvic and 
lower extremity muscles. 
4.  Six weeks of gluteus medius training will decrease COP excursion. 
 
 
 44 
 
Operational Definitions 
Center of Pressure- Represents a weighted average of all the pressures over the surface area in 
contact with the ground.
38 
Center of Gravity- The point about which the mass of the system is evenly distributed, also 
referred to as center of mass.
44 
Static Balance- The process of maintaining the center of gravity within the body's base of 
support.
31  
Dynamic Balance- The ability to transfer the vertical projection of the center of gravity around a 
stationary supporting base.
31 
Postural Sway- Postural sway refers to changes in the center of gravity.
39 
Star Excursion Balance Test- The SEBT is a series of 8 unilateral balance tests that incorporate a 
single-leg stance of 1 leg with a maximum targeted reach of the free leg.
37 
Postural control- The task of controlling the body's position in space for the purposes of stability 
and orientation.
39 
Electromyography- Measurement of action potentials in muscle fibers.
44 
Stabilometry- Represents the method of using a force plate or other similar device to measure the 
displacement of an individual's COP.
38 
Force Platform-  A technical apparatus that provides an indirect assessment of changes in 
postural sway by recording the ground-reaction forces projected from the body.
39 
Maximal voluntary isometric contractions (MVIC)- The maximum output of a muscle or a group 
of muscles during a voluntary isometric contraction.  May be used as a standard reference of 
EMG activity expressed as a percent for statistical analysis.
44 45 
 
Normalization- The expression of an outcome measure relative to a factor that contributes to 
differences in the measure among individuals.
44 
Dominant Leg- Dominant leg will be referred to as the leg a participant stands on while kicking a 
ball.
45 
Proprioception- The special variation of the sense of touch that encompasses the sensation of 
joint movement, described as kinesthesia, and joint position.
32 
Physically Active- 30 minutes of cardio 3 times per week.
46 
 
Assumptions 
1.  Participants in the training group will complete the training protocol as prescribed. 
2.  Participants will fill out the weekly exercise log correctly and honestly. 
2.  Participants in the study will not begin any new exercise training protocol after the study has 
began. 
3.  Any changes observed in postural control or muscle activation will have occurred due to the 
intervention (training protocol) and not a confounding variable.  
 
Delimitations 
1.  Participants will have no history of cardiovascular, neurological, or childbirth/pregnancy 
within the past year. 
2.  Participants will have no history of abdominal, low back, or lower extremity injury within the 
past year. 
3.  Participants will have no restriction from physical activity or surgery within the past two 
years. 46 
 
4.  Participants will have no unresolved lower extremity pathologies or current pain in the spine, 
abdominal, or lower extremities. 
 
Limitations 
1.  Participants will not be observed for every training session over the 6 weeks. 
2.  The training protocol prescribed to the participants has not been validated in previous 
research. 
3.  The current study will be performed on healthy active individuals and may not be generalized 
to an injured athletic population.47 
 
 
 
 
CHAPTER 2 
 
LITERATURE REVIEW 
  A weak or dysfunctional GM is linked to a number of lower extremity injuries, which 
include patellofemoral pain syndrome,
8,11,12 iliotibial band friction syndrome,
14 anterior cruciate 
ligament (ACL) sprains,
9 and chronic ankle instability.
4,5  There has been a renewed interest in 
training of the trunk or trunk muscles to decrease the risk these injuries, improve rehabilitation, 
and improve athletic performance.
2,47,48  The trunk can be defined as the lumbo-pelvic hip 
complex, consisting of the lumbar spine, pelvis, and hip joints, and the active and passive tissues 
that produce or restrict motion of these segments.
23  The GM plays a major role within the trunk 
providing frontal plane stability for the entire pelvis during walking and other functional 
activities.
47  Therefore, developing rehabilitation and strengthening programs targeted 
specifically at the GM has become an area of increased interest. 
Table 1. 
Anatomy of the Thigh 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
Sartorius  Anterior superior 
iliac spine 
Proximal medial 
surface of the 
tibia, below the 
tuberosity 
Flexes the thigh 
and the leg and 
laterally rotates 
the thigh 
Femoral 
Rectus Femoris  Anterior inferior 
iliac spine and 
just above the 
acetabulum  
Tibial tuberosity  Extends the leg 
and flexes the 
thigh 
Femoral 48 
 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
Vastus Lateralis  Greater 
trochanter and 
lateral lip of the 
linea aspera of 
the femur 
Tibial tuberosity  Extends the leg  Femoral 
Vastus Medialis  Medial lip of the 
linea aspera of 
the femur 
Tibial tuberosity  Extends the leg  Femoral 
Vastus Intermedias  Anterior surface 
of the shaft of 
the femur 
Tibial tuberosity  Extends the leg  Femoral 
Biceps Femoris  Long head: 
Ischial tuberosity 
Short head: 
lateral lip of the 
linea aspera 
Lateral furface 
of the head of 
the fibula, and 
the lateral 
condyle of the 
tibia 
Flexes the leg, 
the long head 
extends the 
thigh 
Sciatic 
Semitendinosus  Ischial tuberosity  Medial surface 
of the proximal 
end of the tibia 
Flexes the leg 
and extends the 
thigh 
Tibial 
Semimembranosus  Ischial tuberosity  Medial surface 
of the proximal 
end of the tibia 
Flexes the leg 
and extends the 
thigh 
Tibial 
Adductor Magnus  Symphysis pubis 
and the pubic 
arch 
Medial surface 
of the tibia just 
below the 
condyle 
Adducts and 
laterally rotates 
the thigh 
Obturator 
Adductor Longus  Symphysis pubis 
and the pubic 
arch 
Medial surface 
of the tibia just 
below the 
condyle 
Adducts and 
laterally rotates 
the thigh 
Obturator 
Adductor Brevis  Symphysis pubis 
and the pubic 
arch 
Medial surface 
of the tibia just 
below the 
condyle 
Adducts the 
thigh and flexes 
the leg 
Obturator 
Pectineus  Symphysis pubis 
and the pubic 
arch 
Medial surface 
of the tibia just 
below the 
condyle 
Adducts the 
thigh and flexes 
the leg 
Obturator 
Gracilis  Symphysis pubis 
and the pubic 
arch 
Medial surface 
of the tibia just 
below the 
condyle 
Adducts the 
thigh and flexes 
the leg 
Obturator 
 49 
 
Table 2. 
Anatomy of the Hip 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
Gluteus Medius  Outer surface of 
the ilium 
between the 
posterior and 
anterior gluteal 
lines 
Lateral surface 
of the greater 
trochanter of the 
femur 
Abducts and 
medially rotates 
the thigh 
Superior 
gluteal 
Gluteus Maximus  Posterior gluteal 
line of the ilium 
and the posterior 
surface of the 
sacrum and the 
coccyx 
Gluteal 
tuberosity of the 
femur 
Extends and 
laterally rotates 
the thigh 
Inferior 
gluteal 
Gluteus Minimus  Outer surface of 
the ilium 
between the 
anterior and the 
inferior gluteal 
lines 
Anterior surface 
of the greater 
trochanter of the 
femur 
Abducts and 
medially rotates 
the thigh 
Superior 
gluteal 
Psoas major and 
minor 
Transverse 
processes and 
bodies of the last 
thoracic and all 
of the lumbar 
vertebrae 
Lesser trochanter 
of the femur 
Flexes the thigh 
and the trunk on 
the femur 
Femoral and 
first lumbar 
Tensor Fasciae Latae  Anterior portion 
of the iliac crest 
and the anterior 
superior iliac 
spine 
Iliotibial band of 
the fasciae latae 
Tenses the 
fascia lata and 
assists in 
flexion, 
abduction, and 
medial rotation 
of the thigh 
Superior 
gluteal 
Piriformis  Anterior surface 
of the sacrum 
Superior border 
of the greater 
trochanter of the 
femur 
Rotates the 
thigh laterally 
and assists in 
extending and 
abducting the 
thigh 
Second 
sacral 
Superior Gemellus  Ischial spine  Greater 
trochanter of the 
femur 
Rotates the 
thigh laterally 
Fifth lumbar 
and first and 
second sacral 50 
 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
Inferior Gemellus  Ischial tuberosity  Greater 
trochanter of the 
femur 
Rotates the 
thigh laterally 
Fourth and 
fifth lumbar 
and first 
sacral 
Obturator Internus  Inner surface of 
the obturator 
membrane and 
the bony margins 
of the obturator 
foramen 
Greater 
trochanter of the 
femur 
Rotates the 
thigh laterally 
Fifth lumbar 
and first and 
second sacral 
Obturator Externus  Outer surface of 
the obturator 
membrane and 
the bony margins 
of the obturator 
foramen 
Trochanteric 
fossa of the 
femur 
Rotates the 
thigh laterally 
Obturator 
Quadratus Femoris  Ischial tuberosity  Shaft of the 
femur just below 
the greater 
trochanter 
Rotates the 
thigh laterally 
Fourth and 
fifth lumbar 
 
  The large, superficial muscles of the hip are suited to resist three-dimensional moments 
that are applied to the trunk during functional activity.  Located on the lateral side, the gluteal 
muscles perform many important functions related to trunk stability.  The gluteus maximus is an 
important muscle of the hip functioning in both the sagittal and transverse planes.  The role of 
the gluteus maximus is to stabilize the pelvis during trunk rotation or when the center of gravity 
is grossly shifted.
1  For this reason, the gluteus maximus is important in transferring forces from 
the lower extremities to the trunk.
23  The GM and gluteus minimus function in the frontal and 
transverse planes of motion.  During open chain movements both the GM and gluteus minimus 
work to abduct the hip.  However, during closed chain movements both muscles are the primary 
lateral stabilizers of the hip.
23  A study performed by Dostal et al.
50 determined that the GM 
muscle is in the best position for abduction during 0-40° degrees of hip flexion, but as hip 
flexion increases it loses its efficacy for abduction.  At 90° of hip flexion all portions of both the 51 
 
GM and gluteus minimus become either primary or secondary internal rotators.  In contrast, the 
tensor fasciae latae and the piriformis muscles maintain their action of abduction throughout the 
range of hip flexion.  The authors also noted that the deep external rotators, similar to the 
abducts, are in the best position to perform their action in 0-40° of hip flexion.  Beyond the point 
of 40° of hip flexion the external rotators become hip abductors.  Muscles located on the medial 
side of the hip are also important for hip movement, and these muscles include the adductor 
magnus, adductor longus, adductor brevis, and pectineus.  However, these muscles may not be as 
important to trunk stability as their lateral counterparts.  The reasoning behind this is that greater 
positions of femoral adduction place greater demands on lateral trunk muscles to maintain 
alignment in the frontal plane.
23  The study performed by Dostal et al.
50 reinforces this point in 
supporting the use of extension and abduction as the positions of maximum stability. 
Table 3. 
Anatomy of the Trunk 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
Rectus Abdominis  Pubic crest  Xiphoid process 
and the costal 
cartilages of the 
fifth through the 
seventh ribs 
Compresses the 
abdominopelvic 
cavity; flexes the 
vertebral column 
Intercostals 
Transverse 
Abdominis 
Inguinal 
ligaments, the 
iliac crest, the 
lumbodorsal 
fascia, and the 
costal cartilages 
of the last six 
ribs 
Linea alba and 
the pubic crest 
Compresses the 
abdominopelvic 
cavity 
Intercostals, 
iliohyposgast
ric and 
ilioinguinal 
Internal Oblique  Inguinal 
ligamnet, the 
iliac crest, and 
the lumbodorsal 
fascia 
Linea alba, the 
pubic crest, and 
the lower four 
ribs 
Compresses the 
abdominopelvic 
cavity; assists in 
flexion and 
rotation the 
vertebral column 
Intercostals, 
iliohypogastr
ic, and 
ilioinguinal 52 
 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
External Oblique  External surface 
of the lower 
eight ribs 
Linea alba and 
the anterior half 
of the iliac crest 
Compresses the 
abdominopelvic 
cavity; assists in 
flexing and 
rotating the 
vertebral column 
Intercostals, 
iliohypogastr
ic, and 
ilioinguinal 
Quadratus 
Lumborum 
Iliac crest, and 
the iliolumbar 
ligament 
Lower border of 
the twelfth ribs; 
the transverse 
processes of the 
upper lumbar 
vertebrae 
Pulls the thoracic 
cage toward the 
pelvis; abducts 
the vertebral 
column toward 
the side that is 
being contracted 
Twelfth 
thoracic and 
first lumbar 
Iliocostalis  Crest of the 
sacrum; spinous 
processes of the 
lumbar and 
lower thoracic 
vertebrae; iliac 
crests; angels of 
the ribs 
Angles of the 
ribs; transverse 
processes of the 
cervical 
vertebrae 
Extends the 
vertebral column 
and bends it to 
one side 
Branches of 
the spinal 
nerves 
Longissimus  Transverse 
processes of the 
lumbar, thoracic, 
and lower 
cervical 
vertebrae 
Transverse 
processes of the 
vertebra above 
the vertebra of 
origin, and the 
mastoid process 
of the temporal 
bone 
Extends the 
vertebral column 
Branches of 
the spinal 
nerves 
Spinalis  Spinous process 
of the upper 
lumbar, lower 
thoracic, and 
seventh cercial 
vertebrae 
Spinous 
processes of the 
upper thoracic 
and cervical 
vertebrae 
Extends the 
vertebral column 
Branches of 
the spinal 
nerves 
Multifidus  Posterior surface 
of the sacrum 
and the ilium, 
and the 
transverse 
processes of the 
lumbar, thoracic, 
and lower 
cervical 
vertebrae 
Spinous 
processes of the 
lumbar, thoracic, 
and cervical 
vertebrae 
Extends the 
vertebral 
column; rotates it 
toward the 
opposite side 
Branches of 
the spinal 
nerves 53 
 
Muscle  Origin
49  Insertion
49  Action
49  Innervation
49 
Interspinales  Superior surface 
of all the spinous 
processes 
Inferior surface 
of the spinous 
process of the 
vertebra above 
the vertebra of 
origin 
Extends the 
vertebral column 
Branches of 
the spinal 
nerves 
 
  Possible movements of the vertebral column include flexion and extension in the sagittal 
plane, lateral flexion in the frontal plane, and axial rotation in the transverse plane.  The trunk 
muscles with the largest moment arms are the most capable of stabilizing the vertebral column 
and include the erector spinae, quadratus lumborum, and the rectus abdominis.
25  These muscles 
align parallel to one another allowing for the generation of large compressive forces, which act to 
stiffen the spinal column during co-contraction.
25 
  Muscles of the abdominal wall that function in the sagittal plane include the rectus 
abdominis and transverse abdominis.  Acting alone these anterior trunk muscles produce 
movement in trunk flexion, however, when co-contraction of muscles on the anterior and 
posterior aspect of the trunk occurs they generate an increase in intra-abdominal pressure which 
generates greater trunk stiffness.
23,25  Anterior trunk musculature working in the transverse plane 
include the internal and external oblique muscles, which are primarily involved in trunk rotation.  
However, when these muscles are contracted bilaterally in combination with their antagonist 
they contribute to sagittal plane moment and increase intra-abdominal pressure.
23  Similarly, 
unilateral activation of the quadratus lumborum elevates the ipsilateral pelvis, while co-
contraction bilaterally stiffens the lumbar spine.
23 
  Muscles that form the posterior aspect of the trunk consist of superficial muscles known 
as the erector spinae.  The erector spinae are a group of paired muscles that consist of three 54 
 
columns: the longissimus group, the iliocostalis group, and the spinalis group.  Collectively, the 
erector spinae muscles extend the spine.  As mentioned previously, co-contraction of these 
muscles with anterior trunk muscles increases intra-abdominal pressure.
23  Similarly, the 
multifidus assists the transversus abdominis to increase spinal stiffness and intra-abdominal 
pressure.
23 
  Generation of intra-abdominal pressure through co-contraction of all major abdominal 
muscles has shown to improve stability of the spine.
27,51  However, there may be more evidence 
that the transversus abdominis is more important for controlling spinal stability.  A study 
performed by Hodges and Richardson
28 suggested that the transversus abdominis is the first 
muscle active during the performance of hip movement, followed closely by the multifidus, and 
neither muscle is influenced by the direction of lower limb movement.  The feed-forward 
activation of these muscles has been suggested to contribute to the enhancement of spinal 
stability before the movement of a lower limb.
29  However, without co-contraction of both the 
transversus abdominis and the multifidus an increase of intra-abdominal pressure and spinal 
stiffness may not occur.  For this reason, it is appropriate to say that no single muscle may be 
referred to as being the most important muscle regarding trunk stability.  In other words, trunk 
stability is dependent upon the appropriate combination and intensity of muscle activation to 
generate intra-abdominal pressure. 
The Local and Global Systems 
  One approach at defining mechanical modeling of the spinal system is identifying local 
and global systems within the trunk.  Bergmark
52 describes and defines the role of both the 
global and local systems of the spine from a mechanical engineering standpoint.  The global 
system consists of the muscles and the intra-abdominal pressure, which transfer a load directly 55 
 
between the thoracic cage and the pelvis.  The main role of the global system is to balance the 
outer load so that forces transferred to the lumbar spine can be handled by the local system.  
Whereas, the local system consists of all muscles which have their origin or insertion at the 
vertebrae, with the exception of the psoas.  Therefore, the local system is dependent on the 
magnitude of the outer load and the posture of the lumbar spine.  Bergmark
52 further 
hypothesizes the complexity in communication between these two systems stating that at any 
level of activation of the smaller, intrinsic muscles, there is an upper limit to the possible 
activation level of large, superficial muscles.  Beyond this upper limit the spine buckles causing 
instability either in the direction of flexion-extension (sagittal instability) or a combination of 
lateral bending and axial rotation (lateral-rotation instability).  The only way to ensure sagittal 
stability appears to be that muscle stiffness is high enough to overcome forces produced against 
it.  Whereas, lateral-rotational stability is maintained if forces in the global system are high 
enough. 
  The hypothesis made by Bergmark
52 about the relationship between small, intrinsic 
muscles and large, torque producing muscles was further tested by Natasa et al.
51 during trunk 
rehabilitation exercises.  Natasa et al.
51 reported that the larger, more global muscles are better 
able to alter spine stability than the smaller, intrinsic muscles.  However, the smaller, intrinsic 
muscles did demonstrate a particular mechanical advantage which appeared to come from their 
ability to generate force to spinal stiffness.  In conclusion, the study by Natasa et al.
51 supported 
the Bergmark's hypothesis by reporting that the smaller muscles have a stabilizing role through 
their efficient generation of force, however, as loads increase the need for the stronger global 
muscles is required. 
 56 
 
Central Nervous System 
Mechanoreceptors (Muscle Spindles, tendon organ, joint receptors) 
  The body needs two types of information in order to control movement; it needs to know 
where it is and when it is disturbed by something that happens in its surroundings.  This 
information is provided by sensory receptors which include muscle spindles, tendon organs, and 
joint receptors.
44 
Muscles spindles are fusiform shaped and are arranged parallel with skeletal muscle fibers.
53  
Each muscle spindle has several muscle fibers enclosed within a connective tissue capsule, and 
these smaller muscle fibers are referred to as intrafusal muscle fibers.  Whereas, fibers located 
outside the muscle are referred to as extrafusal fibers.
44  Each muscle spindle has an afferent 
supply in which sensory information is transmitted back to the CNS regarding stimuli that have 
been detected in the surroundings.  However, only the intrafusal fibers of the muscle spindle 
receive an efferent input.  Efferent neurons transmit an output signal or action potential from the 
CNS to a muscle.  Muscle spindles provide information on changes in muscle length in two 
ways.  The first way is for intrafusal muscle fibers to contract and stretch where afferent endings 
are located and the second way is activated by passive stretch of the entire muscle.
53  
  Golgi tendon organs are located with the collagenous fibers of the tendon and the muscle 
fibers to which they are attached.
53  The Golgi tendon organ contains a single afferent connection 
referred to as the Group Ib afferent and no efferent connections.
44  When a muscle is stretched 
either passively or actively, the strands of collagen pinch and excite the Group Ib afferent.  For 
this reason, Golgi tendon organs are ideally suited to encode the forces developed by contracting 
muscle fibers.  However, compared to muscle spindles, Golgi tendon organs are poor at 
identifying changes in muscle length.
53  Therefore these endings do not respond to the 57 
 
longitudinal strains associated with passive joint rotation, but can respond to compressive forces 
applied directly within the musculotendinous junction.
53  Ultimately, Golgi tendon organs are 
designed as a protective mechanism to relax a muscle that is being overstretched.  When a Golgi 
tendon organ senses tension within a muscle it transmits the information to the CNS, and through 
polysynaptic reflexes inhibits the motor neurons of the contracting muscle.
31 
  Bilateral coordination between both legs is necessary to keep the body center of gravity 
over the feet.
54  This bilateral coordination may be provided by a combination of afferent input 
from a number of different joint receptors, muscles, and tendons.
54  It has been suggested that 
mechanoreceptors in joint capsules and ligaments contribute to normal coordination of muscle 
activity in movements and posture.
55  Dyhare-Poulsen and Krogsgaard
55 demonstrated that 
stimulation of the afferent nerve fibers in the human ACL induced changes in the hamstrings and 
quadriceps muscles.  Thus, mechanoreceptor reflexes may contribute to the regulation of muscle 
stiffness and joint stability.  It has also been suggested that impulses from joint receptors can 
influence tension regulation from Golgi tendon organs
56 and muscle spindle afferents.
57  It has 
been proposed  that sensory input from joint afferents plays an important role in the updating and 
formation of motor programs that instruct the CNS to preactivate muscles to protect the knee or 
local joint during the next step.
57    
Feed-Forward 
  Feed-forward mechanisms are preplanned motor programs.
25  Researchers have 
suggested that the CNS initiates contraction of the abdominal muscles in a feed-forward manner 
in advance of the prime mover of the lower limb.
28  Hodges and Richardson
28 observed the 
transversus abdominis was the first muscle to activate during movement of a lower limb 
following contralateral weight shifting.  Other abdominal muscles besides the transversus 58 
 
abdominis were recorded to have feed-forward activation for movement in each direction.  The 
lumbar multifidus (a trunk extensor) has an earlier contraction during hip flexion than hip 
extension, and the rectus abdominis has faster activation with hip extension than with hip 
flexion.
28  These findings are consistent with the need to control trunk movement and maintain 
the position of the center of mass within the base of support.
28  Therefore, anticipatory feed-
forward activation of the trunk muscles is required in preparation for movement. 
Feedback 
  Sensory receptors act to provide information to a system on its own state and the state of 
its surroundings.  This type of communication between sensory receptors and the CNS is referred 
to as feedback.  Feedback mechanisms are utilized to fine tune motor programs as skills are 
performed with greater efficiency over time.
25    Sensory feedback is crucial to stimulate specific 
neural recruitment patterns of the trunk muscles to meet task demands.
25  The specific neural 
recruitment patterns of trunk musculature can change instantly.
25  It is important to develop a 
training program that will introduce athletes to a wide variety of postures and external forces 
encountered during sports participation. 
Hip Strength Deficits 
  Hip muscles play a significant role in transferring forces from the lower extremity 
towards the spine during functional activities.  Recent researchers have suggested weaknesses or 
deficits in hip strength can attribute to lower extremity injury.
1,10,58  Nadler et al.
1 reported that 
female athletes with previous lower extremity injuries or low back pain were found to have 
differences in hip extension strength when compared bilaterally.  Whereas, male athletes did not 
significantly differ in hip extension strength deficits regardless of reported lower extremity injury 
or low back pain.  The authors concluded that it is possible that females may be more prone to 59 
 
changes in relative side-to-side hip strength due to various factors which include anatomy, gait 
differences, and playing style.  A study performed by Leetun et al.
10 demonstrated that athletes 
who sustained a lower extremity injury displayed significantly less hip abduction and external 
rotation strength than uninjured athletes.  It was suggested that hip and trunk weakness reduces 
hip and trunk stability, especially those forces in the transverse and frontal planes.
10  As a result, 
excessive motion in the hip or trunk may predispose an athlete to lower extremity positions 
frequently associated with noncontact injuries.  Additionally, it's been demonstrated that 
weakness in the hip abductors potentially causes chronic injuries such as Illiotibial band 
syndrome (ITBS).
14 
Hip Muscle Activation 
  Traditionally, examination of injuries have focused directly at the injury site or distal to 
the injury site, with no regards to any proximal pathology.  However, considering the closed 
kinetic chain nature of the functional activities involved with athletics it is appropriate to 
consider proximal joint mechanics.  When the distal end of a segment is relatively fixed, motion 
at those segments will influence all other  proximal segments in the chain.
10  For example, 
stability of the hip and hip strength are important for proper gait mechanics and foot position 
during the heel strike phase of the gait.
4  For this reason,  postural stability and muscle 
recruitment patterns at the hip and ankle may be altered after ankle injury.
5,15  Bullock-Saxton et 
al.
15 examined individuals with previous severe unilateral ankle sprains and reported that they 
exhibited a delay in the onset of firing patterns in the ipsilateral and contralateral gluteus 
maximus.  Beckman and Buchanan
5 observed gluteal activation during right or left ankle 
inversion in persons with ankle hypermobility.  What the authors observed was that individuals 60 
 
with ankle hypermobility recruited hip muscles prematurely in response to right or left ankle 
inversion when compared to individuals with symmetrical ankle mobility. 
  Multiple studies have looked at muscle activation during the sidelying hip abduction 
exercise.
2,14,59-61(Table 4)  
Table 4.  
Summary of GM Muscle-Activation During Rehabilitation Exercises (%MVIC) 
Exercise  Ayotte 
et al
62 
Bourdreau 
et al.
63 
Distefano 
et al.
59 
Krause 
et al.
64 
O’Sullivan 
et al.
65 
Ekstrom 
et al.
60 
Bolgla 
and 
Uhl
61 
Wall Squat  52±22        35±20~     
Mini Squat  36±17             
Forward 
Step-up 
44±17             
Lateral 
Step-up 
38±18          43±18   
Retro 
Step-up 
37±18             
Side-lying 
hip 
abduction 
    81±42      39±17  42±23 
Single-leg 
squat 
  30±9*  64±24  50±25       
Lunge    18±9           
Step-up 
and over 
  15±7           
Pelvic 
Drop 
        38±17~     
Lateral 
band walk 
    61±34         
Single-leg 
deadlift 
    58±25         
Sideways 
hop 
    57±35         
Wall Press          75±38~     
Side            74±30   61 
 
Exercise  Ayotte 
et al
62 
Bourdreau 
et al.
63 
Distefano 
et al.
59 
Krause 
et al.
64 
O’Sullivan 
et al.
65 
Ekstrom 
et al.
60 
Bolgla 
and 
Uhl
61 
Bridge 
Unilateral 
Bridge 
          47±24   
Quadruped 
arm/lower 
extremity 
lift 
          42±17   
Pelvic 
Drop 
            57±32 
Abbreviations: MVIC, maximal voluntary isometric muscle contraction; RVC, reference 
voluntary isometric muscle contraction. 
  *Measured in %RVC 
  ~Measurement only taken from the posterior gluteus medius 
 
Distenfano et al.
59 examined gluteal muscle activation during common therapeutic exercises, and 
observed that side-lying hip abduction exercise demonstrated high levels of GM activation.  Two 
more studies
60,61 examined side-lying hip abduction with similar results, and concluded that 
active hip abduction will allow for non-weight-bearing strengthening of the GM if additional 
resistance is applied to the lower extremity.  A more practical study performed by Fredericson et 
al.
14 implemented a rehabilitation program for runners with ITBS using the side-lying hip 
abduction exercise in combination with pelvic drops.  The authors observed that using the side-
lying hip abduction exercise was conducive enough to achieve a strength level equal to or greater 
than that of the noninjured limb.  Controversy, Bolga and Uhl
61 hypothesized that weight bearing 
exercises require greater EMG amplitudes of the hip abductors to stabilize the pelvis in the 
frontal plane and counterbalance external torque produced by the head, arms, trunk, and lower 
extremity than non-weight bearing exercises.  Another study has demonstrated that activation 
levels of the GM on a stance leg to have the greatest levels of EMG amplitude because it was 
acting to stabilize the pelvis, which provides support for the theory that the GM functions as a 62 
 
pelvic stabilizer versus mainly being described as an active abductor.
63  However, Boudreau et 
al.
63 concluded that weight bearing exercises required greater EMG amplitudes than all non-
weight bearing exercises except for side-lying hip abduction. 
  Another common therapeutic exercise that has been studied and used in rehabilitation of 
the GM is the single-limb squat or single-leg squat.
59,63,64  During a single-leg squat the base of 
support is shifted solely to the stance limb.  This unilateral weight bearing position requires the 
GM to stabilize the pelvis and lower extremity.  Krause et al.
64 reported that single leg squat 
exercise on an unstable surface elicited the greatest level of EMG activity and imposed greater 
demands on the GM.  However, the activation of the GM on the unstable surface was not 
statistically greater than EMG activity of the same exercise performed on a stable surface.  
Boudreau et al.
63 had similar results when comparing hip-muscle activation during the lunge, 
single-leg squat, and step-up-and-over exercises.  They reported that the highest muscle 
activation of the GM occurred during the single leg squat.  The study performed by Distefano et 
al.
59 also demonstrated higher levels of GM exercise during the single leg squat when compared 
to exercises requiring bilateral weight bearing such as the lunge.  The authors concluded that the 
reasoning for this is that exercises requiring single-limb balance and hip flexion/extension 
throughout a large range of motion with changes in the body's center of mass result in the 
greatest level of gluteal muscle activation.  Ayotte at el.
62 examined lower extremity muscles 
during 5 unilateral weight-bearing exercises, and also had similar findings supporting a wall 
squat and front step-up.  The authors determined that both the wall squat and the front step-up 
elicited sufficient mean GM EMG signal amplitude to provide an adequate strengthening 
stimulus. 63 
 
  Most studies evaluate the effect of exercises on the GM as one large muscle belly.
59-64  
However, some studies have shown significant differences between muscle activation of each 
GM subdivision.
65,66  O'Sullivan et al.
65 analyzed the three subdivisions of the GM during 
weight-bearing exercises.  The authors determined that a wall press produced the highest level of 
GM activation in the posterior subdivision compared to a wall squat and pelvic drop.  The 
authors also noted that the posterior subdivision was working closer to its maximum level than 
the anterior or middle subdivisions.  However, the authors state that electrode placement location 
for GM subdivisions is unknown, and further research is needed to verify their initial findings. 
Trunk Stability 
Trunk stability has become a popular topic in research across many professions.  
However, the definition of the term trunk stability often depends on individual perspective and is 
not always clear.  For the purpose of this study we will define trunk stability as the ability of the 
lumbopelvic-hip complex to prevent buckling of the vertebral column and return it to 
equilibrium following perturbation.
23  The muscles in the lumbopelvic-hip region must 
continually adapt to changing postures and loads based on movement from the extremities.  
Because of the constantly changing nature of trunk stability it is hard to designate one muscle as 
the most important stabilizing muscle.  Therefore, contributions from every muscle in the 
lumbopelvic-hip region must be able to adapt to increased or decreased demand throughout a 
task.  
Biomechanics 
Landing Strategies 
Researchers support a neuromuscular link between the hip and knee, suggesting that the 
hip abductors assist in controlling knee motion during the dynamic activities associated with 64 
 
sport.
19  More specifically, hip abductor strength may be beneficial to knee landing 
kinematics.
18,19  A study performed by Carcia et al.
18 found that hip-abductor fatigue influences 
frontal-plane tibiofemoral landing angle during the landing phase of a drop jump.  Landing in a 
valgus position of the tibiofemoral joint has been identified as a risk factor for ACL injury, and 
fatigued or weak hip abductors might influence this risk of injury.
18,19  Improving hip-muscle 
performance might help preserve normal landing kinematics, which may lead to decreased injury 
rate.  In contrast, landing kinematics related to the sagittal plane have different implications to 
reduce ACL loading.  In the sagittal plane it has been suggested that landing with increased 
planter-flexor, hip extensor, and hamstring muscle contraction demands may help to stabilize the 
knee joint and reduce ACL loading.
17 
  Findings suggest that because muscles dissipate more kinetic energy during a soft 
landing, that during a stiff landing remaining tissues such as the skeletal system absorb more 
energy and are exposed to greater stress.
67  Much of the research done on landing has 
concentrated on biomechanics and the implications of impact on lower extremity tissues.
17-20  In 
contrast, Devita and Skelly
67 examined the effect of landing stiffness on joint kinetics and 
energetics in the lower extremity.  The authors observed an increased muscular contribution 
during soft landings compared with stiff landings.  More specifically, an increase in the 
contribution of the ankle plantarflexors and decrease in hip and knee extensors as landing 
stiffness increased.  In contrast, during a soft landing, the ankle plantar flexors absorbed 12% 
less energy and knee extensors each absorbed around 50% more energy.   
  More recently, Shimokochi et al.
17 also examined ankle plantarflexor, knee extensor, and 
hip extensor moment during a drop landing.  The authors observed that landing with a slight 
anterior lean, as done in a soft landing, increases plantar-flexor moment and hip extensor 65 
 
moment while decreasing knee extensor moment.  Their findings differed slightly when 
compared to Devita and Skelly.
67  The differences in these findings may be explained by the type 
of landing each study used.  Devita and Skelly
67 used a standard drop landing on both feet, 
whereas, Shimokochi et al.
17 used a single-leg landing.   
Postural Control 
  Postural control can be defined as the task of controlling the body's position in space for 
the purposes of stability and orientation.
39  Sensory mechanisms detect any imbalance at a very 
early stage, and compensatory movements are made to control for activities.
68  Currently there 
are numerous ways to measure postural control, but because conflicting opinions exists on the 
most appropriate measurement it is a controversial topic in the literature.  The various parameters 
for measuring postural control include mean sway amplitude, maximum sway amplitude, 
minimum sway amplitude, peak-to-peak amplitude, sway path, sway velocity, root-mean-square 
amplitude, and root-mean-square velocity.    Palmieri et al.
39 recently examined center of 
pressure (COP) parameters used in the assessment of postural control.  Maximum amplitude 
refers to the maximum absolute displacement of the COP from its mean, whereas, minimum 
amplitude is the minimum displacement of the COP from its average point.
39  These 
measurements of postural control are likely to show a high variance between trials because of the 
high variability between maximum and minimum values.  Peak-to-peak amplitude represents the 
difference between the maximum and minimum amplitudes of COP.
42  Similar to maximum and 
minimum amplitude values, peak-to-peak amplitude is likely to cause a misinterpretation of 
alterations in balance.
39  A more representative measurement of postural control is mean 
amplitude, which is an average value of all data points collected in a trial.
39  While mean 66 
 
amplitude has demonstrated to be reliable during a double-legged stance between trials
69 it has 
been shown to fluctuate with differing degrees of stance width, stance length, and foot angle.
40 
  Three more parameters examined by Palmieri et al.
39 include sway path or total 
excursion, COP velocity, and root-mean-square amplitude and velocity.  Sway path of the COP 
is defined as the total distance traveled by the COP over the course of the trial duration, whereas, 
COP velocity represents the total distance traveled by the COP over time.
39  Palmieri et al.
39 
determined that the information that is provided by the sway path  and COP velocity is 
inadequate to explain the complete nature of postural control.  Root mean-square amplitude can 
be defined as the distribution of COP displacements over time, and it represents the standard 
deviation of the displacement of the COP.
39,42  It has been suggested that root-mean-square 
amplitude and velocity are reliable measures to evaluate postural control.
42 
Instrumentation 
 Star Excursion Balance Test 
   The Star Excursion Balance Test (SEBT) is a multidirectional test of dynamic postural 
control, strength, range of motion, and proprioceptive abilities that involves balancing on 1 leg 
and reaching maximally with the other leg in 8 different directions (3 anterior, 2 lateral, and 3 
posterior).  The SEBT has been shown to have strong intratester and intertester reliability.
37,38  
However, a possible limitation of the SEBT is the practical application, which consists of 6 
practice and 3 test trials each of 8 different directions.  This recommended SEBT protocol can be 
very time-consuming for clinicians to administer.  Therefore, recent research has examined the 
support for a reduction in the number of trials involved in the SEBT.
36,70  This research has 
supported the reduction of trials administered during the SEBT from 8 to 3 (anteromedial, 
medial, posteromedial) and practice trials from 6 to 4 without affecting the validity of the test. 67 
 
Electromyography 
  EMG measurements are made with probes known as electrodes, which measure a change 
in voltage associated with action potentials.  EMG electrodes can be placed on the skin over a 
muscle (surface EMG), under the skin but over the muscle (subcutaneous EMG), or in the 
muscle between outside muscle cells (intramuscular EMG).  In addition EMG electrodes may be 
done with either a pair of electrodes (bipolar) or with a single electrode (monopolar).  When 
using a bipolar arrangement of electrodes the greatest amplitude is recorded when the 
interelectrode distance is relatively large and electrodes are placed on the same side of the 
innervation zone.
71  The innervation zone is known as the area of a muscle that contains the 
neuromuscular junctions.
44  The optimum interelectrode distance depends on the length of the 
muscle fibers.
71   
  One of limitations present while recording EMG is the variability in the recording when 
the same task is performed by different subjects or by the same subject on different days.  To 
reduce variability EMG amplitude can be expressed relative to a standard value, which is a 
process known as normalization.  The most common standard is the interference EMG recorded 
during a maximum voluntary contraction (MVC).
44 
Force Plate 
  A valid and reliable technique to measure balance is stabilometry.  Stabilometry uses a 
force plate or other similar device to measure the displacement of an individual's center of 
pressure.
68  A force platform is a technical apparatus that provides an indirect assessment of 
changes in postural sway by recording the ground-reaction forces projected from the body.
39  
These ground reaction force measurements are then used to collect center of pressure data.  A 68 
 
force plate ideally evaluates four aspects of postural control: steadiness, symmetry, dynamic 
stability, and dynamic balance.
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CHAPTER 3 
 
METHODS 
Study Design 
Experimental, Pretest-Posttest 
A 6-week training program intervention focused on training the GM will be the 
independent variable for this study.  We will measure how training the GM effects the dependent 
variables (postural control,  and muscle activation).  Postural control will be assessed during two 
separate tests (a single-leg drop landing and the Star Excursion Balance Test (SEBT)).  
Electromyography (EMG) will be measured during each test for 4 separate muscles (gluteus 
medius, transversus abdominis/internal oblique, vastus medialis oblique, and biceps femoris).  
 
     
 
 
   
 
 
 
Participants 
Thirty healthy, physically active participants will be recruited for this study to control for 
attrition.  Effect size was calculated and determined that 15 participants per group were needed 
for a power of 80%.  Physically active will be defined as cardio for 30 minutes, 3 times per 
 
 
 
 
 
 
        Pre-period 
           Post-period 
        Control Period  Training Period 70 
 
week.
46  For this study all participants will act as their own control.  Each participant will report 
for one familiarization session and 3 data collection sessions (the pre-control session, the post-
control/pre-training session, and the post-training session).  In addition to participating in the 3 
data-collection sessions participants will participate in a GM training program (3 times a week 
for 6 weeks).  All participants enrolled in the study will be asked to maintain their physical 
activity levels that they engaged in prior to the study.  Participants will report all physical 
activity performed during the training protocol in a weekly exercise log (Appendix B). 
  Participants will be screened using a customized health history questionnaire (HHQ) for 
this study (Appendix B).  All participants volunteering for the study will sign an approved 
institutional review board informed consent form prior to participating in the study (Appendix 
B).  Each participant will be made aware of their right to withdraw from the study at any time.  
The inclusion and exclusion criteria for participants are listed in Table 5.  
Table 5. 
Inclusion and Exclusion Criteria 
Inclusion 
  Age Range, 18-30 years old 
  Bilateral lower extremity range of motion within normal limits 
  Bilateral lower extremity strength with manual muscle testing 5/5 
  Able to perform single-limb balance with eyes open for 30 seconds 
 
Exclusion 
  History of cardiovascular, neurological, or childbirth/pregnancy within the past year 
  History of abdominal, low back, or lower extremity injury within the past year 
  Restriction from physical activity or surgery within the past two years 
  Unresolved lower extremity pathology or current pain in the spine, abdominal, or lower 
extremities 
 
 
 71 
 
Instruments 
Electromyography 
Electromyography (EMG) will be used to measure muscle activity during data collection 
periods.  The Myomonitor IV (Delsys, Boston, MA) will be used to collect EMG data.  EMG 
will be used to record muscle activation of 4 separate muscles (GM, transverse 
abdominis/internal oblique, vastus medialis oblique, and biceps  femoris) during the drop landing 
and SEBT.  Investigators commonly accept the assumption that a high level of muscle activity, 
as evidenced by EMG signal amplitude, will lead to neuromuscular adaptations.
59  Therefore, 
EMG has frequently been used to compare muscle activity level between exercises.
59,62-66   
  Each participant will be prepared for surface EMG electrode placement by using fine 
sand paper and alcohol wipes to debride the skin before electrode placement.  Electrodes will be 
placed bilaterally in parallel arrangement over the muscle belly of  each muscle.
72  
Electromyography recording electrodes will be placed according to referenced muscle placement 
for the most effective measurement (Appendix B).
73,74  To ensure consistency with electrode 
placement, the same investigator will place all electrodes.  Electrode placement for each muscle 
is shown in Table 6. 
Table 6.  
Electrode Placement 
Muscle  Anatomical landmarks 
Gluteus medius  One third the distance from the iliac crest to the greater trochanter, 
starting from the greater trochanter
59,62,63,65,73 
Transverse 
abdominis/Internal 
oblique 
Approximately 2 cm medial and inferior to the right anterior superior 
iliac spine
74 
Vastus medialis  52 mm from the superior medial side of the patella along a line 
medially oriented at an angle of 50° with respect to the anterior 
superior iliac spine
62,73 72 
 
Muscle  Anatomical landmarks 
Biceps femoris  One third the distance from the ischial tuberosity to the lateral side of 
the popliteus cavity, starting from the ischial tuberosity
62,73 
 
Stabilometry 
Stabilometry is a valid and reliable technique to measure balance.
38  Stabilometry uses a 
force platform or other similar device to measure and identify the displacement of an individual's 
center of pressure upon initial contact during landing.
68  Center of pressure is an indirect measure 
of postural control.
39  A force platform (Kistler 9281B11, Amherst, NY) will be used to measure 
COP and vertical force placed on the body during the single leg drop landing. 
Procedures 
Familiarization Session 
A familiarization session will be used to familiarize participants with testing procedures.  
During the familiarization process the participants will read and complete a HHQ and informed 
consent.  Leg dominance for each participant will be determined at this time.  The dominant leg 
will be defined as the leg the participant uses to stand on while kicking a ball.
45  After leg 
dominance is determined each participant will perform practice trials of the SEBT and single leg 
drop landing.  
  The SEBT instrument (Appendix B) will be created by projecting 3 tape measures at 45° 
of each other from the center of a circle (anteromedial, medial, and posteromedial).  Participants 
will place the foot of their stance leg in the middle of the SEBT instrument (Appendix B).  
Participants will be instructed to make a maximal reach with the opposite leg in a specific 
direction.  When maximal reach distance is obtained the participant will be instructed to make a 
light touch on the floor with the most distal part of the reaching foot, and return to a double-leg 73 
 
stance without changing the base of support of the stance leg.  Participants will complete 4 
practice trials in the three different reach directions during the familiarization session.  
Successful trails require that hands remain on hips, the foot position of the stance leg remains in 
the original position, while the heel and toes of the stance leg have to maintain contact with the 
floor.  Trials will be nullified if a participant exhibits any of the following types of errors listed 
in table 7. 
75  
Table 7.  
Types of Balance Errors 
1. Hands lifted off iliac crest 
2. Step, stumble, or fall 
3. Moving hip into >30 degrees of abduction 
4. Lifting forefoot or heel of the stance leg 
5. Remaining out of test position >5 seconds 
 
  For the drop landing, each participant will practice the technique, first at a lower height 
(30cm), then at the testing height (45cm), until the movement can be performed appropriately 
and consistently.  Three correct practice trials at each height must be made prior to end of 
familiarization session.  Correct trials will be defined as the participant landing on their dominant 
leg while maintaining balance for approximately 5 seconds without losing their balance.
76  Trials 
will be considered incomplete if a participant exhibits any of the balance errors described above 
in Table 7.  The participants will be given the following instructions to perform a single-leg drop 
landing: (1) place your hands on your hips,(2) move the dominant limb in front of the platform 
and lean forward as you descend, (3) as you descend place the dominant foot over the center of 74 
 
the force platform and pull the non-dominant foot away from the platform prior to landing, (4) 
after landing look straight forward at the wall, (5) you need to maintain balance on your 
dominant leg while looking straight forward with your hands on your hips for approximately five 
seconds.  Failure to follow these instructions will result in an unacceptable trial.  The number of 
failed landings will be set at 10.  Full instructions for the single-leg drop landing are described in 
Appendix B.  Order and sequencing of the familiarization session is shown in Table 8. 
Pre-control session intro 
All participants will report to the biomechanics laboratory for the pre-control data 
collection session.  At this time demographic information will be obtained.  A copy of the 
demographic table is included in Appendix B.   Two procedures will be used to measure baseline 
dynamic postural control, SEBT and a drop landing onto a force plate.  The SEBT will provide a 
static measure of postural control while stabilometry following a single leg drop landing will 
provide a dynamic measure of postural controlpre- and post-GM training.  EMG measurements 
will be taken during both the SEBT and the drop landing.  Participants will perform a 5-minute 
warm-up on a cycle ergometer at a self selected pace prior to beginning data collection.  
Table 8.  
Familiarization Session 
1. Participants report to the biomechanics laboratory. 
2. Explanation of informed consent and health history questionnaire. 
3. Participants will complete a 5 minute warm-up on a cycle ergometer at a submaximal speed    
prior to the session. 
4. Explanation of SEBT by PI 
5. Practice trials for SEBT Testing 
   Trial Reach 
Direction 
Practice Trials 
   Anteriomedial  Practice Trial 1    Practice Trial 2     Practice Trial 3      Practice Trial 4 
   Medial  Practice Trial 1    Practice Trial 2     Practice Trial 3      Practice Trial 4 
   Posteromedial  Practice Trial 1    Practice Trial 2     Practice Trial 3      Practice Trial 4 
   75 
 
6. Explanation of Single Leg Drop Landing by PI 
7. Practice trials for Single Leg Drop Landing 
    Height  Practice Trials 
 Half of testing height    
(15cm) 
Attempts made until participant can perform landing appropriately 
and consistently.  Three correct practice trials must be made prior to 
attempts at 30cm. 
Testing height (30cm)  Attempts made until participant can perform landing appropriately 
and consistently.  Three correct practice trials must be made prior to 
end of familiarization session. 
 
 
Data collection 
After warm-up maximal voluntary isometric contraction (MVIC) testing will be 
performed to normalize all EMG data for all 4 muscles using manual muscle testing (MMT) 
(Appendix B).  Each participant will complete 3 trials of maximal contraction, holding each 
contraction for 5 seconds, similar to previous studies.
59-62,65  Standardized verbal encouragement 
will be given to each participant during each MVIC trial.
77    A 60-second rest will be taken 
between each repetition, with a 2-minute rest between each different muscle group.
61,62,78  Rest 
periods will be timed using the software program provided by the EMG Works software program 
(Delsys, Boston, MA).  An average of the 3 trials will be calculated to determine MVIC for each 
muscle.  In addition to MVIC testing each participant will have their true leg length measured 
before testing to normalize the excursion measurements for the SEBT.
79  Leg length 
measurements will be taken with the participant in a supine position from the anterior superior 
iliac spine to the center of the ipsilateral medial malleolus.
79   
   Static postural control will be assessed using the SEBT.  Stance leg will be determined as 
the leg the participant uses to stand on while kicking a ball.
45  During the data collection session 
participants will complete 3 test trials in 3 directions (anteromedial, medial, and posteromedial).  
Trials will be disqualified and repeated if a participant exhibits any loss of balance during 76 
 
excursion as defined in table 3.  Reach distances will be randomized in a counterbalance 
technique and performed in a clockwise direction.  Reach distances will be recorded by a 
secondary investigator. The secondary investigator will place a mark on the tape measure that 
corresponds to the touchdown point.  At the conclusion of all trials, the secondary investigator 
will measure the distances of each excursion with a standard tape measure.  The primary 
investigator will be blinded to the results of the SEBT.  The mean of each reach direction will be 
calculated and normalized to the individual's leg length.   
  Participants will perform a single-leg drop landing with their dominant leg onto a force 
plate to assess center of pressure as a measure of postural control.  Participants will practice until 
he/she correctly performs 3 consecutive single-leg drop  landings.  Then data collection will be 
performed during three single-leg drop landing trials.
16,18-20  Trials will be disqualified and 
repeated if a participant exhibits any loss of balance upon landing on the force plate as defined in 
Table 7.  A counterbalance technique will be used to alternate participants between the SEBT 
and single leg drop landing to control for an order effect during testing.  Order and sequencing of 
the pre- and post-training data collection sessions are shown in Table 9.  
Training 
After post-control/pre-training data collection all participants will complete the training 
protocol 3 times per week for 6 weeks.
46  Participants will be required to report to the laboratory 
for a minimum of one exercise session per week.  Participants will be required to fill out an 
exercise log for the remaining workouts completed without supervision, which will be turned in 
weekly.  Each participant will report his/her  physical activity each week in their weekly exercise 
log.  Appendix B contains the weekly exercise logs.  All of the exercises used in the training 
protocol have demonstrated through EMG amplitude to effectively activate the GM.
59-65  During 77 
 
the training protocol participants will receive 60 seconds rest between sets and 2 minutes 
between each exercise for the duration of the 6 weeks.
46  Table 10 contains the training protocol.  
A detailed description of the training protocol is included in Appendix B. 
Table 9. 
 Pre and Post-Control/Training Data Collection  
1. Participants will complete a 5 minute warm-up on a cycle ergometer at a submaximal speed 
prior to the session. 
2. MVIC Testing   
Gluteus medius  Performed in the side-lying position, with the hip in neutral rotation 
and slightly extended and then actively abducted to end range while 
resistance is applied just above the ankle.
80 
 
Internal Oblique/   Supine lying position with knees bent to 90° and hips flexed at 45°.  
Participant will tilt pelvis posterior to flatten low back on the table.
80 
 
Transverse abdominis 
Vastus medialis  Performed in a seated position, with the knee flexed between 45° to 
60° while resistance is applied just above the ankle.
80 
 
Biceps femoris  Performed in a prone position, with the knee between 50° to 70° of 
flexion.  The thigh and lower leg are both placed into slight lateral 
rotation.  Pressure is applied against the leg, proximal to the ankle in 
the direction of knee extension.
80 
3. Leg length 
measurement 
A tape measure will be used to quantify the distance from the 
anterior superior iliac spine to the center of the ipsilateral medial 
malleolus.
79 
   
3. SEBT Testing (Counterbalanced) 
Trial Reach Direction  Test Trials 
Anteriomedial  Test Trial 1                 Test Trial 2                 Test Trial 3             
Medial  Test Trial 1                 Test Trial 2                 Test Trial 3             
Posteromedial  Test Trial 1                 Test Trial 2                 Test Trial 3             
   
4. Single Leg Drop Landing (Counterbalanced) 
Height  Test Trials 
Testing height (30 cm)  Test Trial 1                 Test Trial 2                 Test Trial 3 
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Table 10. 
 GM Training Protocol 
  Week 1  Week 2  Week 3  Week 4  Week 5  Week 6 
1. Wall Squat 
  1x10  1x15  1x15  2x10  2x15  3x15 
2. Forward  
Step-Up 
 
10 
 
15 
 
15 
 
2x10 
 
2x15 
 
3x15 
3.Side-lying    
hip abduction 
 
10 
 
15 
 
15 
 
2x10 
 
2x15 
 
3x15 
 
4. Wall Press 
 
20 sec 
 
30 sec 
 
30 sec 
 
2x20 sec 
 
2x30 sec 
 
3x20 sec 
5. Single-leg   
deadlift 
 
5 
 
8 
 
8 
 
2x5 
 
2x8 
 
3x8 
6. Single-leg   
squat 
 
- 
 
5 
 
8 
 
2x5 
 
2x8 
 
3x8 
7. Sideways    
hop 
 
- 
 
- 
 
8 
 
12 
 
2x8 
 
2x12 
    *All exercises, sets, and repetitions will be performed bilaterally. 
 
Wall squat- Participant stands with his/her back against the wall, and maintains a single limb 
stance.  The non-weight bearing leg is placed into full knee extension and the hip is flexed so 
that the foot is not touching the ground.  The participant will flex the knee of the weight 
bearing foot until the knee has reached 45° of flexion.
62,65 
Forward step-up- The participant will place the weight bearing foot on the step while keeping 
the knee of the non-weight bearing foot in extension with the foot in dorsiflexion and hip 
slightly in extension.  Participants will be allowed to lightly touch, but not hold, a wall to 
remain upright and balanced throughout the procedure.  The height of the step-up will be 
roughly 8 inches.
62 
Side-lying hip abduction- Participant is positioned side-lying on the floor in a starting 
position of full knee extension and neutral hip position.  The hip is slowly abducted to 30° 
while keeping the knee in extension and then slowly returned to the starting position.
59-61 79 
 
Single-leg squat- Participant will maintain a single leg stance.  The non-weight bearing leg 
will be held at 45° knee flexion and not contact the ground.  The participant will be instructed 
to squat down as far as possible without losing their balance and return to a single-leg 
stance.
59,63,64 
Single-leg deadlift- Participants will maintain a single leg stance.  Participants will slowly 
flex their hip and trunk and touch their contralateral middle finger to the ground beside their 
support foot, and return to the starting position.
59 
Sideways hop- Participants will start in a standing position with their feet near each other and 
hands on their hips.  The participant will jump lateral landing on the opposite foot they 
jumped off.  Participants will be instructed to land “as softly as possible,” with their knees 
flexed, and to keep their knees over their toes.
59 
Wall press- Participants will stand next to a wall with the weight bearing limb located 
furthest from the wall.  The non-weight bearing limb will be in 60° of hip flexion and 90° of 
knee flexion.  The participants will be asked to maintain this position while isometrically 
pushing their non-weight bearing leg, knee, and ankle against the wall.
65 
Statistical Analysis  
Effect size was calculated using the following formula: effect size = (mean pretest – 
mean post-test)/standard deviation of pre- and post-test.  Alpha was set at .05 and power at 80%.  
Previous data on pre- and post test COP measurements(Pre: 30.3 ± 6.1 Post: 37.6 ± 9.2) after an 
abdominal training program were used to calculate power.
76  Using this data, an effect size of 
.935 and a total of 15 participants per group would be needed.  Pre-training and post-training 
data analyses will be used to determine variability between groups.  Upon test completion values 
will be entered into SPSS Version 16.0 (SPSS Inc, Chicago, IL).  A 2x2 repeated-measures 80 
 
ANOVA will be used to determine main effects and interactions between the SEBT, single-leg 
drop landing, and muscle activation.  Tukey post hoc tests will be run if main effects are evident.  
The level of significance for all analyses will be set at P = .05.  
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Design  
  A six week GM training protocol was the independent variable (pretest, posttest).  The 
dependent variable was muscle activation of 5 separate muscles bilaterally: gluteus medius 
(GM), transversus abdominis/internal oblique (TrA/IO), vastus medialis (VM), and biceps 
femoris (BF).  
Data Collection Sessions  
  Each participant reported to the laboratory for one familiarization session and three data 
collection sessions.  Data collection session 1 (DC1) occurred within two days following a 
familiarization session.  Two weeks following DC1 participants completed data collection 
session 2 (DC2).  During this time participants were instructed to maintain current levels of 
physical activity, and this period was defined as the control period. Following DC2 participants 
completed a GM training protocol (3 times a week for 6 weeks).  Upon completion of the six 
week GM training protocol participants reported for data collection session 3 (DC3). This time 
period was defined as the intervention period.  A timeline of the study is included in Figure 1.  
Procedures 
  Familiarization Session  
  Participants read and completed a HHQ and informed consent during the familiarization 
session.  Demographic data and leg dominance for each participant was obtained at this time. 
Leg dominance was defined as the plant leg when kicking a ball.  Participants then practiced 
performing a single-leg drop landing.  
  Participants practiced performing a single-leg drop landing at two different heights (30 
and 45cm).  They were allowed to practice the single-leg drop landing at the lower height (30cm) 
first.  Participants were required to perform three correct practice trials at 30 cm before moving 92 
 
to the testing height of 45cm.  At 45cm, each participant was required to perform three correct 
practice trials prior to the end of the familiarization session.  Correct trials were defined as the 
participant landing on their dominant leg while maintaining balance for approximately 5 
seconds.  Trials were considered incomplete if a participant exhibited any of the following 
balance errors: hands lifted off iliac crest; step, stumble, or fall; moving hip into >30 degrees of 
abduction; lifting forefoot or heel of the stance leg; remaining out of test position >5 seconds. 
Trials were determined incomplete off visual inspection from the primary investigator.  
  Participants were re-familiarized to the single-leg drop landing prior to each data 
collection session.  Data collection was then performed during three single-leg drop landing 
trials.  During single-leg drop landing trials participants were instructed to place their hands on 
their hips, move their dominant limb in front of the platform and lean forward, place the 
dominant foot over the center of the force platform, and maintain balance on their dominant leg 
while keeping their hands on their hips for approximately five seconds.  Trials were disqualified 
and repeated after a 3 minute rest period if a participant exhibited any of the balance errors 
previously defined.  
  Data Analysis  
  The Myomonitor IV (Delsys, Boston, MA) surface EMG was used to measure muscle 
activation pre-and post landing during data collection sessions.  Data were collected bilaterally 
from the GM, TrA/IO, VM, and BF.  Electrodes were positioned according to placement 
previously defined in the literature.  To ensure consistency with electrode placement, the same 
investigator positioned all electrodes during each data collection session.  The skin was shaved if 
needed, debrided with fine sand paper, and cleaned with alcohol before electrode placement to 93 
 
reduce impedance. Electrodes were placed over the muscle belly parallel with the muscle fibers.
    
A reference electrode was applied to the lateral malleolus of the dominant leg.  
  A force platform (kistler 9281B11, Amherst, NY) was used to determine the time that 
initial contact during landing occurred for each trial. Mean and peak EMG data were assessed for 
400ms prior to initial contact and 400ms after initial contact during landing.  Electromyography 
measurements were collected using Delsys surface EMG sensors (DE-2.1, Delsys Inc., Boston, 
MA). The Myomonitor IV System is a wireless unit.  All wireless systems have a delay in signal 
transmission, which Delsys estimated to be approximately 60ms.  We accounted for the 60ms 
delay while we processed muscle activation data.  The raw EMG signal was recorded at a 
sampling rate of 1000 Hz.  The input impedance of the amplifier was >1015 megohm//0.2 pF, 
with a common mode rejection ratio of 90 dB, high and low pass filters of 20 and 450Hz, a 
signal to noise ratio of -92 dB, and a gain of 1000.  
  Maximal voluntary isometric contraction (MVIC) testing was performed to normalize all 
EMG data using manual muscle testing.   Each participant completed 3 trials of maximal 
contraction, holding each contraction for 5 seconds, similar to previous studies.
33-37  Data from 
the initial 1 second and final 1 second were excluded, and the remaining 3 seconds of data were 
analyzed.  The average root mean square (RMS) of the 3 trials was used to determine the MVIC 
of each muscle.  The normalized muscle activity was expressed as a percentage of the MVIC. A 
60-second rest period was taken between each repetition, with a 2-minute rest between each 
different muscle group.  Rest periods were timed using the software program provided by the 
EMG Works software program (Delsys, Boston, MA).  
  Three correct single-leg drop landing trials were used to determine mean and peak 
normalized muscle activation values. Matlab software (R2008b, The Mathworks, Inc, Natick, 94 
 
MA) processed the raw muscle activation data upon completion of data collection.  All muscle 
activation data were integrated and smoothed using a RMS algorithm with a 50ms moving 
window.  Mean and peak muscle activation data were normalized to reference values. 
Results 
  All 18 participants recruited for the study completed the duration training protocol and 
study.  No significant differences were discovered between DC1 and DC2 (control period). 
Significant differences were noted between DC2 and DC3 (intervention period) in the BF and 
GM.  The GM training protocol produced increased mean muscle activation of the dominant BF 
and decreased muscle activation of the non-dominant GM.  Significant differences were 
observed in the dominant BF pre-mean (F=4.752, P=.044).  No other differences were observed 
in the dominant BF pre-peak (F=3.222, P=.090), post-mean (F=1.049, P=.320), and post-peak 
(F=1.726, P=.206).  Decreased muscle activation was observed in the non-dominant GM pre-
mean (F=14.301, P=.001), pre-peak (F=9.490, P=.007), post-mean (F=5.373, P=.033), and post-
peak (F=4.678, P=.045). 
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Post-control period normalized muscle activation   
Pre-Mean Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  17.10±11.72  12.66±7.50  2.775  .114 
Dominant GM  61.82±83.78  36.82±38.02  3.680  .072 
Dominant TrA  103.70±96.84  85.61±98.17  .700  .414 
Dominant VM  27.95±14.20  22.16±9.60  1.741  .206 
Non-dominant BF  56.39±39.84  49.67±31.78  2.021  .173 
Non-dominant GM  45.19±47.32  49.87±39.52  .200  .660 
Non-dominant TrA  64.21±116.78  58.14±73.43  .182  .675 
Non-dominant VM  18.49±9.21  55.19±165.90  .882  .361 
         
Pre-Peak Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  41.96±26.79  32.20±21.55  4.285  .054 
Dominant GM  159.85±230.65  86.87±75.61  2.98  .102 
Dominant TrA  275.85±280.07  215.60±270.54  1.304  .269 
Dominant VM  86.02±43.32  67.10±33.96  1.734  .206 
Non-dominant BF  100.19±68.22  82.74±49.84  3.139  .094 
Non-dominant GM  128.38±155.73  128.74±121.33  .000  .992 
Non-dominant TrA  214.38±397.25  215.91±280.88  .001  .981 
Non-dominant VM  31.43±13.97  96.03±294.05  .889  .359 
         
Post-Mean Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  86.86±55.58  95.74±136.16  .154  .699 
Dominant GM  114.16±120.32  87.87±65.03  1.362  .259 
Dominant TrA  226.61±225.83  201.04±202.22  .293  .595 
Dominant VM  120.54±85.72  142.08±153.06  .255  .620 
Non-dominant BF  22.76±21.41  16.39±10.27  2.123  .163 
Non-dominant GM  87.25±79.63  92.17±77.85  .044  .837 
Non-dominant TrA  215.72±309.10  222.50±206.03  .012  .916 
Non-dominant VM  42.65±26.50  73.20±147.93  .707  .412 
         
Post-Peak Muscle Activation (Mean ± SD) 
Muscle  DC1  DC2  F-Value  P-Value 
Dominant BF  165.30±125.39  178.54±275.74  .077  .785 
Dominant GM  222.24±258.89  168.53±129.82  .975  .337 
Dominant TrA  428.76±431.69  364.80±370.26  .523  .480 
Dominant VM  230.88±201.63  273.51±351.21  .180  .677 
Non-dominant BF  51.57±58.18  34.49±25.34  1.707  .209 
Non-dominant GM  177.92±167.82  190.24±191.48  .052  .822 
Non-dominant TrA  388.33±563.85  405.13±390.36  .023  .881 
Non-dominant VM  83.76±52.00  160.61±348.98  .851  .369 
Abbreviations: DC1 indicates data collection session 1; DC2 indicates data collection session 2. 
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Muscle Activation data pre-landing following training (%) 
  Pre-Mean Muscle Activation  Pre-Peak Muscle Activation 
Muscle  DC2  DC3  DC2  DC3 
Dominant BF
  12.66±7.50  19.35±15.77
b  32.20±21.55  63.10±80.17 
Dominant GM  36.82±38.02  37.55±31.85  86.87±75.61  95.89±90.55 
Dominant TrA  85.61±98.17  103.04±101.74  215.60±270.54  264.77±283.44 
Dominant VM  22.16±9.60  22.11±10.55  67.10±33.96  72.09±35.47 
Non-dominant BF  49.67±31.78  52.99±31.99  82.74±49.84  96.93±74.28 
Non-dominant GM  49.87±39.52  26.93±21.92
c  128.74±121.33  66.80±55.54
d 
Non-dominant TrA  58.14±73.43  78.87±111.14  215.91±280.88  290.43±362.71 
Non-dominant VM  55.19±165.90  17.96±9.56  96.03±294.05  31.50±20.99 
Abbreviations: DC2 indicates data collection session 2; DC3 indicates data collection session 3. 
aValues are presented as means and standard deviations of muscle activation (%). 
bSignificant increase in pre-mean muscle activation pre-landing following training. 
cSignificant decrease in pre-mean muscle activation pre-landing following training. 
dSignificant decrease in pre-peak muscle activation pre-landing following training. 97 
 
Muscle Activation data post-landing following training (%) 
  Post-Mean Muscle Activation  Post-Peak Muscle Activation 
Muscle  DC2  DC3  DC2  DC3 
Dominant BF
  95.74±136.16  131.88±167.85  178.54±275.74  292.27±432.99 
Dominant GM  87.87±65.03  89.72±67.78  168.53±129.82  181.33±159.36 
Dominant TrA  201.04±202.22  270.19±336.46  364.80±370.26  567.74±942.08 
Dominant VM  142.08±153.06  113.41±54.41  273.51±351.21  205.35±108.43 
Non-dominant BF  16.39±10.27  17.78±13.74  34.49±25.34  47.99±63.97 
Non-dominant GM  92.17±77.85  53.13±30.27
b  190.24±191.48  101.46±63.50
c 
Non-dominant TrA  222.50±206.03  285.67±283.38  405.13±390.36  470.74±447.15 
Non-dominant VM  73.20±147.93  49.33±27.61  160.61±348.98  101.21±63.18 
Abbreviations: DC2 indicates data collection session 2; DC3 indicates data collection session 3. 
aValues are presented as means and standard deviations of muscle activation (%). 
bSignificant decrease in post-mean muscle activation post-landing following training. 
cSignificant decrease in post-mean muscle activation post-landing following training. 
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Increase in Muscle Activation of the left BF.  
aIndicates increased mean muscle activation of the 
BF prior to landing after GM training.   
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Decreases in Muscle Activation of the GM.  
aIndicates decreased mean muscle activation of the 
GM pre-landing after GM training.  
bIndicates decreased peak muscle activation of the GM pre-
landing after GM training.  
cIndicates decreased mean muscle activation of the GM post-landing 
after GM training.  
dIndicates decreased peak muscle activation of the GM post-landing after GM 
training. 
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Exercise Log: Week 1 
Exercise  Desired Set x Reps  Day 1  Day 2  Day 3 
1. Wall squat  1x10       
2. Forward step-up  1x10       
3. SL hip 
abduction  1x10       
4. Wall press  1x20 secs       
5. Single-leg 
deadlift  1x5       
 
 
In the space below please include any additional physical activity performed for this week 
(include the day, activity, and amount of time): 
 
Day  Activity  Time 
 
Sunday 
 
   
 
Monday 
 
   
 
Tuesday 
 
   
 
Wednesday 
 
   
 
Thursday 
 
   
 
Friday 
 
   
 
Saturday 
 
   
 
If extra space is needed, please use the back of this sheet. 
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Exercise Log: Week 2 
Exercise  Desired Set x Reps  Day 1  Day 2  Day 3 
1. Wall squat  1x15       
2. Forward step-up  1x15       
3. SL hip 
abduction  1x15       
4. Wall press  1x30 secs       
5. Single-leg 
deadlift  1x8       
6. Single-leg squat  1x5       
 
 
In the space below please include any additional physical activity performed for this week 
(include the day, activity, and amount of time): 
 
Day  Activity  Time 
 
Sunday 
 
   
 
Monday 
 
   
 
Tuesday 
 
   
 
Wednesday 
 
   
 
Thursday 
 
   
 
Friday 
 
   
 
Saturday 
 
   
 
If extra space is needed, please use the back of this sheet.   103 
 
Exercise Log: Week 3 
Exercise  Desired Set x Reps  Day 1  Day 2  Day 3 
1. Wall squat  1x15       
2. Forward step-up  1x15       
3. SL hip 
abduction  1x15       
4. Wall press  1x30 secs       
5. Single-leg 
deadlift  1x8       
6. Single-leg squat  1x5       
7. Sideways hop  1x8       
 
In the space below please include any additional physical activity performed for this week 
(include the day, activity, and amount of time): 
 
Day  Activity  Time 
 
Sunday 
 
   
 
Monday 
 
   
 
Tuesday 
 
   
 
Wednesday 
 
   
 
Thursday 
 
   
 
Friday 
 
   
 
Saturday 
 
   
 
If extra space is needed, please use the back of this sheet.104 
 
Exercise Log: Week 4 
Exercise  Desired Set x Reps  Day 1  Day 2  Day 3 
1. Wall squat  2x10       
2. Forward step-up  2x10       
3. SL hip 
abduction  2x10       
4. Wall press  2x20 secs       
5. Single-leg 
deadlift  2x5       
6. Single-leg squat  2x5       
7. Sideways hop  1x12       
 
In the space below please include any additional physical activity performed for this week 
(include the day, activity, and amount of time): 
 
Day  Activity  Time 
 
Sunday 
 
   
 
Monday 
 
   
 
Tuesday 
 
   
 
Wednesday 
 
   
 
Thursday 
 
   
 
Friday 
 
   
 
Saturday 
 
   
 
If extra space is needed, please use the back of this sheet. 105 
 
Exercise Log: Week  
Exercise  Desired Set x Reps  Day 1  Day 2  Day 3 
1. Wall squat  2x15       
2. Forward step-up  2x15       
3. SL hip 
abduction  2x15       
4. Wall press  2x30 secs       
5. Single-leg 
deadlift  2x8       
6. Single-leg squat  2x8       
7. Sideways hop  2x8       
 
In the space below please include any additional physical activity performed for this week 
(include the day, activity, and amount of time): 
 
Day  Activity  Time 
 
Sunday 
 
   
 
Monday 
 
   
 
Tuesday 
 
   
 
Wednesday 
 
   
 
Thursday 
 
   
 
Friday 
 
   
 
Saturday 
 
   
 
If extra space is needed, please use the back of this sheet. 106 
 
Exercise Log: Week 6 
Exercise  Desired Set x Reps  Day 1  Day 2  Day 3 
1. Wall squat  3x15       
2. Forward step-up  3x15       
3. SL hip 
abduction  3x15       
4. Wall press  3x20 secs       
5. Single-leg 
deadlift  3x8       
6. Single-leg squat  3x8       
7. Sideways hop  2x12       
 
In the space below please include any additional physical activity performed for this week 
(include the day, activity, and amount of time): 
 
Day  Activity  Time 
 
Sunday 
 
   
 
Monday 
 
   
 
Tuesday 
 
   
 
Wednesday 
 
   
 
Thursday 
 
   
 
Friday 
 
   
 
Saturday 
 
   
 
If extra space is needed, please use the back of this sheet.   107 
 
Indiana State University 
Department of Applied Medicine and Rehabilitation 
HEALTH HISTORY QUESTIONNAIRE 
Study Title:  The Effects of a Gluteus Medius Training Protocol on Muscle Activation and 
Postural Control 
Please answer the following questions to the best of your knowledge: 
1.  Do you regularly exercise 30 minutes at least three times a week?  YES      NO 
2.  Are you currently under a doctor’s care?  YES      NO 
3.  Women only: Are you pregnant or do you think you might be? Or have 
you been pregnant in the past two year? 
YES      NO 
4.  Do you have a pacemaker or automatic implanted cardiac defibrillator 
(AICD)? 
YES      NO 
5.  Do you have, or suspect that you have, any circulatory problems or 
vascular (problems with your veins or arteries) disorders, conditions, 
disorders, or diseases? 
YES      NO 
6.  Do you have, or suspect that you have, any rheumatoid (joint) or muscular 
conditions, disorders or diseases? 
YES      NO 
7.  Do you have, or suspect that you have, a mitral valve prolapse, or any 
other disease, condition, or disorder that may be aggravated by 
participating in this study (see attachment for clarification)? 
YES      NO 
8.  Do you experience numbness, tingling, or decreased sensation in 
extremities, or have other neurological problems, conditions, disorders, or 
diseases? 
YES      NO 
9.  Do you have any problems, conditions, disorders or diseases that affect 
your ability to keep your balance? 
YES      NO 
10.  Have you suffered from an abdominal, lower extremity, or low back 
injury in the past year? 
If YES, please list all injuries in the past year below. 
 
 
 
YES      NO 
11.  Have you had an abdominal, lower extremity or low back surgery in the 
past two years?   
If YES, please list all surgeries in the past two years below. 
 
 
 
YES      NO 
 
If you answered “YES” to any question or you are unsure about your answers, you will be asked 
for more detail to help the investigators better assess whether your condition increases your risk 
for participation. The questions and responses will be recorded on the back of this page. 
 
I certify that all the information provided is correct. 
 
        ________            ____________ 
Participant Signature              Date 108 
 
 
 
Indiana State University 
Applied Medicine and Rehabilitation 
CURRENT HEALTH QUESTIONNAIRE 
1.  Have you experienced any vomiting or diarrhea in the last 48 hours?  YES      NO 
2.  Have you experienced any musculoskeletal injury within the last week?  YES      NO 
3.  Have you had the cold or the flu within the last week?  YES      NO 
4.  Have you had a gastrointestinal illness within the last week?  YES      NO 
5.  Have you had any other general illness the investigator should know 
about in the last week? 
YES      NO 
6.  Have you being following habits of good health within the last week such 
as eating well, drinking fluids, and getting sufficient sleep? 
YES      NO 
7.  Do you feel dizzy or  “unwell” in other ways that the primary 
investigators should be aware of? 
YES      NO 
 
 
** If you answered yes to some of the questions above, the investigator may ask to delay you 
participation. Data collection will be delayed until all symptoms have resolved to ensure your 
safety during the study. 
 
If you answered “YES” to any question or you are unsure about your answers, you will be asked 
for more detail to help the investigators better assess whether your condition increases your risk 
for participation. The questions and responses will be recorded on the back of this page. 
 
I certify that all the information provided is correct. 
 
 
        ________        _____________    
Participant Signature              Date 
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CONSENT TO PARTICIPATE IN RESEARCH 
 
The Effects of a Gluteus Medius Training Protocol on Muscle Activation and Postural Control 
 
 
You are asked to participate in a research study conducted by Nathan Dorpinghaus, LAT, ATC 
and Matt Gage PhD, LAT, ATC from the Applied Medicine and Rehabilitation Department at 
Indiana State University.  This study is being conducted to apply towards completion of Nathan 
Dorpinghaus’s thesis at Indiana State University.  Your participation in this study is entirely 
voluntary. Please read the information below and ask questions about anything you do not 
understand, before deciding whether or not to participate. 
 
  PURPOSE OF THE STUDY 
The purpose of this study is to examine the effects that a six week hip training (strengthening) 
program has on muscle contraction and balance during two different tasks (Star Excursion 
Balance Test (SEBT) & single-leg drop landing in healthy participants. 
 
  PROCEDURES 
If you volunteer to participate in this study, you will be asked to do the following things: All 
participants will complete four sessions.  During the first session you will complete a health 
history questionnaire and become familiar with the study’s procedures.  This session will last 
approximately 1 hour.  The second session must occur within no more than 2 days following the 
familiarization session and will serve as the pre-training data collection session.  During the data 
collection sessions muscle contraction data will be collected over five different muscles during 
performance of the SEBT and a single-leg drop landing.  Electrodes will be placed on your skin 
over five abdomen and thigh muscles.  This session will take approximately 1 hour.  After 
completion of the pre-training data collection all of the participants will complete another data 
collection sessions two weeks later.  After the familiarization and first two data collection 
sessions are complete all participants will begin the training protocol.  The training protocol is 3 
times per week for 6 weeks.  One training session per week will need to be completed under 
supervision in the Biomechanics laboratory.  The remaining 2 sessions may be completed at 
home on your own time.  Participants completing exercise sessions at home will keep an exercise 
log provided to them prior to starting the training protocol.  Participants’ time investment will 
include 3 days per week for approximately 1 hour.  Therefore, total time investment for the 
training protocol will be approximately 18 hours.  After the 6 week training protocol all 
participants will be asked to complete a post-training data collection session.  This session will 
last approximately 1 hour and will be completed in the same sequence as the pre-training data 
collection session.  The sequences of events are listed below. 
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 Sequence of Familiarization Session 
1.  Report to the Biomechanics laboratory. 
2.  Explanation of informed consent, health history questionnaire, and questions. 
3.  You will complete a 5 minute warm-up on an exercise bike. 
4.  The primary investigator will explain the Star Excursion Balance Test (SEBT) to you. 
5.  You will practice the SEBT 4 times in each of the 3 directions for a total of 12 practice 
trials. 
6.  The primary investigator will explain the single-leg drop landing to you. 
7.  You will practice the single-leg drop landing at a height of 15 cm until you are 
comfortable with the procedure.  Three correct trials must be performed prior to attempts 
made at 30 cm 
8.  You will practice the single-leg drop landing at a height of 30 cm until you comfortable 
with the procedure.  Three correct practice trials must be performed prior to end of 
familiarization session. 
 
Sequence of Data Collection Session 
1.  Report to the biomechanics laboratory. 
2.  Your demographic data will be measured (height, age, gender, and leg dominance). 
3.  You will expose your trunk for preparation of electrodes. 
4.  Fine sandpaper and alcohol wipes will be used to cleanse your skin of any dead skin over 
the electrode sites. 
5.  Electrodes will be placed on you at 4 different sites 
6.  The primary investigator will perform manual muscle testing on you 
7.  You will practice performing the SEBT. 
8.  You will correctly perform 3 test trials in 3 directions of the SEBT. 
9.  You will practice performing the single-leg drop landing. 
10. You will correctly perform 3 test trials of the single-leg drop landing. 
 
  POTENTIAL RISKS AND DISCOMFORTS 
There is potential that you may fall if you lose your balance during the SEBT or single-leg drop 
landing.  However, the risk of injury (i.e. twisted ankle or knee) is minimal because during the 
SEBT one leg will always maintain contact with the ground, and during the single-leg drop 
landing the task is performed from a box that is only 12" (30 cm) high.  There is a potential for 
an injury to occur during the training protocol (i.e. strained muscle).  However, this risk is 
minimal because all the tasks included in the training protocol consist of body-weight exercises 
only.  If a problem was to arise a certified/licensed athletic trainer will be onsite during all data 
collection sessions to evaluate any potential problems and provide initial first aid/treatment.  If 
additional medical treatment is needed you will incur the costs. 
 
 
 
  POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
Participants in the training group will learn how to correctly perform new exercises that will help 
with overall fitness and potentially improve balance, which may lead to a decreased chance of 
lower extremity injury. 
 
  CONFIDENTIALITY 111 
 
Any information that is obtained in connection with this study and that can be identified with you 
will remain confidential and will be disclosed only with your permission or as required by law.  
All data will be kept in a filing cabinet in the Applied Medicine Research Center.  Data will be 
secured for three years after the completion of the study.  At that time it will be destroyed. 
 
  PARTICIPATION AND WITHDRAWAL 
You can choose whether or not to be in this study. If you volunteer to be in this study, you may 
withdraw at any time without consequences of any kind or loss of benefits to which you are 
otherwise entitled. You may also refuse to answer any questions you do not want to answer. 
There is no penalty if you withdraw from the study and you will not lose any benefits to which 
you are otherwise entitled.  
 
  IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about this research, please contact Nathan Dorpinghaus, 
LAT, ATC at 641-799-6618, ndorpinghaus@indstate.edu or Matt Gage, PhD, LAT, ATC at 812-
237-3961, 260 Student Services Building, Matt.Gage@indstate.edu 
 
  RIGHTS OF RESEARCH SUBJECTS 
If you have any questions about your rights as a research subject, you may contact the Indiana 
State University Institutional Review Board (IRB) by mail at Indiana State University, Office of 
Sponsored Programs, Terre Haute, IN 47809, by phone at (812) 237-8217, or e-mail the IRB at 
irb@indstate.edu. You will be given the opportunity to discuss any questions about your rights as 
a research subject with a member of the IRB. The IRB is an independent committee composed of 
members of the University community, as well as lay members of the community not connected 
with ISU. The IRB has reviewed and approved this study.  
 
 
 
I understand the procedures described above. My questions have been answered to my 
satisfaction, and I agree to participate in this study. I have been given a copy of this form. 
 
________________________________________ 
Printed Name of Subject 
 
 
________________________________________    _________________________ 
Signature of Subject            Date 
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Electrode Placement 
Muscle  Anatomical landmarks 
Gluteus medius  One third the distance from the iliac crest to the greater trochanter, 
starting from the greater trochanter.
59,62,63,65,73 
Transverse 
abdominis/Internal 
oblique 
Approximately 2 cm medial and inferior to the right anterior superior 
iliac spine.
74 
Vastus medialis 
oblique 
52 mm from the superior medial side of the patella along a line medially 
oriented at an angle of 50° with respect to the anterior superior iliac 
spine.
62,73 
Biceps femoris  One third the distance from the ischial tuberosity to the lateral side of 
the popliteus cavity, starting from the ischial tuberosity.
62,73 
 
 
 
 
 
 
                                
         Figure 1. Electrode placement biceps femoris.         Figure 2. Electrode placement gluteus medius.           
                 
          
                                               
        Figure 3. Electrode placement TrA/IO            Figure 4. Electrode placement vastus medialis. 
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Star Excursion Balance Test 
 
             
Figure 1. Star Excursion Balance Test.               Figure 2. Starting position. 
 
 
 
            
Figure 3. Anteromedial reach direction.                  Figure 4. Medial reach direction. 
 
 
            
Figure 5. Posteromedial reach direction.                 Figure 6. Measurement of reach distance. 
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Single-leg Drop Landing Instructions 
 
Participants will be given the following instructions prior to practicing the landings during the 
familiarization session: 
 
1.  Place your hands on your hips 
2.  Move your dominant limb in front of the platform 
3.  Move the dominant limb in front of the platform and lean forward. As you descend  
4.  As you descend place the dominant  foot over the center of the force plate and pull the 
non-dominant foot away from the platform prior to landing  
5.  After landing look straight forward at the wall  
6.  You need to maintain balance on your dominant leg while looking straight forward with 
your hands on your hips for approximately five seconds   
 
 
                                       
Figure 1.  Step off                                                            Figure 2. Landing 
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Demographic Table 
Subject 
#  Age  Height 
(cm) 
Weight 
(kg) 
Gender 
(m/f) 
Dominant 
Limb 
(L/R) 
Leg 
Length 
Signed 
IC 
1               
2               
3               
4               
5               
6               
7               
8               
9               
10               
11               
12               
13               
14               
15               
16               
17               
18               
19               
20               
21               
22               
23               
24               
25               
26               
27               
28               
29               
30               
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Maximal Voluntary Isometric Contraction Testing 
 MVIC Testing 
Muscle 
 
Procedure 
Gluteus medius  Performed in the side-lying position, with the hip in neutral rotation 
and slightly extended and then actively abducted to end range while 
resistance is applied just above the ankle.
80  
 
Internal Oblique/   Supine lying position with knees bent to 90° and hips flexed at 45°.  
Participant will tilt pelvis posterior to flatten low back on the table.
80  
 
Transverse abdominis 
Vastus medialis  Performed in a seated position, with the knee flexed between 45° to 60° 
while resistance is applied just above the ankle.
80  
 
Biceps femoris  Performed in a prone position, with the knee between 50° to 70° of 
flexion.  The thigh and lower leg are both placed into slight lateral 
rotation.  Pressure is applied against the leg, proximal to the ankle in 
the direction of knee extension.
80   
 
 
                                                                                           
Figure 1. Gluteus Medius                             Figure 2. Biceps Femoris               
 
 
                            
Figure 3. Transverse Abdominus/Internal Oblique  Figure 4. Vastus Medialis   117 
 
Gluteus Medius Training Protocol 
  Week 1  Week 2  Week 3  Week 4  Week 5  Week 6 
1. Wall Squat 
  1x10  1x15  1x15  2x10  2x15  3x15 
2. Forward  
Step-Up 
 
10 
 
15 
 
15 
 
2x10 
 
2x15 
 
3x15 
3.Side-lying    
hip abduction 
 
10 
 
15 
 
15 
 
2x10 
 
2x15 
 
3x15 
 
4. Wall Press 
 
20 sec 
 
30 sec 
 
30 sec 
 
2x20 sec 
 
2x30 sec 
 
3x20 sec 
5. Single-leg   
deadlift 
 
5 
 
8 
 
8 
 
2x5 
 
2x8 
 
3x8 
6. Single-leg   
squat 
 
- 
 
5 
 
8 
 
2x5 
 
2x8 
 
3x8 
7. Sideways    
hop 
 
- 
 
- 
 
8 
 
12 
 
2x8 
 
2x12 
 
Wall squat- Participant stands with his/her back against the wall, and maintains a single limb 
stance.  The non-weight bearing leg is placed into full knee extension and the hip is flexed so 
that the foot is not touching the ground.  The participant will flex the knee of the weight 
bearing foot until the knee has reached 45° of flexion.  
Forward step-up- The participant will place the weight bearing foot on the step while keeping 
the knee of the non-weight bearing foot in extension with the foot in dorsiflexion and hip 
slightly in extension.  Participants will be allowed to lightly touch, but not hold, a wall to 
remain upright and balanced throughout the procedure.  The height of the step-up will be 
roughly 8 inches.  
Side-lying hip abduction- Participant is positioned side-lying on the floor in a starting 
position of full knee extension and neutral hip position.  The hip is slowly abducted to 30° 
while keeping the knee in extension and then slowly returned to the starting position.  
Single-leg squat- Participant will maintain a single leg stance.  The non-weight bearing leg 
will be held at 45° knee flexion and not contact the ground.  The participant will be instructed 
to squat down as far as possible without losing their balance and return to a single-leg stance.  
Single-leg deadlift- Participants will maintain a single leg stance.  Participants will slowly 
flex their hip and trunk and touch their contralateral middle finger to the ground beside their 
support foot, and return to the starting position.  
Sideways hop- Participants will start in a standing position with their feet near each other and 
hands on their hips.  The participant will jump lateral landing on the opposite foot they 
jumped off.  Participants will be instructed to land “as softly as possible,” with their knees 
flexed, and to keep their knees over their toes.  
Wall press- Participants will stand next to a wall with the weight bearing limb located 
furthest from the wall.  The non-weight bearing limb will be in 60° of hip flexion and 90° of 
knee flexion.  The participants will be asked to maintain this position while isometrically 
pushing their non-weight bearing leg, knee, and ankle against the wall.  
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    Wall squat exercise side view.                         Wall squat exercise front view. 
 
 
         
Forward step-up exercise side view                      Forward step-up exercise front view. 
 
 
           
Side-lying hip abduction exercise.                        Single-leg squat exercise. 
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Wall press exercise side view.                              Wall press exercise front view. 
 
 
           
Single-leg deadlift side view.                               Single-leg deadlift front view. 
 
 
 
Sideways hop landing and takeoff position. 
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Form A2        RESEARCH DESCRIPTION 
 
Provide responses to the following items in the textboxes provided, save document with 
your answers, and upload the completed Form A2 in IRBNet.   If an item does not apply to 
your research project, simply indicate “Not applicable.” The completed Form A2 should 
not exceed 9 pages.  Use a font size of 11 or larger. A proposal, thesis, or dissertation will 
not be accepted in lieu of responses.   
 
PROJECT DESCRIPTION 
 
Muscle activation of  5 trunk muscles (gluteus medius, internal oblique, transverse abdominus, 
vastus medialus, and biceps femoris) will be measured before (pre-) and after (post-) a 6-week 
training protocol.  Participants will act as their own control for this study.  The participants will 
undergo a familiarization session followed by three data collection sessions (pre-control, post-
control/pre-training, and post-training).  During the data collection sessions participants will 
perform two tests to assess postural control, the Star Excursion Balance Test (SEBT) and a 
single-leg drop landing.  After the post-control/pre-training data collection is complete each 
participant will participate in a 6 week training protocol designed to specifically train the gluteus 
medius (hip muscle).  After the training protocol is complete all participants will complete the 
post-training data collection.   The purpose of this study is to examine the effects that a gluteus 
medius training protocol has on muscle activation and balance using both the SEBT and Center 
of Pressure (COP) measurements in healthy participants.  There are 4 experimental hypothesis 
for this study (2 pre-training and 2 post-training). 
 
Hypothesis 
1.  Six weeks of gluteus medius training will increase muscle activation of lumbo-pelvic and 
lower extremity muscles. 
2.  Six weeks of gluteus medius training will decrease COP excursion. 
 
METHODOLOGY 
 
2.  PARTICIPANTS –  
 
Approximately 30 participants will be recruited to participate in this study.  The participants will 
be selected based on the following inclusion criteria: 1) physically active, 2) between 18 and 30 
years of age, 3) range of motion within normal limits on each side of the body, 4) strength testing 
within normal limits on each side of the body, 5) ability to balance on one leg with eyes open for 
30 seconds.  Participants will be excluded from the study based on the following exclusion 
criteria: 1) history of cardiovascular, neurological, or childbirth/pregnancy within the past year, 
2) history of abdominal, low back, or lower body injury within the past year, 3) restriction from 
physical activity or surgery within the past two years, 4) Unresolved lower body injury or current 
pain in the spine, abdominal, or lower body.  These criterions will be self reported by the 
participants.  Inclusion/Exclusion criteria will be determined during the familiarization session.  
The principle investigator will confirm these criterions through the use of a previously IRB 
approved Health History Questionnaire.  A copy of the questionnaire is in Appendix A.   
 
3.  RECRUITMENT— 
 
Participants will be recruited from the Health 111, PE 101, and 101L courses and through a 
global email that will be sent to the ISU faculty and staff.  A copy of the recruiting script that 
will be read or sent via email by the PI is in Appendix C. Interested individuals that meet the 121 
 
inclusion/exclusion criterion will provide the PI with their phone number and email address. The 
PI will then contact the participant to set up a familiarization session.  
 
4.  LOCATION OF STUDY—  
 
Familiarization and data collection sessions will be held in the in the Biomechanics lab which is 
located in the Arena Building (C-63) on the Indiana State University campus.  Training sessions 
will be located at the Applied Medicine and Rehabilitation lab in the Student Services building 
(A-15).  In addition, participants will complete 2 training protocol sessions per week at home. 
      
 
5.   INSTRUMENTS, RESEARCH MATERIALS, RECORDS—  
 
Three instruments and a health history questionnaire (HHQ) will be used for data collection.  The 
HHQ will be used to ensure that participants meet the inclusion and exclusion criteria.  The 
Myomonitor IV Surface Electromyography (EMG) System (Delsys Inc., Boston, MA) will be 
used to measure muscle activation.  The SEBT instrument (Appendix B) will be created on the 
floor by projecting 3 tape measures at 45° of each other from the center of a circle.  A force 
platform (Kistler 9281B11, Amherst, NY) will be used to measure balance and vertical force 
placed on the body during the single leg drop landing. 
 
6.   PROCEDURES—  
 
The familiarization session will be used to familiarize participants to the procedures of the study.  
During the familiarization session participants will fill out the HHQ .The PI will review the HHQ 
immediately upon completion to ensure that the participants meet the inclusion/exclusion 
criteria.  Once it is confirmed that the participant meets the criterion the HHQ will be destroyed. 
Participants will then be taught how to correctly perform the SEBT and a single-leg drop 
landing. 
 
 Participants will practice performing the SEBT and single leg drop landing.  For the SEBT three 
separate reach directions will be used (forward, to the side, and behind).  Participants will place 
the dominant foot of their stance leg in the middle of the SEBT instrument.  Participants will be 
instructed to stand on one leg and make a maximal reach with the opposite leg in a specific reach 
direction.  When maximal reach distance is obtained the participant will be instructed to make a 
light touch on the floor with the furthest part of the reaching foot, and return to standing on two 
feet.  Participants will complete 4 practice trials in three different reach directions during the 
familiarization session.  SEBT is included in Appendix B. 
 
For the single-leg drop landing, each participant will practice the technique, first at a lower 
height (15cm), then at the testing height (30cm), until the movement can be performed 
appropriately and consistently.  Instructions for appropriately performing the single-leg drop 
landing are included in Appendix C.  The participants will be given the following instructions to 
perform a single-leg drop landing: drop off the box, instead of jumping up, and land on the 
center of the force plate while maintaining balance for at least 5 seconds.  Participants will also 
be instructed to keep their hands on their hips throughout the procedure.   
 
Sequence of Familiarization Session 
1.  Participants report to the biomechanics laboratory 
2.  PI explains informed consent, health history questionnaire, and asks for questions 
3.  Participants complete a 5 minute warm-up on a cycle ergometer 
4.  Explanation of SEBT by PI 
5.  Participant practices the SEBT 4 times in each direction (3 directions) for a total of 12 
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6.  Explanation of single-leg drop landing by PI 
7.  Participant practices single-leg drop landing at a height of 15 cm until he/she is comfortable 
with the procedure.  Three correct practice trials must be performed prior to attempts made at 
30 cm. 
8.  Participant practices single-leg drop landing at a height of 30 cm until he/she is comfortable 
with the procedure.  Three correct practice trials must be performed prior to end of 
familiarization session. 
 
This session will take approximately 1 hour. 
 
The pre-training data collection session will occur no more than two days following the 
familiarization session.  Demographic data (height, weight, gender, and leg dominance) will be 
collected at this time.  Participants will perform a 5 minute warm-up on a cycle ergometer at a 
self-selected pace. 
 
After warm-up each participant will have their true leg length measured before testing to 
normalize excursion measurements for the SEBT.  Leg length measurements will be taken with 
the participant in a supine position from the anterior superior iliac spine to the center of the 
ipsilateral medial malleolus.   
 
Maximal voluntary isometric contraction (MVIC) testing will be performed to normalize all 
EMG data for all five muscles.  To obtain MVIC, electrodes will be placed on four muscles on 
each side of the body for each participant (gluteus medius, tansverse abdominus/internal oblique, 
vastus medialus, and biceps femoris).  The participant will expose his/her trunk for placement of 
surface EMG electrodes.  Fine sand paper and alcohol wipes will be used to debride the skin 
before electrode placement.  The electrodes will remain in place throughout the data collection 
session to measure muscle activation during the SEBT and single-leg drop landing.  Electrode 
placement is included in Appendix E. 
 
MVIC data will be collected for each muscle through the use of manual muscle testing (MMT).  
Each participant will complete 3 trials of maximal contraction, holding each contraction for 5 
seconds.  A 60 second rest will be taken between each repetition, with at least a 2 minute rest 
between testing each different muscle.  An average of the 3 trials will be used to normalize the 
EMG data  for each muscle.  Manual muscle testing positions for each muscle are included in 
Appendix D. 
 
Balance will be assessed using the SEBT.  The dominant leg will be used as the stance leg for the 
SEBT.  Dominant leg will be determined as the leg a participant stands on while kicking a ball.  
During the data collection session participants will complete 3 test trials in 3 directions (forward, 
to the side, and behind).  Reach distances will be recorded by having a secondary investigator 
place a mark on the tape measure that corresponds to the touchdown point.  At the conclusion of 
all trials, the primary investigator will measure the distances of each excursion with a standard 
tape measure. 
 
Balance will also be assessed through the use of the force plate during a single-leg drop landing.  
Participants will perform a single-leg drop landing with their dominant leg onto a force plate.  
Participants will be allowed practice attempts until they perform 3 consecutive correct landings.  
During data collection 3 acceptable test trials of the drop landing will be performed and 
recorded.  Trials will be disqualified and repeated if a participant exhibits a loss of balance upon 
landing on the force plate.  A loss of balance will be determined by the following criteria 1) 
hands lifted off iliac crest, 2) step, stumble, or fall, 3) moving hip into >30 degrees of abduction, 
4) lifting forefoot or heel of the stance leg, 5) remaining out of test position >5 seconds.  
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1.  Participants report to the biomechanics laboratory 
2.  PI gives participant demographic questionnaire to fill out and asks for questions 
3.  Leg length measurement 
4.  Participant exposes trunk for preparation of electrodes 
5.  PI debrides skin with fine sand paper and alcohol wipes 
6.  Electrodes are placed over the gluteus medius, transverse abdominus/internal oblique, vastus 
medialis, biceps femoris 
7.  PI will perform manual muscle testing on each muscle to gather MVIC data 
8.  Participants will perform one of the two tasks (SEBT or Single-leg drop landing) depending 
which counterbalance group they are in. 
 
This session will last approximately 1 hour. 
 
After the post-control/pre-training data collection is complete each participant will complete the 
training protocol 3 times per week for 6 weeks (Appendix F).  Participants time investment will 
include 3 days per week for approximately 1 hour.  Therefore, participants total time investment 
for the training protocol will be approximately 18 hours.  Each participant will be required to 
report to the laboratory for a minimum of one exercise session per week.  Participants will be 
required to fill out an exercise log for the remaining workouts completed without supervision, 
which will be turned in weekly (Appendix G).  If a participant misses a training session they will 
be asked to make up that training session at some point during the same week.  Directions for 
each exercise will be given verbally and in written form.  
 
For the Post-training data collection participants will follow the exact same sequence as previous 
data collection session listed above.  This session will last approximately 1 hour. 
 
  
7.  DATA COLLECTION, STORAGE, AND CONFIDENTIALITY 
 
To protect participant confidentiality, the informed consent forms, health history questionnaires, 
and all data collected will be numbered in correlation with each participant.  All data will be kept 
in a filing cabinet in the Applied Medicine Research Center.  Data will be secured for 7 years 
after the completion of the study, and then be destroyed. 
 
8.  INFORMED CONSENT— 
 
All participants will have the informed consent verbally explained to them during the 
familiarization study.  Each participant will be given time to read the informed consent and ask 
the PI any questions.  After the PI has explained the study and answered questions each 
participant will read and sign the informed consent.  
 
RISKS/BENEFITS 
 
9.  RISKS –  
 
The short-term risk of this study is that a participant may fall or lose their balance during the 
single-leg drop landing resulting in a sprain or strain.  However, this risk is minimal because the 
height of the single-leg drop land is only 30cm.  In addition, we are using healthy, physically 
active participants in this study and a single-leg drop landing from 30cm should place the 
participant at no greater risk than what they currently experience during routine physical activity. 
 
There is also a short-term risk that a participant may sustain an injury (sprain/strain) during the 
gluteus medius training protocol.  However, this risk is minimal because all the exercises 
included in the training protocol consist of body-weight exercises only, which will place no 124 
 
additional force on the body than what is not already currently experienced during routine 
physical activity. 
 
There are no long-term potential risks for participating in this study.  
 
10. SAFETY PRECAUTIONS— 
 
Each participant will be instructed how to do a task appropriately before performing it 
themselves.  If an injury were to occur an allied healthcare professional (certified athletic trainer) 
will be on site during the familiarization session and both data collection sessions to provide 
initial first aid and treatment.  If an injury were to occur outside of supervision (i.e. participant 
completing training protocol at home) they will be instructed to report any complications or 
injuries to a certified athletic trainer during their weekly visit. 
 
11. BENEFITS— 
 
Participants in this study will learn how to correctly perform new exercises that will help with 
overall fitness and potentially improve balance, which may lead to a decreased chance of lower 
extremity injury. 
 
12. BENEFITS VS. RISKS— 
 
The benefit of this study is that participants will learn how to appropriately complete a training 
program that will improve their muscular endurance, muscular recruitment, and overall physical 
fitness level.  The knowledge gained from this study may be used by clinicians for rehabilitating 
an athlete with a lower extremity injury.  This knowledge may also be used as a preventative 
measure to decrease the risk of lower extremity injuries.  The risk is not greater than minimal 
risk because the participants will not be completing any task that is not currently experienced 
during routine physical activity.  This study has no long-term or minimal short term risks. 
 
13. INCENTIVES AND RESEARCH RELATED COSTS—Describe the incentives, if any, 
being offered for participation in the research study.  If monetary compensation is offered, 
indicate how much subjects (or other entity) will be paid and describe terms of payment. 
Describe what will be done if subjects withdraw before completion of the research (e.g., will 
monetary payments be prorated or paid in full?).  Also, if applicable, describe any costs 
which will be accrued by the subjects as a consequence of participating in the research. 
 
 
      Not Applicable 
 
QUALIFICATIONS OF INVESTIGATORS 
 
 
14. Briefly describe the qualifications of the investigators(s) conducting this research project.   
 
Nathan Dorpinghaus 
  Certified and licensed athletic trainer 
 
Matt Gage 
  PhD in Physical Medicine and Rehabilitation 
  Certified and licensed athletic trainer 
  Seven years of professional clinical experience 
  Studied and instructed core stability programs with patients for the past 12 years 
  Three published manuscripts 125 
 
  Served as PI on four other research studies 
 
15.  Briefly describe the training that will be provided for research assistants working on this 
research project. 
 
 
          Not Applicable 
 
16.  STUDENTS’S THESIS OR DISSERTATION PROJECT:  In the case of student thesis or 
dissertation project, the student’s thesis or dissertation proposal must first be approved by the 
thesis or dissertation committee prior to submission to the IRB.  Evidence of committee 
approval (e.g., signed proposal defense form) must be included in the submission packet.  For 
thesis, dissertation, or other student research, a faculty member or EAP staff person must 
agree to supervise the project.  You must give your sponsor “read only” access in IRBNet to 
allow their electronic signature. 
 
           
     
         Not Applicable 
 
OTHER (Provide information regarding the following if applicable) 
 
17. DATA SAFETY AND MONITORING FOR NIH SPONSORED RESEARCH—The 
National Institutes of Health policy requires that grantees have in place procedures for data 
safety monitoring of clinical trials.  The IRB is required to review and approve the data 
safety monitoring plans.  For NIH funded clinical trials, include a description of the Data 
Safety Monitoring Plan. 
 
         Not applicable 
 
18. Describe any requirements imposed by funding agencies that are not already covered in this 
application. 
 
          Not applicable 
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Participant Demographics 
Subje
ct # 
A
ge 
Height 
(cm) 
Weight 
(kg) 
Weight 
(Newtons) 
Gen
der 
Dominant 
Limb 
Leg 
Length L 
Leg 
Length R 
2% of 
BW (N) 
1  23  189  97.7  958.11  M  L  98  98  19.16 
2  23  183.5  103.35  1013.5  M  L  100  99  20.27 
3  23  170.5  85.85  841.9  M  R  90  91  16.84 
4  22  167.5  72.95  715.4  M  L  88.5  88  14.31 
5  23  166.5  70.9  695.29  F  L  85  84  13.91 
6  24  155.5  57  558.98  F  L  78  77  11.18 
7  23  166  64.2  629.59  F  L  87  87  12.59 
8  19  177.5  89.3  875.73  M  L  92  92  17.51 
9  23  177.5  78.15  766.39  M  L  93.5  93  15.33 
10  18  160.5  63  617.82  F  L  85  84  12.36 
11  22  156.2  56.3  552.11  F  L  82  83  11.04 
12  19  164.8  67.2  659.01  F  L  89  89  13.18 
13  19  171  64.05  628.12  F  L  87  86  12.56 
14  20  165.5  94.1  922.81  F  R  89  89  18.46 
15  19  161.5  64.45  632.04  F  L  89  89  12.64 
16  19  171  99.5  975.76  M  L  93  94  19.52 
17  20  166  103.25  1012.5  F  L  87  84  20.25 
18  23  161  68.4  670.77  F  L  85  87  13.42 
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Data Collection Session 1: Left Biceps Femoris (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  20.96345  14.33886  7.666672  14.32  1  105.3937  91.78521  106.5701  101.25 
2  33.08278  100.0789  40.79295  57.98  2  97.46354  98.7314  98.76353  98.32 
3  30.64195  33.82184  30.10714  31.52  3  17.59154  22.31388  22.81103  20.91 
4  34.8771  32.9811  25.72465  31.19  4  118.4028  86.03618  77.00487  93.81 
5  27.35676  25.83842  29.01071  27.40  5  81.17479  97.19586  59.02294  79.13 
6  65.79507  69.73334  18.26694  51.27  6  26.23074  94.60253  72.63654  64.49 
7  10.82467  13.22767  15.76335  13.27  7  113.0786  655.2158  422.8516  397.05 
8  95.37824  52.23852  200.5737  116.06  8  283.3151  267.4038  171.1048  240.61 
9  63.24221  50.42717  55.07076  56.25  9  129.3706  141.5592  103.3455  124.76 
10  56.38823  48.87534  41.16733  48.81  10  204.7455  187.8629  199.876  197.49 
11  49.44056  34.03219  29.22836  37.57  11  317.6773  101.0642  232.3691  217.04 
12  42.54144  36.3067  62.31316  47.05  12  131.2586  209.6725  138.4449  159.79 
13  20.25145  19.87493  26.1625  22.10  13  146.1337  167.8914  168.9843  161.00 
14  283.2174  196.164  283.1654  254.18  14  206.0861  372.9146  207.5626  262.19 
15  20.12033  16.9217  16.0816  17.71  15  84.84981  81.62966  89.16861  85.22 
16  25.05719  54.66502  29.89943  36.54  16  87.86083  116.3533  120.8516  108.36 
17  49.14473  60.93688  39.49546  49.86  17  134.7314  142.7813  141.0644  139.53 
18  22.52526  28.04475  18.8839  23.15  18  92.10112  154.3828  160.8473  135.78 
Mean pre emg 
     
Mean post emg 
   
  
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  6.889798  4.726183  5.154628  5.59  1  69.86279  48.02041  59.93865  59.27 
2  18.36995  50.93469  15.66363  28.32  2  55.37752  68.74455  54.05835  59.39 
3  15.96975  26.08072  24.36137  22.14  3  10.57476  4.727061  5.554597  6.95 
4  15.20058  11.95058  10.41167  12.52  4  62.88915  49.87912  51.71076  54.83 
5  18.66348  19.04848  16.69876  18.14  5  45.09329  48.56152  38.4391  44.03 
6  53.52742  40.94279  10.50833  34.99  6  15.32022  69.41815  54.3639  46.37 
7  7.559655  9.697539  6.601817  7.95  7  57.49255  219.8158  144.3223  140.54 
8  27.68096  26.37303  95.56072  49.87  8  171.9947  160.054  105.5362  145.86 
9  25.3739  25.0087  27.72593  26.04  9  68.28524  77.40109  67.62864  71.10 
10  18.42747  20.36989  19.74183  19.51  10  114.4414  119.5244  112.7299  115.57 
11  13.28972  10.8599  11.15562  11.77  11  122.0909  52.01364  97.88913  90.66 
12  15.6162  19.06356  18.87282  17.85  12  90.96903  129.8902  100.793  107.22 
13  5.446536  6.60557  5.818551  5.96  13  93.61661  88.04946  94.16377  91.94 
14  138.0706  102.1144  120.6297  120.27  14  86.02755  121.495  80.31616  95.95 
15  9.321802  8.88925  9.915441  9.38  15  36.69063  37.01761  43.81757  39.18 
16  9.847926  8.656483  7.528708  8.68  16  65.21422  60.10154  73.54653  66.29 
17  15.23712  13.82647  12.98388  14.02  17  70.98991  76.21401  71.51374  72.91 
18  8.52738  8.164409  7.975089  8.22  18  65.95647  82.74615  98.41526  82.37 129 
 
Data Collection Session 2: Left Biceps Femoris (%MVIC) 
Max Peak pre emg        Max Peak post emg       
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  15.41705  18.54343  10.3317  14.76  1  72.55013  102.6426  126.5008  100.56 
2  12.63432  22.38569  12.02055  15.68  2  74.06495  61.94905  68.16512  68.06 
3  88.03629  48.70518  67.16554  67.97  3  6.957023  9.925361  21.94766  12.94 
4  51.83236  38.35043  39.00851  43.06  4  110.9307  85.39522  68.63094  88.32 
5  20.03662  22.39151  19.1787  20.54  5  64.60044  58.73966  43.5111  55.62 
6  16.74475  16.60897  11.26022  14.87  6  88.33648  74.86051  77.19839  80.13 
7  11.0583  9.228571  11.92554  10.74  7  57.94045  73.52278  59.09504  63.52 
8  59.52951  47.50929  58.11714  55.05  8  151.6053  95.0568  125.3669  124.01 
9  72.12649  93.39021  65.74543  77.09  9  175.1043  153.9832  187.1407  172.08 
10  23.51543  27.78114  38.43242  29.91  10  114.3248  127.4456  134.6837  125.48 
11  25.62342  39.26856  26.14002  30.34  11  65.42036  80.81337  87.05017  77.76 
12  36.09992  43.73824  31.93052  37.26  12  285.4003  428.2408  389.0195  367.55 
13  37.3972  28.5479  23.09888  29.68  13  120.4341  84.58799  135.2123  113.41 
14  180.4262  162.4164  180.7351  174.53  14  67.60085  70.63299  58.10947  65.45 
15  22.29709  13.91093  23.33714  19.85  15  86.02027  82.90473  70.09905  79.67 
16  39.42538  49.67233  34.45409  41.18  16  151.3772  165.2344  132.731  149.78 
17  26.66907  41.25213  29.76529  32.56  17  157.6303  116.7183  137.8398  137.40 
18  9.198799  26.42486  14.34478  16.66  18  92.73288  118.0511  104.8628  105.22 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  11.66778  11.74683  7.443756  10.29  1  40.44277  65.07289  67.62012  57.71 
2  7.60868  7.764876  5.729942  7.03  2  45.16978  34.30475  36.03425  38.50 
3  49.30158  33.14874  41.775  41.41  3  5.420624  6.115396  10.21746  7.25 
4  17.88697  16.33869  16.7307  16.99  4  63.20272  44.98128  45.29116  51.16 
5  11.61579  12.17681  13.90536  12.57  5  31.10217  28.17879  26.09484  28.46 
6  8.541099  9.763729  8.680561  9.00  6  50.57654  41.67247  53.51635  48.59 
7  5.479023  5.502077  6.711098  5.90  7  35.21605  38.03596  36.82163  36.69 
8  18.29071  16.84834  17.14379  17.43  8  109.1237  77.39429  85.74551  90.75 
9  35.62505  37.63344  35.48821  36.25  9  108.4375  108.2774  115.3603  110.69 
10  9.123924  7.192014  8.59628  8.30  10  58.95825  73.33647  78.9755  70.42 
11  11.43201  12.42092  11.77013  11.87  11  37.2945  45.83273  48.0861  43.74 
12  14.57895  17.40292  10.59729  14.19  12  118.7035  165.6076  161.7369  148.68 
13  10.93176  8.471768  9.213836  9.54  13  64.20977  54.8716  70.09629  63.06 
14  105.9051  97.89356  120.8896  108.23  14  36.34493  43.30429  30.91022  36.85 
15  13.01896  10.40792  10.86047  11.43  15  42.52736  41.89937  39.65506  41.36 
16  6.749868  8.566625  8.545484  7.95  16  108.272  95.50203  79.12598  94.30 
17  12.56678  19.33303  15.17496  15.69  17  78.01497  69.52152  80.76095  76.10 
18  6.351203  6.818447  6.309858  6.49  18  58.20906  75.26481  66.70504  66.73 130 
 
Data Collection Session 3: Left Biceps Femoris (%MVIC) 
Max Peak pre emg        Max Peak post emg       
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  51.38171  53.86732  45.19461  50.15  1  1549.949  1599.354  1677.093  1608.80 
2  19.41282  39.16606  53.00672  37.20  2  238.2544  194.9249  227.8432  220.34 
3  38.06038  30.48215  42.06952  36.87  3  14.90017  13.32448  16.72455  14.98 
4  193.4487  50.32059  19.92705  87.90  4  135.1489  225.8667  170.9446  177.32 
5  23.0937  20.27534  21.74499  21.70  5  135.0974  92.36036  66.54253  98.00 
6  12.04643  13.1652  42.13747  22.45  6  96.07464  86.78632  71.64103  84.83 
7  6.58036  9.954129  9.630434  8.72  7  39.0923  47.35714  40.51124  42.32 
8  578.2933  219.3794  204.2135  333.96  8  578.6246  221.4441  406.7713  402.28 
9  68.49049  89.4612  85.60948  81.19  9  198.7475  270.66  254.1576  241.19 
10  22.61198  42.52403  30.16524  31.77  10  78.31042  145.9098  104.4068  109.54 
11  30.16153  34.84279  36.41269  33.81  11  88.64482  106.8306  81.7113  92.40 
12  25.52277  19.3216  27.19585  24.01  12  110.2625  106.6734  80.42363  99.12 
13  192.39  281.9102  92.11381  188.80  13  192.3917  482.8698  366.1242  347.13 
14  131.1785  108.3366  115.4638  118.33  14  88.49596  166.7875  54.26001  103.18 
15  14.11865  16.71484  15.2578  15.36  15  51.11719  45.42796  77.752  58.10 
16  20.13625  30.86627  31.67555  27.56  16  60.51325  74.29819  78.09996  70.97 
17  54.54279  57.61668  49.45504  53.87  17  109.3998  148.4285  149.9665  135.93 
18  26.63353  26.68722  14.88877  22.74  18  181.3006  119.6413  140.4684  147.14 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  22.29239  31.04408  20.73409  24.69  1  628.7699  641.2006  679.7929  649.92 
2  10.22942  9.423824  19.82427  13.16  2  101.5303  115.495  107.4753  108.17 
3  25.99654  23.33526  22.088  23.81  3  9.833965  7.062084  8.434805  8.44 
4  83.11615  14.23297  7.529989  34.96  4  42.69749  102.2211  67.23316  70.72 
5  14.97564  12.10531  12.49321  13.19  5  54.25112  40.40868  34.63865  43.10 
6  6.467082  6.777497  9.345687  7.53  6  61.1863  46.42649  56.6172  54.74 
7  3.959927  5.643734  4.751788  4.79  7  24.69008  34.4794  27.1849  28.78 
8  100.4766  44.13889  39.55246  61.39  8  203.6721  167.9155  223.2463  198.28 
9  37.64216  35.88059  41.57679  38.37  9  114.2798  157.1381  160.6703  144.03 
10  8.373423  10.81725  11.55507  10.25  10  47.21237  74.73131  63.43407  61.79 
11  13.12721  16.5648  17.93993  15.88  11  51.70839  55.56921  44.42622  50.57 
12  10.67016  11.15614  10.242  10.69  12  66.73865  57.77602  50.30573  58.27 
13  47.02402  62.34438  19.81615  43.06  13  79.47119  193.1593  139.3243  137.32 
14  78.58831  79.88308  72.91293  77.13  14  49.48497  66.70798  39.23828  51.81 
15  8.004158  8.415211  8.358635  8.26  15  27.16357  26.17718  40.89427  31.41 
16  8.052426  7.896691  8.310772  8.09  16  36.92154  46.08077  51.25187  44.75 
17  22.84325  17.08505  15.19149  18.37  17  75.72139  82.46501  89.01817  82.40 
18  6.303791  6.593604  5.820289  6.24  18  97.44515  77.17911  87.77691  87.47 131 
 
Data Collection Session 1: Left Gluteus Medius (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  87.39158  115.4664  33.82928  78.90  1  149.2515  200.9082  127.3213  159.16 
2  15.46843  98.26259  13.14301  42.29  2  38.26262  83.15553  44.72591  55.38 
3  25.54397  10.87858  8.094542  14.84  3  25.69872  23.41161  27.23569  25.45 
4  89.10242  82.36688  66.34333  79.27  4  149.7205  123.3423  98.90154  123.99 
5  159.9576  209.3372  142.7507  170.68  5  327.2042  292.0083  255.4514  291.55 
6  70.94615  63.15017  38.78705  57.63  6  8.485647  16.47891  62.81927  29.26 
7  73.8181  95.36541  88.50209  85.90  7  277.2522  193.4449  126.8912  199.20 
8  102.4589  73.8242  185.6823  120.66  8  138.8423  314.5744  98.73431  184.05 
9  26.94154  38.11637  52.06091  39.04  9  125.615  130.4216  125.116  127.05 
10  1108.421  1004.019  808.9366  973.79  10  1215.967  1145.755  1053.513  1138.41 
11  97.47557  57.93023  50.28462  68.56  11  117.9468  68.32331  49.89791  78.72 
12  262.9682  201.0965  213.8946  225.99  12  357.9104  227.7038  232.3358  272.65 
13  34.97176  52.57453  38.92064  42.16  13  48.16193  56.13422  58.17341  54.16 
14  60.0103  161.8145  212.5937  144.81  14  440.6562  271.0502  403.4366  371.71 
15  479.2852  537.1923  475.2375  497.24  15  501.537  582.5697  496.6861  526.93 
16  53.38966  34.56977  49.9406  45.97  16  82.24118  86.13538  73.6127  80.66 
17  94.30278  86.60572  72.93838  84.62  17  279.0431  201.7025  246.8028  242.52 
18  147.4059  133.3844  136.9384  139.24  18  369.4511  166.1731  178.6126  238.08 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  20.84283  23.15391  16.32857  20.11  1  62.04074  78.84014  51.76698  64.22 
2  7.160272  34.57785  6.286684  16.01  2  22.56979  31.55234  26.13958  26.75 
3  13.45698  4.87253  4.344611  7.56  3  16.02928  14.48075  15.35017  15.29 
4  30.46723  29.12312  23.83399  27.81  4  72.9922  73.35243  56.18919  67.51 
5  64.41501  73.94773  52.48288  63.62  5  193.5161  137.0762  126.8324  152.47 
6  32.77741  33.07049  12.43732  26.10  6  6.111443  7.606332  32.78938  15.50 
7  47.52653  59.03708  50.98258  52.52  7  148.5472  114.0246  94.76943  119.11 
8  28.34291  22.57556  122.7454  57.89  8  81.02288  128.1556  29.56286  79.58 
9  10.96918  11.1864  14.1598  12.11  9  50.69721  53.71546  57.05111  53.82 
10  312.2058  270.6333  237.578  273.47  10  445.8126  526.5233  474.1921  482.18 
11  26.51954  27.64193  34.28972  29.48  11  79.87348  38.74619  35.12078  51.25 
12  80.12646  60.58061  66.36771  69.02  12  193.0336  123.1081  116.3836  144.18 
13  12.99737  14.38366  11.69003  13.02  13  29.38832  34.17714  31.66594  31.74 
14  26.69975  49.69879  49.42524  41.94  14  226.0075  138.9145  221.2002  195.37 
15  267.9439  298.8079  330.4238  299.06  15  318.3996  368.6563  363.4646  350.17 
16  24.84954  17.79204  14.74722  19.13  16  47.91155  47.20262  40.74278  45.29 
17  47.99642  41.34828  36.42207  41.92  17  137.9484  118.5197  116.1237  124.20 
18  36.94624  40.17097  40.13796  39.09  18  179.5853  112.3493  114.5317  135.49 132 
 
Data Collection Session 2: Left Gluteus Medius (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  39.37388  81.68082  56.08095  59.05  1  70.17647  140.6504  106.2792  105.70 
2  23.20092  28.87908  22.30652  24.80  2  32.7383  45.07763  33.5513  37.12 
3  32.53545  55.90639  43.93996  44.13  3  53.28418  78.97057  57.4788  63.24 
4  112.1211  103.9407  98.78047  104.95  4  137.4997  133.5372  118.9867  130.01 
5  31.69473  77.78619  60.16001  56.55  5  82.11401  89.67551  94.95514  88.91 
6  38.49921  43.30902  33.15501  38.32  6  43.04967  48.63937  46.26698  45.99 
7  68.89358  78.03873  88.13586  78.36  7  313.0314  652.8041  184.9668  383.60 
8  33.88697  28.89429  34.31323  32.36  8  165.7811  167.9099  181.6984  171.80 
9  137.2437  219.8987  140.6835  165.94  9  253.7364  447.3029  444.4887  381.84 
10  305.8521  235.6207  191.0078  244.16  10  338.9445  302.7079  300.0854  313.91 
11  126.3645  105.605  76.73064  102.90  11  144.0091  147.2718  128.0512  139.78 
12  79.09459  72.7704  114.4272  88.76  12  120.4805  139.5464  102.9006  120.98 
13  29.85  39.18678  36.31018  35.12  13  43.24394  45.68065  46.40231  45.11 
14  62.10595  81.04993  55.20147  66.12  14  90.81283  121.7449  104.8364  105.80 
15  235.7065  289.6418  352.3076  292.55  15  315.1044  393.2695  382.017  363.46 
16  26.48897  41.25222  55.81066  41.18  16  64.31621  126.8052  64.86067  85.33 
17  43.81297  59.16086  47.59583  50.19  17  92.35451  87.20415  86.14788  88.57 
18  60.37786  58.7062  55.17568  58.09  18  119.4758  116.5816  101.5521  112.54 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  16.25508  38.00201  16.1146  23.46  1  34.002  59.67498  49.65345  47.78 
2  9.088511  11.93488  10.17139  10.40  2  23.78912  26.2252  22.07209  24.03 
3  15.21651  18.08457  16.9228  16.74  3  29.84643  39.93012  32.53867  34.11 
4  48.03202  51.5676  39.31292  46.30  4  93.33608  72.82231  75.37606  80.51 
5  18.24857  21.8362  21.74275  20.61  5  42.06651  52.43891  55.98408  50.16 
6  10.22328  7.942837  6.21874  8.13  6  20.32378  19.67837  21.68346  20.56 
7  52.33928  52.93166  48.4741  51.25  7  147.791  254.5316  121.394  174.57 
8  6.811796  5.606366  8.653813  7.02  8  71.02019  78.84329  80.77541  76.88 
9  47.26001  65.22705  43.96881  52.15  9  158.8699  217.8382  222.1949  199.63 
10  94.41702  96.61207  66.63759  85.89  10  179.802  170.8404  164.3766  171.67 
11  57.61016  51.0588  45.74161  51.47  11  74.36206  81.3495  83.47055  79.73 
12  22.20853  27.26729  38.5117  29.33  12  47.49751  60.4426  49.92948  52.62 
13  7.535159  10.83693  11.28918  9.89  13  24.48584  21.98824  24.28721  23.59 
14  32.949  37.38153  27.56084  32.63  14  53.89817  85.23521  66.44907  68.53 
15  165.9511  134.2438  191.9829  164.06  15  220.1548  229.8557  219.4202  223.14 
16  16.28317  22.83106  26.1607  21.76  16  33.76789  68.11168  41.53697  47.81 
17  30.50922  34.57474  28.02901  31.04  17  62.63012  61.00683  59.50899  61.05 
18  20.89853  19.88509  21.121  20.63  18  82.05213  77.28692  64.33649  74.56 133 
 
Data Collection Session 3: Left Gluteus Medius (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  94.9306  321.7205  486.6061  301.09  1  381.4692  454.6327  525.9756  454.03 
2  17.96212  16.55893  21.60439  18.71  2  68.67953  62.78908  43.19928  58.22 
3  56.78794  62.39628  61.56377  60.25  3  76.93213  97.98272  96.24265  90.39 
4  98.69188  62.2252  35.09141  65.34  4  20.63939  77.89978  64.15015  54.23 
5  32.08994  29.49294  34.25866  31.95  5  85.15143  53.29185  35.61267  58.02 
6  12.77928  39.80506  18.25466  23.61  6  34.75118  42.53138  30.85846  36.05 
7  80.13695  99.03837  72.9334  84.04  7  203.0674  197.1447  121.7982  174.00 
8  9.49742  8.725739  9.085135  9.10  8  12.89264  12.54191  10.69021  12.04 
9  143.0423  188.4232  162.126  164.53  9  239.328  337.7807  272.1378  283.08 
10  111.4475  108.6895  158.2085  126.12  10  121.3192  135.0847  167.2406  141.21 
11  141.8988  101.1501  117.9299  120.33  11  426.4116  336.8763  246.5227  336.60 
12  226.2521  400.4792  257.299  294.68  12  417.0874  509.1728  385.6217  437.29 
13  23.30486  21.23192  26.94167  23.83  13  31.30099  32.10928  42.24961  35.22 
14  85.02335  28.71369  43.21364  52.32  14  85.60005  120.2157  94.85058  100.22 
15  181.7592  251.0891  156.6835  196.51  15  264.4261  323.8638  278.8607  289.05 
16  88.08079  68.39609  76.06619  77.51  16  109.0841  104.1028  140.3715  117.85 
17  50.14694  45.42597  42.30028  45.96  17  76.50037  60.76024  63.5545  66.94 
18  47.33508  43.19296  33.08617  41.20  18  541.3718  458.2027  450.8415  483.47 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  25.80048  109.1831  112.2825  82.42  1  171.7682  191.5198  221.1463  194.81 
2  10.34213  10.9049  12.25834  11.17  2  39.12669  34.89574  27.455  33.83 
3  21.73494  17.27156  23.20372  20.74  3  49.73088  56.95606  54.03784  53.57 
4  45.83442  17.33918  10.00572  24.39  4  14.4946  33.93286  29.91075  26.11 
5  17.50794  19.54325  19.44563  18.83  5  42.66515  28.60968  21.37329  30.88 
6  4.986452  11.29227  5.289206  7.19  6  21.74837  23.55724  23.04762  22.78 
7  62.23258  53.03242  42.28599  52.52  7  107.3659  105.6273  79.0648  97.35 
8  3.112588  2.525141  2.879679  2.84  8  8.283887  6.948302  6.922387  7.38 
9  34.76203  49.0323  43.12419  42.31  9  114.884  140.1879  125.4243  126.83 
10  39.85683  36.64623  50.83372  42.45  10  91.51565  83.97157  89.18683  88.22 
11  68.25283  65.70285  61.31798  65.09  11  201.1855  158.8642  122.3522  160.80 
12  72.46477  95.26133  78.57179  82.10  12  198.7782  203.7693  204.4802  202.34 
13  7.122602  8.219634  9.088373  8.14  13  19.80396  16.25122  21.62781  19.23 
14  20.77316  16.84105  15.68243  17.77  14  52.21452  63.1725  60.54298  58.64 
15  117.3396  128.1637  105.5126  117.01  15  179.4109  189.2952  172.7625  180.49 
16  32.09006  29.27306  29.89647  30.42  16  74.35209  71.17925  66.04262  70.52 
17  29.52785  22.1377  22.18901  24.62  17  62.46889  39.27281  40.47747  47.41 
18  13.93787  11.98064  11.72709  12.55  18  183.949  163.6992  165.078  170.91 134 
 
Data Collection Session 1: Left Transverse Abdominis/Internal Oblique (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  33.76982  44.61847  13.0723  30.49  1  57.67369  77.63485  49.19946  61.50 
2  38.31378  243.3868  32.55394  104.75  2  94.77273  205.9681  110.7817  137.17 
3  86.85587  36.98988  27.52346  50.46  3  87.38206  79.60532  92.60815  86.53 
4  1092.18  1009.618  813.2085  971.67  4  1835.211  1511.877  1212.293  1519.79 
5  682.7062  893.4607  609.2666  728.48  5  1396.522  1246.304  1090.278  1244.37 
6  193.4922  172.2301  105.7843  157.17  6  23.14299  44.9431  171.3276  79.80 
7  128.3372  165.7984  153.8662  149.33  7  482.0195  336.3155  220.608  346.31 
8  408.1978  294.1167  739.7611  480.69  8  553.1497  1253.269  393.3589  733.26 
9  20.52042  29.0319  39.65297  29.74  9  95.67655  99.33756  95.29646  96.77 
10  806.8324  730.8371  588.8342  708.83  10  885.1162  834.008  766.864  828.66 
11  125.3206  74.47869  64.64902  88.15  11  151.6397  87.84069  64.15185  101.21 
12  149.0079  113.949  121.2009  128.05  12  202.8059  129.0257  131.6504  154.49 
13  209.358  314.7368  232.9979  252.36  13  288.3208  336.0469  348.2544  324.21 
14  21.2585  57.3224  75.3108  51.30  14  156.1014  96.01885  142.9164  131.68 
15  109.3214  122.5296  108.3982  113.42  15  114.3969  132.8799  113.2905  120.19 
16  422.3971  273.5018  395.1095  363.67  16  650.6585  681.4678  582.3935  638.17 
17  80.06494  73.52998  61.92614  71.84  17  236.9131  171.2494  209.5405  205.90 
18  453.8303  410.6611  421.6031  428.70  18  1137.458  511.6101  549.9087  732.99 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  8.054078  8.947122  6.30968  7.77  1  23.97376  30.46537  20.00377  24.81 
2  17.73529  85.64592  15.5715  39.65  2  55.90315  78.15204  64.74515  66.27 
3  45.7571  16.56782  14.77276  25.70  3  54.50356  49.23817  52.19443  51.98 
4  373.4544  356.9789  292.147  340.86  4  894.7076  899.1231  688.7434  827.52 
5  274.9262  315.6123  223.9993  271.51  5  825.9356  585.0472  541.3265  650.77 
6  89.39417  90.19348  33.92043  71.17  6  16.6678  20.74483  89.42682  42.28 
7  82.62771  102.6395  88.63624  91.30  7  258.2581  198.2385  164.7623  207.09 
8  112.9186  89.94137  489.0195  230.63  8  322.7963  510.5736  117.7789  317.05 
9  8.354839  8.520291  10.78502  9.22  9  38.61428  40.91318  43.45383  40.99 
10  227.2582  196.9971  172.9358  199.06  10  324.5121  383.2623  345.1699  350.98 
11  34.09517  35.53818  44.08499  37.91  11  102.6903  49.81451  45.15345  65.89 
12  45.40274  34.32731  37.6065  39.11  12  109.3803  69.7578  65.94742  81.70 
13  77.80858  86.10762  69.98223  77.97  13  175.9329  204.6011  189.5678  190.03 
14  9.45832  17.60568  17.50877  14.86  14  80.06262  49.21013  78.35963  69.21 
15  61.11604  68.15589  75.36724  68.21  15  72.62461  84.0878  82.9036  79.87 
16  196.5994  140.7633  116.674  151.35  16  379.0565  373.4478  322.3401  358.28 
17  40.74991  35.10552  30.92306  35.59  17  117.121  100.6256  98.59133  105.45 
18  113.7493  123.6775  123.5759  120.33  18  552.9034  345.8986  352.6178  417.14 135 
 
Data Collection Session 2: Left Transverse Abdominis/Internal Oblique (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  23.29649  48.32839  33.18162  34.94  1  41.52156  83.21912  62.8826  62.54 
2  77.09788  95.96673  74.12576  82.40  2  108.7911  149.7954  111.4928  123.36 
3  114.5925  196.9069  154.7601  155.42  3  187.6712  278.1408  202.4451  222.75 
4  492.0006  456.1037  433.4602  460.52  4  603.3647  585.9768  522.1277  570.49 
5  132.7235  325.7342  251.9235  236.79  5  343.8572  375.5214  397.6301  372.34 
6  99.96256  112.4512  86.08645  99.50  6  111.7778  126.2913  120.1315  119.40 
7  140.8889  159.5909  180.2398  160.24  7  640.1562  1334.999  378.2612  784.47 
8  87.60566  74.69843  88.70763  83.67  8  428.5825  434.086  469.7324  444.13 
9  31.11032  49.84651  31.89006  37.62  9  57.51683  101.3944  100.7565  86.56 
10  1467.082  1130.203  916.2077  1171.16  10  1625.817  1452  1439.421  1505.75 
11  90.90296  75.96918  55.19779  74.02  11  103.596  105.9431  92.11633  100.55 
12  76.61392  70.48809  110.8384  85.98  12  116.7018  135.1697  99.6733  117.18 
13  327.0574  429.3577  397.8396  384.75  13  473.8107  500.5091  508.416  494.25 
14  63.48  82.8431  56.42276  67.58  14  92.822  124.4384  107.1558  108.14 
15  82.36621  101.2136  123.1118  102.23  15  110.1113  137.4257  133.4936  127.01 
16  209.6705  326.5273  441.7629  325.99  16  509.0877  1003.712  513.3973  675.40 
17  81.52012  110.077  88.55866  93.39  17  171.8384  162.2554  160.2901  164.79 
18  311.7076  303.0775  284.8508  299.88  18  616.8074  601.8661  524.2744  580.98 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  9.617703  22.48478  9.534583  13.88  1  20.11808  35.30811  29.37863  28.27 
2  30.20161  39.66025  33.80007  34.55  2  79.05253  87.14775  73.34674  79.85 
3  53.59381  63.69533  59.60348  58.96  3  105.1216  140.6371  114.6039  120.12 
4  210.7701  226.2846  172.5097  203.19  4  409.5696  319.5528  330.7589  353.29 
5  76.41695  91.44036  91.04902  86.30  5  176.1559  219.5909  234.4366  210.06 
6  26.54459  20.62345  16.14686  21.10  6  52.77036  51.09458  56.30076  53.39 
7  107.035  108.2464  99.13062  104.80  7  302.236  520.5228  248.2534  357.00 
8  17.61007  14.49375  22.37211  18.16  8  183.6036  203.8281  208.8231  198.75 
9  10.71287  14.78563  9.966825  11.82  9  36.01253  49.37943  50.36701  45.25 
10  452.8905  463.4195  319.6408  411.98  10  862.4569  819.471  788.4657  823.46 
11  41.44307  36.73021  32.90518  37.03  11  53.4939  58.52046  60.04628  57.35 
12  21.512  26.4121  37.30385  28.41  12  46.00784  58.54693  48.36353  50.97 
13  82.56045  118.7369  123.6921  108.33  13  268.2839  240.9185  266.1076  258.44 
14  33.67797  38.20857  28.1706  33.35  14  55.09063  87.12098  67.91921  70.04 
15  57.9906  46.91067  67.08728  57.33  15  76.93178  80.32168  76.67509  77.98 
16  128.8876  180.7167  207.072  172.23  16  267.2859  539.1303  328.7812  378.40 
17  56.76664  64.3311  52.15187  57.75  17  116.532  113.5117  110.7247  113.59 
18  107.8911  102.6591  109.0396  106.53  18  423.6036  399.0026  332.1445  384.92 136 
 
Data Collection Session 3: Left Transverse Abdominis/Internal Oblique (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  62.99066  213.4758  322.8847  199.78  1  253.1218  301.6689  349.0081  301.27 
2  43.56367  40.1605  52.3973  45.37  2  166.569  152.2829  104.7716  141.21 
3  92.92512  102.1023  100.7401  98.59  3  125.8881  160.3343  157.487  147.90 
4  1649.551  1040.041  586.5233  1092.04  4  344.9699  1302.029  1072.215  906.40 
5  298.6683  274.4975  318.8531  297.34  5  792.5237  495.9993  331.4552  539.99 
6  136.7529  425.9596  195.3457  252.69  6  371.8773  455.1343  330.2208  385.74 
7  156.3528  193.2308  142.2982  163.96  7  396.1986  384.6432  237.6368  339.49 
8  101.1204  92.90417  96.73071  96.92  8  137.2697  133.5355  113.8202  128.21 
9  53.46074  70.42142  60.59308  61.49  9  89.44664  126.2424  101.709  105.80 
10  748.6192  730.0935  1062.725  847.15  10  814.9299  907.3963  1123.395  948.57 
11  92.51122  65.94497  76.88459  78.45  11  277.9998  219.6271  160.7209  219.45 
12  73.35174  129.8368  83.41728  95.54  12  135.2212  165.0757  125.02  141.77 
13  389.694  355.0313  450.5072  398.41  13  523.4019  536.9179  706.4802  588.93 
14  97.56045  32.94767  49.5857  60.03  14  98.22219  137.9421  108.8367  115.00 
15  130.1642  179.8137  112.2066  140.73  15  189.3649  231.9303  199.702  207.00 
16  418.26  324.7853  361.2075  368.08  16  517.9963  494.3422  666.5676  559.64 
17  128.7454  116.625  108.6002  117.99  17  196.4043  155.9936  163.1675  171.86 
18  410.919  374.9609  287.2233  357.70  18  4699.685  3977.688  3913.785  4197.05 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  17.11977  72.44784  74.50445  54.69  1  113.9758  127.0819  146.7404  129.27 
2  25.08285  26.44775  29.73026  27.09  2  94.89428  84.63291  66.58684  82.04 
3  35.56604  28.26236  37.96948  33.93  3  81.37727  93.20023  88.42498  87.67 
4  766.0835  289.8097  167.2372  407.71  4  242.265  567.159  499.9328  436.45 
5  162.9504  181.8935  180.9848  175.28  5  397.0942  266.2768  198.926  287.43 
6  53.36074  120.8402  56.60055  76.93  6  232.7324  252.0894  246.6359  243.82 
7  121.4201  103.47  82.50292  102.46  7  209.4784  206.0863  154.261  189.94 
8  33.14016  26.88553  30.66034  30.23  8  88.19972  73.97955  73.70363  78.63 
9  12.99199  18.32537  16.11727  15.81  9  42.93681  52.39394  46.87615  47.40 
10  267.7279  246.1615  341.4623  285.12  10  614.7325  564.0571  599.0893  592.63 
11  44.49756  42.83509  39.97637  42.44  11  131.1633  103.5718  79.76774  104.83 
12  23.49334  30.88407  25.47326  26.62  12  64.4446  66.06276  66.29323  65.60 
13  119.1011  137.4453  151.9719  136.17  13  331.1534  271.746  361.6512  321.52 
14  23.83626  19.32435  17.99488  20.39  14  59.9138  72.48759  69.47033  67.29 
15  84.03101  91.78256  75.56127  83.79  15  128.4825  135.5609  123.7213  129.25 
16  152.3827  139.0059  141.9662  144.45  16  353.0679  338.0014  313.6097  334.89 
17  75.80873  56.83552  56.96725  63.20  17  160.3804  100.8276  103.9204  121.71 
18  120.9956  104.0048  101.8037  108.93  18  1596.874  1421.084  1433.053  1483.67 137 
 
Data Collection Session 1: Left Vastus Medialis (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  25.37997  35.62453  60.85379  40.62  1  120.4164  125.9949  195.1157  147.18 
2  21.34046  492.6507  22.33641  178.78  2  443.0098  177.4184  553.7539  391.39 
3  28.51416  12.65304  15.15023  18.77  3  40.83104  27.75774  41.14457  36.58 
4  56.39764  42.95919  68.78325  56.05  4  108.4622  114.1791  178.0545  133.57 
5  75.3463  120.2664  71.32917  88.98  5  156.0667  180.154  234.3033  190.17 
6  142.2028  135.935  28.35976  102.17  6  98.54956  143.2065  97.47668  113.08 
7  93.15993  96.55439  100.7444  96.82  7  1054.992  827.6234  456.2912  779.64 
8  69.87371  82.53572  191.3492  114.59  8  132.617  138.9283  91.37344  120.97 
9  62.19091  69.43148  71.76413  67.80  9  73.1696  84.54294  75.54772  77.75 
10  28.64058  26.91856  37.23862  30.93  10  77.12676  87.34429  105.2006  89.89 
11  53.52143  46.6023  38.91632  46.35  11  72.05971  47.53747  57.03206  58.88 
12  66.16695  58.09926  67.02288  63.76  12  157.2478  157.9843  105.6061  140.28 
13  41.40245  42.11661  71.8901  51.80  13  94.40613  183.7654  123.2564  133.81 
14  17.57008  31.81753  28.85337  26.08  14  69.01703  68.20343  64.04543  67.09 
15  103.658  95.52999  145.1157  114.77  15  283.9905  237.9154  252.4653  258.12 
16  243.1849  110.2824  177.2072  176.89  16  438.7472  838.1845  627.6862  634.87 
17  100.2969  111.1528  66.89749  92.78  17  259.9511  301.3557  260.2134  273.84 
18  36.47795  44.074  66.43447  49.00  18  261.5634  295.4455  324.1226  293.71 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  15.09386  16.03471  16.34586  15.82  1  70.20753  74.5485  102.3818  82.38 
2  7.829997  151.1738  8.408795  55.80  2  149.5214  53.30781  182.8813  128.57 
3  16.97141  8.845755  11.02556  12.28  3  26.87193  15.54476  19.60714  20.67 
4  18.0638  17.93985  18.31588  18.11  4  78.42437  75.53142  94.47521  82.81 
5  34.96003  49.11982  29.9264  38.00  5  111.7811  112.1416  151.107  125.01 
6  78.41527  73.59202  11.87352  54.63  6  77.32552  85.28167  52.87182  71.83 
7  35.08196  27.2028  32.44016  31.57  7  441.4259  331.976  238.1704  337.19 
8  18.75042  20.55698  104.0902  47.80  8  77.26145  86.021  52.25995  71.85 
9  15.72597  10.60515  11.92693  12.75  9  45.89028  55.14587  46.083  49.04 
10  12.91494  15.17674  15.60932  14.57  10  44.45474  54.6062  55.77682  51.61 
11  14.0817  14.04778  10.68265  12.94  11  42.25684  35.27572  36.40392  37.98 
12  29.24034  29.78684  28.54085  29.19  12  85.69321  84.70562  77.48673  82.63 
13  12.13414  7.715262  14.33561  11.40  13  66.5779  113.411  75.24286  85.08 
14  11.64396  12.85752  10.47743  11.66  14  39.01055  29.79023  36.22778  35.01 
15  26.9869  28.16924  41.43712  32.20  15  161.6272  173.8946  167.7529  167.76 
16  37.03568  22.92704  22.41651  27.46  16  246.7013  370.3177  337.1804  318.07 
17  27.90866  28.805  24.24625  26.99  17  122.0006  140.1498  120.3344  127.49 
18  17.01615  21.91507  23.26921  20.73  18  135.4839  140.2105  167.9695  147.89 138 
 
Data Collection Session 2: Left Vastus Medialis (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  245.8676  46.87217  118.4138  137.05  1  377.4253  260.6085  257.8233  298.62 
2  17.27491  11.10484  16.64587  15.01  2  48.07739  58.82133  52.13786  53.01 
3  5.405293  5.839663  5.00292  5.42  3  17.26724  18.90471  9.943377  15.37 
4  118.0952  125.9548  119.9913  121.35  4  136.2929  147.868  178.9561  154.37 
5  53.61809  63.49281  86.92686  68.01  5  218.415  326.3357  275.6378  273.46 
6  108.639  125.1946  66.93897  100.26  6  243.3081  238.55  276.855  252.90 
7  74.80214  42.09521  25.70138  47.53  7  285.4885  345.0649  282.153  304.24 
8  50.35542  77.79057  68.74678  65.63  8  121.1152  368.7321  372.8389  287.56 
9  30.04518  39.49795  40.15884  36.57  9  60.06655  70.8711  40.16991  57.04 
10  19.18725  32.25916  21.31029  24.25  10  46.16051  64.26194  75.16545  61.86 
11  67.99201  67.39591  60.82911  65.41  11  141.0811  133.8492  96.85848  123.93 
12  7610.689  9684.443  5348.211  7547.78  12  23057.37  11770.68  8080.892  14302.98 
13  85.47714  73.70692  94.65368  84.61  13  1544.717  819.8489  2385.984  1583.52 
14  54.06428  73.63218  46.86247  58.19  14  106.0268  88.41605  75.4467  89.96 
15  70.43187  54.10034  93.44025  72.66  15  231.936  285.6963  296.2562  271.30 
16  68.25381  165.1822  74.80923  102.75  16  243.1388  237.9885  165.3835  215.50 
17  31.58111  41.14046  33.27289  35.33  17  65.89477  70.5749  80.9006  72.46 
18  56.75483  81.98353  77.49211  72.08  18  232.9205  270.188  257.2203  253.44 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  74.73009  19.81775  26.48008  40.34  1  208.5979  150.7757  160.4073  173.26 
2  5.697137  5.061957  5.897359  5.55  2  34.02307  30.74094  31.35899  32.04 
3  4.45956  4.104677  3.5365  4.03  3  8.029917  8.769722  6.6913  7.83 
4  26.01554  24.74326  15.87245  22.21  4  95.20666  95.3518  119.8804  103.48 
5  26.08243  32.34736  42.25927  33.56  5  111.4602  213.1455  173.1204  165.91 
6  43.39955  33.95404  22.99962  33.45  6  153.6941  155.1833  150.6369  153.17 
7  20.57629  20.48747  16.70646  19.26  7  139.0851  130.9323  113.3968  127.80 
8  17.30475  20.17546  19.3695  18.95  8  59.68505  128.0261  147.9157  111.88 
9  11.50506  11.27891  10.43371  11.07  9  28.63598  36.30031  25.95284  30.30 
10  11.13797  13.48506  11.55282  12.06  10  31.02454  40.43026  39.59785  37.02 
11  25.83973  27.13857  22.7534  25.24  11  91.60529  79.33858  51.51442  74.15 
12  1914.841  4478.344  3286.927  3226.70  12  17317.91  5197.423  4127.515  8880.95 
13  35.04348  21.85741  31.90683  29.60  13  698.4285  497.893  904.7931  700.37 
14  23.08198  30.88796  20.9788  24.98  14  57.23984  52.65027  43.75851  51.22 
15  21.96807  18.62349  26.01886  22.20  15  119.5018  140.3984  139.8973  133.27 
16  25.31544  28.85985  25.36767  26.51  16  115.6842  180.8662  121.9599  139.50 
17  12.31377  16.72387  13.35108  14.13  17  46.09603  46.94823  49.75621  47.60 
18  26.07277  32.20914  33.57675  30.62  18  131.9504  150.0389  168.9456  150.31 139 
 
Data Collection Session 3: Left Vastus Medialis (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  122.8918  68.56778  110.2691  100.58  1  249.7441  346.7869  197.7525  264.76 
2  9.967824  9.177625  12.17467  10.44  2  82.85673  55.86306  73.78708  70.84 
3  7.669238  10.94836  9.973368  9.53  3  13.93241  24.61344  27.06054  21.87 
4  154.2391  97.86844  48.80393  100.30  4  111.6633  157.9409  159.8523  143.15 
5  84.65614  52.63711  78.35623  71.88  5  429.7585  327.4078  268.3888  341.85 
6  52.1945  20.18492  33.43244  35.27  6  463.7017  298.1303  364.7295  375.52 
7  31.5539  27.83895  46.06088  35.15  7  309.5832  297.153  248.2816  285.01 
8  106.5138  76.8088  54.53613  79.29  8  107.2106  82.77592  65.6975  85.23 
9  37.81601  57.74533  78.08324  57.88  9  74.98862  56.84543  80.3174  70.72 
10  30.94137  36.22156  40.48778  35.88  10  97.28404  116.5267  113.36  109.06 
11  62.3754  39.07819  54.31824  51.92  11  101.2877  171.7059  109.9619  127.65 
12  174.6425  190.3357  135.6084  166.86  12  358.248  470.0703  460.1437  429.49 
13  74.42064  42.09168  54.92122  57.14  13  222.6147  176.5513  220.2658  206.48 
14  88.40294  62.41368  58.5235  69.78  14  103.1673  177.18  155.4935  145.28 
15  115.783  104.6704  64.07755  94.84  15  252.3588  523.3874  292.2207  355.99 
16  159.6761  111.656  142.8591  138.06  16  217.9964  260.496  244.4548  240.98 
17  113.7477  94.57104  61.21932  89.85  17  147.4851  159.5607  136.7254  147.92 
18  191.8298  129.1497  95.92935  138.97  18  256.6785  497.4917  291.7538  348.64 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  29.1877  24.88751  42.01608  32.03  1  137.241  156.2941  140.3065  144.61 
2  5.009123  4.429396  5.615393  5.02  2  43.33859  36.25045  48.27183  42.62 
3  6.585731  7.955983  7.45805  7.33  3  9.512998  13.50825  16.15138  13.06 
4  72.96716  19.83582  10.18786  34.33  4  54.7577  91.87423  78.06439  74.90 
5  30.60147  21.93679  24.06141  25.53  5  198.0046  193.2246  164.703  185.31 
6  16.36127  8.093014  11.32201  11.93  6  173.7059  139.636  161.2482  158.20 
7  18.31363  16.22435  16.45829  17.00  7  123.7072  124.6227  98.86676  115.73 
8  21.31845  19.85235  16.48927  19.22  8  73.21131  55.88085  48.87442  59.32 
9  11.07374  13.99569  16.06833  13.71  9  52.1375  29.14202  53.25182  44.84 
10  9.317819  9.804191  11.42731  10.18  10  55.59164  60.27418  66.15282  60.67 
11  21.49274  16.41306  17.6872  18.53  11  56.86236  81.67908  64.78773  67.78 
12  47.71237  48.03537  42.55565  46.10  12  247.2646  286.4094  181.3662  238.35 
13  14.28092  10.27932  12.62899  12.40  13  131.6684  96.31186  118.8167  115.60 
14  28.25719  29.83834  23.1396  27.08  14  73.73652  96.76101  85.55902  85.35 
15  35.88191  35.18824  27.83806  32.97  15  157.422  242.374  182.8666  194.22 
16  32.93832  28.44302  36.12216  32.50  16  152.285  190.9332  154.5256  165.91 
17  49.49093  26.13435  23.56287  33.06  17  111.1692  120.6283  96.37042  109.39 
18  45.9934  40.09948  35.02776  40.37  18  170.8345  253.2067  178.1397  200.73 140 
 
Data Collection Session 1: Right Biceps Femoris (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  114.3727  124.7858  120.4402  119.87  1  26.2593  27.86815  50.9571  35.03 
2  43.20381  41.99906  45.49239  43.57  2  20.50373  9.966764  13.74733  14.74 
3  40.32495  5.0691  5.615302  17.00  3  32.75876  31.1809  26.23356  30.06 
4  51.179  50.93414  55.04275  52.39  4  34.57386  54.62239  28.86892  39.36 
5  128.8087  68.50139  98.60585  98.64  5  39.91072  26.18342  18.25576  28.12 
6  16.00285  27.6551  90.4698  44.71  6  11.16429  9.020666  16.16996  12.12 
7  112.6153  88.14793  81.20724  93.99  7  119.543  95.31153  132.3448  115.73 
8  63.75159  79.22833  52.79461  65.26  8  29.30522  22.32224  17.84542  23.16 
9  68.50572  73.21505  109.116  83.61  9  24.49107  38.9659  11.17356  24.88 
10  53.51241  91.44323  101.0761  82.01  10  36.85713  34.9144  35.32875  35.70 
11  105.2955  118.4682  146.9308  123.56  11  35.75994  77.38462  9.203343  40.78 
12  87.13849  151.8281  125.0269  121.33  12  39.44135  40.6367  30.33732  36.81 
13  22.24148  26.50125  10.55449  19.77  13  15.25861  23.25084  26.18896  21.57 
14  43.9739  158.6666  60.75225  87.80  14  518.4877  500.8775  605.9962  541.79 
15  56.00584  75.68962  96.13996  75.95  15  39.13351  52.58903  24.59911  38.77 
16  288.0203  223.0145  187.5552  232.86  16  48.80812  54.67584  126.3203  76.60 
17  237.8471  232.1965  156.616  208.89  17  70.38317  66.58391  60.66318  65.88 
18  62.72256  41.01334  49.92819  51.22  18  34.45113  29.87388  43.52333  35.95 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  70.51374  69.84836  75.16281  71.84  1  9.054343  9.715347  12.77914  10.52 
2  24.75013  18.79729  30.08107  24.54  2  11.218  4.882548  8.069065  8.06 
3  13.53372  4.022828  4.323813  7.29  3  13.63212  15.01025  15.00642  14.55 
4  31.89008  32.35883  40.53587  34.93  4  17.49072  29.60782  17.42465  21.51 
5  63.64099  47.10041  59.42602  56.72  5  23.80232  15.63502  13.98198  17.81 
6  11.85826  15.17196  47.76672  24.93  6  7.637763  6.601057  10.63786  8.29 
7  25.59389  29.45496  26.09578  27.05  7  63.54203  41.73056  57.88307  54.39 
8  32.25012  38.91043  26.17347  32.44  8  17.95153  15.26213  8.464729  13.89 
9  36.65074  43.32046  58.91847  46.30  9  10.54819  15.56927  5.569368  10.56 
10  30.24097  52.39809  60.15494  47.60  10  24.43679  17.88061  18.69973  20.34 
11  56.93888  65.49647  73.05792  65.16  11  21.32638  32.82585  5.607423  19.92 
12  64.76094  72.86561  70.81088  69.48  12  21.78293  26.22433  19.10547  22.37 
13  12.47378  15.06056  6.868356  11.47  13  11.61301  12.77174  14.78081  13.06 
14  18.48667  29.61015  17.14421  21.75  14  244.5631  261.4261  278.1749  261.39 
15  44.28131  53.7887  59.23373  52.43  15  13.54722  9.634948  12.25931  11.81 
16  164.8291  164.2005  146.3032  158.44  16  32.47762  30.22552  34.02776  32.24 
17  136.4954  122.1042  100.1982  119.60  17  14.40992  18.68976  18.43861  17.18 
18  33.01612  25.36831  30.46728  29.62  18  23.93712  20.35345  31.01985  25.10 141 
 
Data Collection Session 2: Right Biceps Femoris (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  63.23198  65.6969  73.25707  67.40  1  35.37845  15.77559  34.70513  28.62 
2  20.15553  34.05034  38.21433  30.81  2  9.398132  10.75295  18.68442  12.95 
3  5.879269  9.827251  5.57447  7.09  3  57.37135  54.0983  64.97359  58.81 
4  178.9153  122.8186  136.6114  146.12  4  85.30463  136.779  49.75484  90.61 
5  92.38828  93.34079  100.8399  95.52  5  26.29865  26.79514  21.46893  24.85 
6  59.29758  55.79277  79.24957  64.78  6  18.0451  17.12875  12.18355  15.79 
7  29.18405  27.03384  26.20261  27.47  7  6.027095  8.56293  6.775127  7.12 
8  15.85474  62.53288  32.70424  37.03  8  27.52008  18.64076  34.83048  27.00 
9  105.1856  60.00217  88.58085  84.59  9  23.1502  24.56279  31.61214  26.44 
10  61.77773  115.7505  45.14735  74.23  10  18.73199  108.0849  14.71515  47.18 
11  109.7402  124.4175  61.14383  98.43  11  8.865366  10.04896  8.712569  9.21 
12  78.53922  74.63039  75.47299  76.21  12  23.99314  38.07311  20.17173  27.41 
13  24.99468  26.75369  26.99588  26.25  13  31.64556  25.59555  19.73499  25.66 
14  96.53328  96.51691  57.04266  83.36  14  1479.274  1365.997  893.7126  1246.33 
15  43.44229  55.68257  56.47322  51.87  15  12.96598  11.83204  12.6916  12.50 
16  228.4242  178.7479  155.0658  187.41  16  33.84172  60.59784  27.92238  40.79 
17  143.1902  130.7554  150.7346  141.56  17  58.99439  73.34516  107.8741  80.07 
18  32.66192  36.1441  42.43285  37.08  18  72.80633  63.21801  62.45174  66.16 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  46.21654  46.53015  52.92028  48.56  1  12.04576  8.722478  16.85897  12.54 
2  14.19704  17.78986  23.83063  18.61  2  5.177874  5.459375  4.457233  5.03 
3  4.465374  4.463127  4.663305  4.53  3  27.59918  26.14073  34.71297  29.48 
4  96.99541  77.41411  83.68557  86.03  4  34.81239  51.31238  18.52  34.88 
5  47.84703  46.65539  56.77141  50.42  5  16.25996  16.20049  14.51327  15.66 
6  39.2644  30.24307  46.24658  38.58  6  8.788124  10.19401  7.7194  8.90 
7  15.61126  14.1621  15.57331  15.12  7  4.209295  5.233777  5.128165  4.86 
8  9.930307  26.15998  19.50248  18.53  8  15.30581  11.61547  19.73415  15.55 
9  53.0104  34.93256  38.82194  42.25  9  12.35477  15.85126  16.36921  14.86 
10  32.7821  50.11051  27.42417  36.77  10  13.09245  16.61368  11.75194  13.82 
11  59.34706  59.38247  40.17092  52.97  11  6.350394  5.927062  5.516401  5.93 
12  50.80593  50.11395  47.72596  49.55  12  13.13076  17.07221  12.63048  14.28 
13  13.7599  19.00731  13.79569  15.52  13  17.01514  14.25813  13.37787  14.88 
14  29.70212  22.36527  15.17759  22.41  14  707.6682  689.3758  483.7729  626.94 
15  30.49578  36.93407  34.41447  33.95  15  9.916259  6.933964  7.8582  8.24 
16  133.5215  110.2153  100.9184  114.89  16  23.43987  37.19273  17.97211  26.20 
17  98.83584  97.16157  102.6465  99.55  17  17.92864  22.57498  24.17539  21.56 
18  22.54784  22.52548  24.1985  23.09  18  33.95638  31.95261  35.15079  33.69 142 
 
Data Collection Session 3: Right Biceps Femoris (%MIVC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  132.6199  100.6778  128.1846  120.49  1  23.58483  24.73587  25.98416  24.77 
2  48.45533  32.22881  28.37713  36.35  2  16.26346  17.1404  16.73802  16.71 
3  7.551144  9.071852  11.72506  9.45  3  86.81297  29.83006  46.65784  54.43 
4  69.59371  57.55313  93.47202  73.54  4  27.55939  143.615  74.34133  81.84 
5  60.83988  67.43865  64.60445  64.29  5  13.62828  15.59975  13.81687  14.35 
6  63.44083  83.70094  69.90836  72.35  6  20.03421  15.35811  17.24555  17.55 
7  35.29993  38.79176  32.10313  35.40  7  7.096381  6.752768  6.041115  6.63 
8  48.50215  61.50915  30.80515  46.94  8  44.21941  31.07522  18.84729  31.38 
9  113.3292  138.2716  69.04021  106.88  9  19.19398  21.10307  23.37184  21.22 
10  42.89462  49.22723  48.07856  46.73  10  19.28882  25.68449  20.3896  21.79 
11  74.27402  71.26761  89.20182  78.25  11  6.850972  6.894958  6.680538  6.81 
12  102.7885  100.1433  90.76492  97.90  12  31.97187  22.03464  46.25903  33.42 
13  353.7279  267.6245  414.5485  345.30  13  99.91492  230.1822  505.522  278.54 
14  55.64825  127.9671  71.69832  85.10  14  1523.262  1342.134  947.8958  1271.10 
15  134.3303  80.95415  84.52472  99.94  15  16.55147  16.06635  13.39107  15.34 
16  207.123  171.366  228.6459  202.38  16  32.59305  37.88933  33.67337  34.72 
17  102.2168  101.8614  97.3536  100.48  17  83.55958  54.77047  73.32761  70.55 
18  68.46533  49.82042  68.64304  62.31  18  75.85017  66.0602  68.62702  70.18 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  101.0146  63.53029  71.94443  78.83  1  9.173689  10.38972  11.82022  10.46 
2  31.02672  25.35431  22.60187  26.33  2  7.082235  5.355884  5.361732  5.93 
3  4.961082  4.101781  4.867795  4.64  3  47.03133  23.12142  26.30557  32.15 
4  39.61245  41.4718  56.55267  45.88  4  16.23157  57.87072  28.30939  34.14 
5  33.97954  31.04164  40.42175  35.15  5  10.21085  11.21001  9.392553  10.27 
6  37.96849  41.57122  37.24435  38.93  6  12.67035  10.62719  12.17565  11.82 
7  17.59052  19.0212  17.94072  18.18  7  5.072508  4.638978  4.111275  4.61 
8  28.78215  32.4412  17.47064  26.23  8  17.19454  15.98711  12.3994  15.19 
9  68.44733  61.66866  38.96622  56.36  9  8.246309  13.05563  11.62543  10.98 
10  25.96017  28.36783  25.99819  26.78  10  11.06378  14.29349  15.4088  13.59 
11  43.67425  38.64719  50.36031  44.23  11  4.432642  4.466765  4.589893  4.50 
12  57.33418  47.97127  51.64181  52.32  12  12.83082  12.582  12.90665  12.77 
13  129.0391  100.9488  125.9543  118.65  13  30.02823  31.88417  57.35337  39.76 
14  20.30616  34.85616  18.9822  24.71  14  587.5198  503.0923  379.3659  489.99 
15  75.30197  50.78286  51.48584  59.19  15  9.431398  9.976343  7.668126  9.03 
16  125.3749  113.0243  155.7904  131.40  16  21.47447  22.24541  18.59042  20.77 
17  69.8837  67.37009  62.66695  66.64  17  24.58184  12.30276  18.13844  18.34 
18  29.53984  24.32009  29.91503  27.92  18  42.49525  38.42788  32.05636  37.66 143 
 
Data Collection Session 1: Right Gluteus Medius (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  50.07402  53.58437  45.77973  49.81  1  124.0624  91.54934  117.9681  111.19 
2  15.9521  67.75586  9.742075  31.15  2  51.72738  66.16779  52.69301  56.86 
3  26.83792  9.992948  8.313659  15.05  3  29.40541  28.92387  24.16652  27.50 
4  220.6159  176.3475  197.4135  198.13  4  285.4509  244.2524  293.6796  274.46 
5  84.82331  105.667  65.19452  85.23  5  122.2671  111.6811  95.54019  109.83 
6  60.55154  50.24184  36.81247  49.20  6  12.89039  16.61861  47.92517  25.81 
7  108.954  94.91769  114.4758  106.12  7  299.1002  173.8358  245.2072  239.38 
8  77.09994  60.84416  70.00229  69.32  8  91.61451  88.53399  48.14688  76.10 
9  85.81858  119.1544  122.5517  109.17  9  134.2484  153.3883  139.2948  142.31 
10  290.053  261.6102  224.0031  258.56  10  322.2613  279.7408  265.8213  289.27 
11  151.1247  122.6327  126.8903  133.55  11  160.306  144.8026  159.3739  154.83 
12  822.9671  667.5986  596.0574  695.54  12  831.3432  698.8102  651.1046  727.09 
13  40.13748  41.36832  35.19508  38.90  13  47.93783  49.4713  37.59405  45.00 
14  65.8757  180.6807  84.10245  110.22  14  160.8886  180.8026  171.2845  170.99 
15  142.1188  172.8087  192.3716  169.10  15  184.5469  179.3574  262.8076  208.90 
16  66.16047  45.25122  75.24189  62.22  16  102.7551  93.98424  103.4715  100.07 
17  32.24323  37.28217  32.34731  33.96  17  112.6709  95.99883  92.34073  100.34 
18  61.02913  67.36474  55.09851  61.16  18  156.0051  138.337  137.2578  143.87 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  16.14449  16.96403  14.46015  15.86  1  53.78433  41.42179  48.39694  47.87 
2  5.7376  26.43036  5.070424  12.41  2  30.26424  29.89698  30.40491  30.19 
3  13.01189  5.990303  5.84659  8.28  3  20.05025  17.89629  16.5432  18.16 
4  44.56876  41.52206  34.51277  40.20  4  117.476  115.9932  119.6344  117.70 
5  37.35195  44.91547  27.82427  36.70  5  63.42091  56.23622  48.98012  56.21 
6  31.15438  28.31552  13.66514  24.38  6  9.641772  10.29603  27.91057  15.95 
7  44.1964  54.67859  45.04108  47.97  7  173.2889  115.7073  123.583  137.53 
8  25.5991  23.04094  54.3143  34.32  8  52.38484  53.74555  21.90922  42.68 
9  17.24882  20.27181  23.55994  20.36  9  54.95764  61.40275  57.7796  58.05 
10  114.7104  97.61611  101.6675  104.66  10  147.1457  125.9483  140.0609  137.72 
11  54.04575  60.73528  56.07048  56.95  11  67.48309  68.02548  78.5825  71.36 
12  251.011  211.6202  164.6859  209.11  12  319.5926  370.9755  328.1289  339.57 
13  12.05555  15.63884  12.0212  13.24  13  25.53948  24.74804  22.55356  24.28 
14  35.51329  61.3663  35.319  44.07  14  97.47963  83.2689  98.75387  93.17 
15  72.72193  71.38009  66.32759  70.14  15  85.64929  94.0096  115.5185  98.39 
16  28.22329  18.81322  24.54519  23.86  16  53.6253  47.49865  49.43568  50.19 
17  20.87996  19.13978  17.87798  19.30  17  48.34665  43.48922  40.63483  44.16 
18  35.0334  34.1974  33.89615  34.38  18  87.92678  95.94724  79.83322  87.90 144 
 
Data Collection Session 2: Right Gluteus Medius (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  56.07317  195.7887  100.8743  117.58  1  200.0478  208.3112  226.7614  211.71 
2  20.42443  12.51516  21.26694  18.07  2  56.58847  55.3133  57.39765  56.43 
3  14.24607  16.06316  11.87477  14.06  3  51.02519  44.97231  41.93685  45.98 
4  260.1262  311.2628  188.0272  253.14  4  362.4229  414.2045  380.5078  385.71 
5  121.9134  62.02591  89.58412  91.17  5  110.7737  39.67432  76.3889  75.61 
6  49.8496  42.66733  37.35611  43.29  6  67.56591  60.01053  55.79296  61.12 
7  112.2812  134.8266  184.2407  143.78  7  139.9854  151.807  160.1465  150.65 
8  46.68398  38.88973  46.91112  44.16  8  235.1778  288.6087  521.3986  348.40 
9  233.0035  299.8106  261.9211  264.91  9  280.3182  379.7339  307.1049  322.39 
10  148.59  164.0197  120.7992  144.47  10  200.908  183.567  159.6224  181.37 
11  194.4765  176.8262  156.636  175.98  11  141.163  137.6692  130.0651  136.30 
12  227.464  245.5262  251.8294  241.61  12  217.6881  228.5532  164.3789  203.54 
13  25.97036  20.26869  16.40083  20.88  13  31.80833  21.92089  21.54573  25.09 
14  92.47557  90.76139  45.83315  76.36  14  288.6134  442.6913  387.2894  372.86 
15  599.7615  444.5173  425.9486  490.08  15  992.1805  641.6033  846.4604  826.75 
16  33.93785  47.36928  29.96632  37.09  16  87.43576  75.37455  98.5504  87.12 
17  75.98824  92.29517  96.42744  88.24  17  143.5839  150.8779  112.3411  135.60 
18  28.68685  24.77943  44.3643  32.61  18  51.14986  46.58131  44.75508  47.50 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  37.20556  74.5469  44.8971  52.22  1  88.98611  86.82107  103.8335  93.21 
2  7.223898  8.120988  9.373007  8.24  2  30.92083  30.90301  31.63151  31.15 
3  6.682178  8.325907  8.252166  7.75  3  26.44167  25.29326  33.55793  28.43 
4  65.31617  71.17922  45.60911  60.70  4  145.2757  170.6871  158.9653  158.31 
5  39.91207  23.79458  26.8602  30.19  5  39.83313  27.15596  30.61669  32.54 
6  20.51442  18.17447  21.43786  20.04  6  40.10878  41.04724  34.48838  38.55 
7  75.55419  69.71606  89.49476  78.26  7  123.4625  94.76378  126.3403  114.86 
8  20.01611  14.93877  16.81835  17.26  8  107.0798  109.6635  179.4229  132.06 
9  68.96438  70.94201  60.30595  66.74  9  138.9566  159.7192  137.4969  145.39 
10  79.73212  88.29171  70.02044  79.35  10  147.5421  108.8957  109.4072  121.95 
11  96.89555  88.85203  86.62069  90.79  11  79.6678  69.2755  62.09592  70.35 
12  70.08742  78.32869  94.18455  80.87  12  90.60137  98.12578  87.54997  92.09 
13  7.133386  6.468951  6.635684  6.75  13  17.91995  13.04504  13.86531  14.94 
14  20.41297  24.92306  19.54345  21.63  14  119.7685  170.7876  144.5451  145.03 
15  180.1949  154.6709  144.4348  159.77  15  402.4014  282.9007  361.4223  348.91 
16  14.42406  14.41435  16.41866  15.09  16  43.22343  40.85178  46.49346  43.52 
17  53.22396  72.94398  66.02353  64.06  17  93.36703  93.66834  80.05505  89.03 
18  18.03837  14.86887  21.17753  18.03  18  30.55417  29.84187  25.91072  28.77 145 
 
Data Collection Session 3: Right Gluteus Medius (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  21.17874  58.05487  37.38718  38.87  1  43.5748  82.76587  73.04838  66.46 
2  9.476094  15.0494  9.831303  11.45  2  38.19123  23.82322  30.73434  30.92 
3  14.90985  18.22018  14.04113  15.72  3  46.70756  43.7386  50.47591  46.97 
4  55.41921  45.76676  39.59259  46.93  4  17.96092  51.87162  45.57902  38.47 
5  38.43409  36.98276  35.12809  36.85  5  180.0472  132.0983  76.84071  129.66 
6  21.22701  29.2043  35.80171  28.74  6  42.74482  35.31898  51.61155  43.23 
7  86.73696  100.0525  126.9308  104.57  7  105.1381  118.9474  116.5545  113.55 
8  8.199288  6.45326  6.824818  7.16  8  60.91347  66.0807  66.62742  64.54 
9  71.30047  64.58883  79.46344  71.78  9  83.03276  81.08004  98.6306  87.58 
10  30.14018  29.25657  28.68513  29.36  10  31.40244  37.8925  32.69891  34.00 
11  136.4924  151.04  115.7341  134.42  11  189.5018  181.964  126.5302  166.00 
12  173.261  144.6131  84.38663  134.09  12  169.2336  140.8032  88.43234  132.82 
13  13.16675  13.42704  11.73547  12.78  13  21.75547  20.75442  18.24018  20.25 
14  93.38365  75.76719  88.40728  85.85  14  156.2032  211.1663  171.62  179.66 
15  211.9143  209.4303  250.691  224.01  15  277.7576  234.112  263.5204  258.46 
16  124.4381  71.67436  72.44915  89.52  16  190.4068  246.4224  155.3823  197.40 
17  86.62161  88.58951  95.11638  90.11  17  126.6512  87.17164  97.71324  103.85 
18  28.27855  36.84585  22.69492  29.27  18  120.6924  166.3729  158.5382  148.53 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  4.776748  13.26773  14.88005  10.97  1  25.8382  34.69815  33.1659  31.23 
2  7.021451  6.996382  6.010848  6.68  2  22.81691  17.67882  17.47808  19.32 
3  9.127197  7.867825  9.711284  8.90  3  28.43198  27.24692  29.85915  28.51 
4  34.82145  14.15507  9.97389  19.65  4  12.10567  24.04165  25.16389  20.44 
5  14.75015  14.08815  11.72568  13.52  5  87.60093  66.68738  50.69905  68.33 
6  9.592118  15.25587  11.3107  12.05  6  28.14346  20.87266  31.71085  26.91 
7  38.06672  51.84278  55.23941  48.38  7  64.49792  85.17286  83.42587  77.70 
8  3.437898  2.759483  2.611385  2.94  8  27.72696  29.27791  28.87206  28.63 
9  19.03794  19.28651  28.71366  22.35  9  42.02276  40.51409  47.62442  43.39 
10  12.91228  14.0623  15.80264  14.26  10  20.81721  22.5343  24.40126  22.58 
11  59.011  69.08926  51.35913  59.82  11  96.56304  122.6193  69.16228  96.11 
12  55.48635  41.11085  28.86617  41.82  12  68.50236  52.62003  41.87476  54.33 
13  5.420903  6.579985  5.881002  5.96  13  16.00187  13.39435  12.38527  13.93 
14  43.08555  38.69527  47.00825  42.93  14  102.7583  112.5677  104.5009  106.61 
15  61.42101  86.31138  93.87543  80.54  15  124.1387  117.4071  125.4755  122.34 
16  43.84194  38.28586  35.98988  39.37  16  84.69805  105.6056  71.34396  87.22 
17  58.11594  49.21554  55.93463  54.42  17  86.14356  64.28413  61.34909  70.59 
18  13.69159  14.13324  12.73121  13.52  18  50.7216  68.6639  64.06566  61.15 146 
 
Data Collection Session 1: Right Transverse Abdominis/Internal Oblique (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  14.75871  23.02855  11.0193  16.27  1  42.94063  49.10368  14.09818  35.38 
2  32.4969  78.45686  62.19489  57.72  2  218.7621  112.6098  97.29264  142.89 
3  194.0648  50.81316  43.74296  96.21  3  376.289  237.6239  264.1889  292.70 
4  1779.258  1606.675  1707.63  1697.85  4  1783.638  3507.673  1685.992  2325.77 
5  237.2628  203.0798  258.4248  232.92  5  578.8923  531.7167  729.6545  613.42 
6  86.83419  67.6882  20.05269  58.19  6  93.86516  87.66799  52.5682  78.03 
7  43.2919  45.18048  31.8328  40.10  7  83.9672  68.38697  94.45936  82.27 
8  61.31336  71.80361  85.53543  72.88  8  84.92839  98.79394  81.29329  88.34 
9  13.83147  10.96168  36.62432  20.47  9  25.24165  17.24881  36.6844  26.39 
10  70.66354  60.42074  55.35648  62.15  10  202.4513  158.9436  213.3349  191.58 
11  53.86557  42.47224  113.4769  69.94  11  608.2238  236.8889  336.6568  393.92 
12  42.13581  39.58627  31.54203  37.75  12  59.79459  40.66204  59.28532  53.25 
13  94.62844  74.6922  122.5136  97.28  13  205.8879  333.1807  211.6715  250.25 
14  57.05802  73.83494  54.18774  61.69  14  94.31374  129.7438  76.5071  100.19 
15  28.62945  51.46429  70.86027  50.32  15  113.2677  229.3922  143.1014  161.92 
16  154.3214  212.6319  573.7698  313.57  16  1338.902  1042.321  886.7498  1089.32 
17  592.6797  378.1911  360.1663  443.68  17  592.965  632.0411  988.4953  737.83 
18  513.8603  460.1874  484.0478  486.03  18  498.8641  478.4049  526.0038  501.09 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  3.883492  4.797708  2.066963  3.58  1  21.31668  21.46597  9.489311  17.42 
2  9.96677  39.69569  20.15817  23.27  2  113.75  86.56514  56.44904  85.59 
3  70.28308  20.86976  25.98788  39.05  3  289.7707  134.9228  155.6617  193.45 
4  550.6612  523.0385  447.1743  506.96  4  862.4977  1852.335  1182.476  1299.10 
5  85.25601  87.60844  76.30122  83.06  5  395.6268  321.4344  428.2659  381.78 
6  54.44363  31.43635  8.143423  31.34  6  74.56901  44.06316  37.35499  52.00 
7  14.2635  12.14388  9.547822  11.99  7  61.20909  50.9451  57.82548  56.66 
8  24.55993  22.39349  53.53182  33.50  8  60.53833  71.81045  56.85684  63.07 
9  2.952654  2.348148  4.654485  3.32  9  10.54936  8.191438  12.72145  10.49 
10  12.43893  11.66837  12.03618  12.05  10  125.5925  101.1429  140.3709  122.37 
11  28.42008  30.0458  51.66895  36.71  11  239.1207  117.1652  157.2248  171.17 
12  8.273337  6.678746  6.527067  7.16  12  39.96063  28.26146  36.69531  34.97 
13  15.97104  12.91224  23.77959  17.55  13  101.541  171.6598  128.5466  133.92 
14  38.40755  37.48775  31.80295  35.90  14  65.53153  61.65302  50.87028  59.35 
15  13.818  24.92117  22.06882  20.27  15  74.64514  113.4932  92.99562  93.71 
16  38.05623  63.89616  142.3726  81.44  16  608.467  354.3278  495.7318  486.18 
17  143.7007  144.4053  89.74614  125.95  17  326.6257  422.8095  602.2694  450.57 
18  150.9395  113.6245  86.53633  117.03  18  308.1832  343.6113  256.9068  302.90 147 
 
Data Collection Session 2: Right Transverse Abdominis/Internal Oblique (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  16.84613  37.62188  36.23425  30.23  1  25.19993  49.96892  38.92969  38.03 
2  82.48889  61.89156  81.02587  75.14  2  177.3855  167.3022  89.53327  144.74 
3  132.7313  76.69117  106.459  105.29  3  142.9159  194.0593  207.7753  181.58 
4  812.8175  823.1593  636.1725  757.38  4  727.4661  711.7692  527.8246  655.69 
5  95.9286  146.3771  101.1364  114.48  5  1252.365  457.0009  678.1589  795.84 
6  27.20955  17.34368  21.69891  22.08  6  112.193  139.6801  71.6161  107.83 
7  111.9486  97.35999  88.30251  99.20  7  112.6577  102.0292  110.9117  108.53 
8  312.4913  138.2505  157.2665  202.67  8  357.3281  558.2676  327.1104  414.24 
9  17.56966  25.12991  13.95195  18.88  9  29.69762  35.54895  49.58375  38.28 
10  81.70934  92.61126  157.775  110.70  10  970.113  413.24  515.698  633.02 
11  43.36112  43.80786  38.33406  41.83  11  72.71432  52.56311  81.36883  68.88 
12  22.23358  35.37103  39.05577  32.22  12  56.24738  74.15632  45.29651  58.57 
13  125.4165  100.2342  82.87318  102.84  13  861.9697  446.2126  287.3711  531.85 
14  41.20184  45.21873  40.793  42.40  14  50.27123  65.64047  51.07408  55.66 
15  36.90299  81.13919  86.85691  68.30  15  134.7027  131.2351  150.9599  138.97 
16  817.248  275.8495  204.7096  432.60  16  825.3791  1907.933  795.6078  1176.31 
17  300.8982  547.1623  882.8348  576.97  17  868.0226  778.3019  1294.734  980.35 
18  1039.718  1083.435  810.434  977.86  18  1062.278  1297.447  851.1868  1070.30 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  4.139851  6.331052  8.448963  6.31  1  16.04466  28.88535  23.78565  22.91 
2  14.86872  13.90716  18.20074  15.66  2  114.7362  98.698  66.51576  93.32 
3  67.59585  28.54158  34.01638  43.38  3  93.50325  114.6127  123.2721  110.46 
4  327.9353  278.9152  241.728  282.86  4  272.7367  364.9827  291.1831  309.63 
5  44.71007  60.94941  49.76188  51.81  5  579.2503  233.8184  386.9902  400.02 
6  12.27897  9.48283  13.33588  11.70  6  72.0773  72.67018  43.87375  62.87 
7  27.13644  28.97744  32.76713  29.63  7  67.99878  79.35816  66.12582  71.16 
8  63.35389  43.49962  46.00382  50.95  8  296.3361  362.7446  211.5494  290.21 
9  5.679686  4.15526  2.937552  4.26  9  18.09354  19.32312  25.04656  20.82 
10  37.45188  36.45639  54.37767  42.76  10  463.1234  234.7422  272.7036  323.52 
11  15.31573  19.23253  19.24445  17.93  11  52.42943  40.84963  51.76027  48.35 
12  5.859953  9.241506  6.868337  7.32  12  35.36046  49.13833  32.90518  39.13 
13  38.49068  29.23176  21.07483  29.60  13  391.6622  208.5169  190.2212  263.47 
14  21.56933  24.79363  26.11941  24.16  14  35.58819  42.79897  33.38119  37.26 
15  16.29409  20.74258  18.56193  18.53  15  99.26294  103.5491  111.8569  104.89 
16  98.43123  67.06565  61.73413  75.74  16  569.7507  899.1458  510.2951  659.73 
17  84.06572  115.22  124.2752  107.85  17  522.5127  454.963  665.3024  547.59 
18  166.2338  230.1678  207.4235  201.28  18  628.7452  602.3437  440.8069  557.30 148 
 
Data Collection Session 3: Right Transverse Abdominis/Internal Oblique (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  35.79106  37.03492  18.2115  30.35  1  40.0073  39.82629  54.60738  44.81 
2  129.9699  182.2987  91.3702  134.55  2  307.3171  258.8156  165.8945  244.01 
3  69.65555  76.4025  123.3164  89.79  3  196.5978  215.3374  182.5009  198.15 
4  1149.852  1102.816  1169.711  1140.79  4  614.1911  1851.744  1321.09  1262.34 
5  149.3779  97.87071  302.1606  183.14  5  1165.289  624.4406  601.321  797.02 
6  78.01966  76.46122  58.05459  70.85  6  427.6972  182.1548  192.7151  267.52 
7  78.21879  118.067  170.0355  122.11  7  95.08033  310.7411  199.6043  201.81 
8  560.5057  365.1556  359.0403  428.23  8  812.414  542.0341  776.5208  710.32 
9  50.11761  54.97051  84.31025  63.13  9  60.22024  62.1366  84.92439  69.09 
10  107.1999  60.90119  119.7927  95.96  10  696.9361  635.5966  877.089  736.54 
11  83.32436  90.57981  75.8761  83.26  11  134.867  133.2834  143.6229  137.26 
12  98.70212  27.86953  39.62655  55.40  12  106.1786  39.37334  69.54031  71.70 
13  1472.819  1008.563  1014.749  1165.38  13  1970.917  1270.635  1666.695  1636.08 
14  76.60868  53.39084  57.34024  62.45  14  157.6113  152.645  106.2488  138.84 
15  299.7957  223.0458  211.2608  244.70  15  365.3567  350.1323  293.4254  336.30 
16  189.3071  213.6665  54.42197  152.47  16  333.7117  307.9782  287.024  309.57 
17  445.0512  299.1317  180.8315  308.34  17  803.1864  581.9069  338.6325  574.58 
18  940.2035  818.832  612.0724  790.37  18  978.1566  852.0531  604.2734  811.49 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  7.079795  8.670345  5.965418  7.24  1  26.80497  30.05576  31.78801  29.55 
2  34.12181  50.93517  34.21704  39.76  2  213.8041  160.2855  124.4103  166.17 
3  28.79898  26.98047  48.86013  34.88  3  122.5304  116.3682  116.4333  118.44 
4  771.8115  422.2725  288.304  494.13  4  401.0008  966.4312  858.3001  741.91 
5  79.39387  46.24563  91.93441  72.52  5  696.7751  400.9785  373.4942  490.42 
6  35.43137  27.95941  25.13343  29.51  6  204.7487  129.8209  130.2687  154.95 
7  23.36107  32.20476  35.06075  30.21  7  68.24808  142.3554  101.7385  104.11 
8  119.7201  128.7532  105.7075  118.06  8  523.0522  420.7652  458.0971  467.30 
9  13.95692  12.1396  16.09629  14.06  9  42.60893  36.40626  44.68894  41.23 
10  43.37207  48.93376  46.61314  46.31  10  346.376  363.5019  426.6689  378.85 
11  35.25788  40.7393  30.43164  35.48  11  78.94836  80.5306  67.12996  75.54 
12  17.30101  6.712951  11.99788  12.00  12  48.63248  27.36222  49.99527  42.00 
13  134.5286  165.5187  126.7955  142.28  13  1370.303  788.0566  1143.152  1100.50 
14  42.52411  36.72789  37.42717  38.89  14  110.9461  87.10702  89.88455  95.98 
15  74.66009  57.80394  52.66726  61.71  15  236.2654  271.4778  225.3777  244.37 
16  57.70303  62.19804  29.21216  49.70  16  206.3231  182.1222  185.5253  191.32 
17  113.3255  83.36218  61.55569  86.08  17  477.8134  355.3863  233.1332  355.44 
18  146.818  107.6481  124.3562  126.27  18  448.0255  436.3767  325.9189  403.44 149 
 
Data Collection Session 1: Right Vastus Medialis (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  40.04911  32.80349  38.98979  37.28  1  49.69753  39.57356  72.40195  53.89 
2  23.49536  63.47038  25.93316  37.63  2  34.78551  60.77283  73.61485  56.39 
3  112.684  69.59663  95.5832  92.62  3  117.1202  89.08309  119.6023  108.60 
4  22.74049  27.18026  21.60728  23.84  4  95.95641  62.96251  82.26135  80.39 
5  39.59751  31.0853  44.24526  38.31  5  124.316  156.051  104.3271  128.23 
6  92.54737  39.44241  11.5306  47.84  6  24.15961  98.92392  87.55951  70.21 
7  15.42259  17.69083  20.40206  17.84  7  130.4846  252.0184  193.2937  191.93 
8  14.93488  18.25223  102.6474  45.28  8  81.21298  70.11063  77.77154  76.37 
9  9.927933  11.21401  8.845397  10.00  9  49.94638  32.25442  63.3073  48.50 
10  23.50312  26.13944  19.99793  23.21  10  51.76193  76.80572  98.96856  75.85 
11  12.2921  14.05086  12.95385  13.10  11  13.41174  14.07458  12.43555  13.31 
12  18.23905  20.69217  20.20153  19.71  12  53.69897  33.08437  45.13413  43.97 
13  54.2163  12.96851  24.90375  30.70  13  55.18591  125.8583  68.43759  83.16 
14  42.23965  86.06381  55.99579  61.43  14  122.7042  134.4139  101.1069  119.41 
15  59.36705  61.82629  72.41291  64.54  15  135.7447  100.8192  85.10714  107.22 
16  41.37043  26.33263  54.01534  40.57  16  242.1475  246.5122  164.5392  217.73 
17  39.56086  26.07883  20.98813  28.88  17  49.94087  31.29642  72.00876  51.08 
18  39.79546  43.30175  43.57543  42.22  18  87.05575  133.7526  96.39339  105.73 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  25.54485  21.84012  27.54518  24.98  1  23.52507  22.62054  32.18506  26.11 
2  10.75115  24.51968  12.44512  15.91  2  20.65007  41.8875  42.80381  35.11 
3  51.33789  17.13053  18.08905  28.85  3  87.01936  69.1704  82.05043  79.41 
4  18.11381  17.92801  15.83352  17.29  4  51.1289  42.99186  43.94559  46.02 
5  26.54874  21.72239  21.69494  23.32  5  56.72636  63.75325  51.51523  57.33 
6  40.58736  22.12254  9.763093  24.16  6  15.20038  50.392  44.90406  36.83 
7  11.27308  12.41406  13.27556  12.32  7  63.50834  122.7658  92.5329  92.94 
8  10.10131  11.483  35.3335  18.97  8  31.65624  26.87369  16.69246  25.07 
9  6.262236  6.249634  5.752187  6.09  9  24.70259  17.03499  27.63384  23.12 
10  14.39409  13.34567  13.67642  13.81  10  27.00349  41.93318  48.75782  39.23 
11  8.042445  8.664605  7.894697  8.20  11  8.94014  7.882941  7.261423  8.03 
12  14.92587  15.10438  15.70752  15.25  12  27.27935  22.99462  29.22911  26.50 
13  23.63657  9.808175  10.16128  14.54  13  28.30869  64.13303  35.35933  42.60 
14  20.63364  40.18425  15.84292  25.55  14  88.84015  100.0679  66.89921  85.27 
15  40.48308  51.15437  50.19966  47.28  15  63.41659  47.50301  49.81904  53.58 
16  26.14129  15.11603  32.58231  24.61  16  141.846  124.7834  89.21734  118.62 
17  20.72171  16.73143  15.48637  17.65  17  30.99542  25.2687  33.89231  30.05 
18  23.06016  23.87217  26.71528  24.55  18  47.66723  49.33558  55.53499  50.85 150 
 
Data Collection Session 2: Right Vastus Medialis (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  42.50888  78.69616  28.12087  49.78  1  172.2027  485.02  118.6045  258.61 
2  25.79129  30.99349  24.9329  27.24  2  68.56358  73.03639  54.79971  65.47 
3  32.15812  49.29434  33.81366  38.42  3  104.045  96.79944  69.07647  89.97 
4  8.249415  12.72195  9.018229  10.00  4  22.76659  35.39977  23.05399  27.07 
5  26.426  26.81689  34.88181  29.37  5  181.253  194.7769  141.1373  172.39 
6  9.724931  11.55984  8.995417  10.09  6  46.69247  58.92854  36.75138  47.46 
7  21.88397  15.51427  27.43427  21.61  7  127.3833  91.46607  87.40902  102.09 
8  1345.437  1076.645  1395.176  1272.42  8  1905.735  1566.796  1137.131  1536.55 
9  4.334014  4.981359  8.771683  6.03  9  30.07997  43.33119  15.30794  29.57 
10  11.82774  14.6353  15.31352  13.93  10  39.68056  35.39999  43.79292  39.62 
11  22.4859  22.45123  20.96963  21.97  11  16.57085  9.939676  9.772213  12.09 
12  105.9573  27.1086  37.49742  56.85  12  138.1688  126.4692  146.8171  137.15 
13  29.54793  27.43538  24.07391  27.02  13  124.9785  95.60484  103.6503  108.08 
14  67.24061  53.46751  40.84513  53.85  14  257.8461  331.4234  300.2552  296.51 
15  30.55514  31.31409  35.97176  32.61  15  148.1519  45.99192  57.35873  83.83 
16  15.17722  19.66992  24.92028  19.92  16  42.10247  31.73937  50.08738  41.31 
17  15.50786  22.01256  19.24578  18.92  17  35.68509  33.28136  34.48112  34.48 
18  36.7614  64.12517  40.86603  47.25  18  136.2431  78.77681  54.95941  89.99 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  28.40284  39.10748  18.50536  28.67  1  65.69613  211.3371  53.39192  110.14 
2  15.8493  16.14675  15.57403  15.86  2  29.91078  31.16008  25.99922  29.02 
3  8.379397  12.61818  9.092305  10.03  3  55.26072  56.79229  47.19024  53.08 
4  5.861792  7.675771  6.141607  6.56  4  16.13641  17.38097  14.53954  16.02 
5  21.68006  21.21332  19.93161  20.94  5  75.35375  80.38139  62.45735  72.73 
6  7.787784  8.059918  6.970798  7.61  6  27.21898  27.46244  18.03792  24.24 
7  15.69424  12.10614  14.0134  13.94  7  55.17579  46.36731  43.93608  48.49 
8  738.3016  557.2372  861.5286  719.02  8  718.687  730.4162  519.7179  656.27 
9  2.037794  2.672618  4.21934  2.98  9  11.71911  16.78852  6.663377  11.72 
10  8.490133  8.420489  9.650921  8.85  10  28.2251  19.63959  23.79756  23.89 
11  12.44357  12.90416  12.51649  12.62  11  9.661101  6.497445  6.809572  7.66 
12  43.76059  22.3966  23.71972  29.96  12  84.57366  58.54532  70.14162  71.09 
13  11.6213  17.0857  14.20717  14.30  13  59.42782  47.91226  56.94278  54.76 
14  22.49391  23.62799  19.47807  21.87  14  160.1959  202.3278  184.0451  182.19 
15  23.324  25.71828  25.4315  24.82  15  54.58308  25.32897  28.65539  36.19 
16  10.88115  11.41306  15.41674  12.57  16  22.37244  19.5572  29.23239  23.72 
17  13.18882  17.17096  16.56952  15.64  17  23.3672  23.40616  23.8682  23.55 
18  24.8467  33.94312  31.3585  30.05  18  66.9048  40.04319  40.40436  49.12 151 
 
Data Collection Session 3: Right Vastus Medialis (%MVIC) 
Peak pre emg           Peak post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  40.4863  23.26153  28.79936  30.85  1  86.61862  162.7689  120.2171  123.20 
2  17.48474  12.69786  9.283513  13.16  2  14.66956  25.30513  29.37408  23.12 
3  35.64063  65.17618  99.19518  66.67  3  81.17834  87.53234  109.7827  92.83 
4  125.8242  16.69218  18.86277  53.79  4  81.89076  87.34629  73.1171  80.78 
5  26.7724  28.81051  25.27913  26.95  5  216.3956  149.4351  173.453  179.76 
6  24.49876  19.66353  24.50249  22.89  6  169.9511  172.4168  237.1541  193.17 
7  19.14282  16.24492  21.25088  18.88  7  175.5359  108.5211  141.6741  141.91 
8  32.65252  30.37137  25.74539  29.59  8  125.3931  118.2735  121.9938  121.89 
9  4.038741  6.469202  7.682945  6.06  9  62.66953  24.64402  110.2068  65.84 
10  8.825591  9.660791  10.59595  9.69  10  33.4959  35.40734  56.4152  41.77 
11  12.49874  12.69226  14.15833  13.12  11  16.67917  22.61979  17.76082  19.02 
12  33.58656  49.09175  30.82774  37.84  12  123.3989  110.296  67.32815  100.34 
13  33.92697  17.75046  13.92481  21.87  13  64.24647  40.8798  56.72834  53.95 
14  59.16817  65.29974  59.73676  61.40  14  252.3539  279.9298  140.5711  224.28 
15  34.04764  85.67183  51.08651  56.94  15  84.54961  186.0139  167.6345  146.07 
16  33.17082  27.09034  45.14508  35.14  16  73.08596  88.52926  57.06736  72.89 
17  46.86919  20.90043  30.24234  32.67  17  46.90341  38.09456  88.12764  57.71 
18  74.86027  50.19631  109.8975  78.32  18  396.9778  163.3276  139.5204  233.28 
Mean pre emg           Mean post emg          
Subject  trial 1  trial 2  trial 3  Mean  Subject  trial 1  trial 2  trial 3  Mean 
1  24.7333  17.21981  20.90241  20.95  1  41.09432  62.24005  54.31419  52.55 
2  9.847781  7.573212  6.225762  7.88  2  8.167226  10.5326  15.9054  11.54 
3  11.56157  14.19002  12.6568  12.80  3  48.53518  55.48278  71.23634  58.42 
4  44.47974  7.819755  11.6957  21.33  4  37.144  36.26835  29.15315  34.19 
5  19.07528  18.0293  18.76242  18.62  5  96.12951  73.65372  72.47785  80.75 
6  12.39932  11.54022  14.81167  12.92  6  77.88448  74.73057  105.7166  86.11 
7  14.61798  13.94828  17.80212  15.46  7  64.0337  46.57978  79.49345  63.37 
8  18.30176  17.22186  17.40266  17.64  8  69.30567  51.75265  73.56869  64.88 
9  3.157896  3.081007  2.926617  3.06  9  27.89938  12.55753  61.31406  33.92 
10  6.620135  7.806656  8.643606  7.69  10  18.77538  17.87503  25.02669  20.56 
11  9.199745  8.77356  9.816626  9.26  11  10.12351  10.80347  9.885624  10.27 
12  26.97124  29.11419  23.22922  26.44  12  55.25472  71.58669  34.31276  53.72 
13  17.58944  12.26418  9.040838  12.96  13  40.85255  26.64465  28.07926  31.86 
14  23.60117  23.64621  25.70857  24.32  14  129.8398  168.8635  90.65157  129.78 
15  25.87472  35.11374  30.31579  30.43  15  42.50813  81.98926  78.15714  67.55 
16  15.63123  18.81543  21.7336  18.73  16  39.93447  57.78893  34.52851  44.08 
17  36.92299  16.9591  22.29276  25.39  17  38.82156  23.9746  43.88191  35.56 
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Due to the vast amount of statistical analysis of the current study we have elected to only 
include relevant tables of the statistics ran (i.e. subject demographics and significant differences).  
The remainder of the statistics have been stored on a flash drive for future reference. 
   154 
 
 
Participant Demographic Descriptive Statistics 
  N  Minimum  Maximum  Mean  Std. Deviation 
Age  18  18.00  24.00  21.2222  2.01627 
Height  18  155.50  189.00  168.3889  8.92207 
Weight  18  56.30  103.35  77.7583  16.39273 
Gender  18  1.00  2.00  1.6111  .50163 
Valid N (listwise)  18         
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Descriptive Statistics 
  Mean  Std. Deviation  N 
D2Lbfpremean  12.6589  7.50772  18 
D3Lbfpremean  19.3483  15.77229  18 
 
 
Tests of Within-Subjects Effects 
Repeated Measures Analysis of Variance: Pre-mean Non-dominant Biceps Femoris (DC2-DC3) 
Source  Type III Sum 
of Squares  df  Mean Square  F  Sig. 
factor1  Sphericity Assumed  402.738  1  402.738  4.752  .044 
Greenhouse-Geisser  402.738  1.000  402.738  4.752  .044 
Huynh-Feldt  402.738  1.000  402.738  4.752  .044 
Lower-bound  402.738  1.000  402.738  4.752  .044 
Error(factor1)  Sphericity Assumed  1440.737  17  84.749     
Greenhouse-Geisser  1440.737  17.000  84.749     
Huynh-Feldt  1440.737  17.000  84.749     
Lower-bound  1440.737  17.000  84.749     
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Descriptive Statistics 
  Mean  Std. Deviation  N 
D2Rgmpremean  49.8739  39.51803  18 
D3Rgmpremean  26.9311  21.91681  18 
 
 
Tests of Within-Subjects Effects 
Repeated Measures Analysis of Variance: Pre-mean Dominant Gluteus Medius (DC2-DC3) 
Source  Type III Sum 
of Squares  df  Mean Square  F  Sig. 
factor1  Sphericity Assumed  4737.339  1  4737.339  14.301  .001 
Greenhouse-Geisser  4737.339  1.000  4737.339  14.301  .001 
Huynh-Feldt  4737.339  1.000  4737.339  14.301  .001 
Lower-bound  4737.339  1.000  4737.339  14.301  .001 
Error(factor1)  Sphericity Assumed  5631.437  17  331.261     
Greenhouse-Geisser  5631.437  17.000  331.261     
Huynh-Feldt  5631.437  17.000  331.261     
Lower-bound  5631.437  17.000  331.261     
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Descriptive Statistics 
  Mean  Std. Deviation  N 
D2Rgmpremax  128.7394  121.33166  18 
D3Rgmpremax  66.8044  55.54454  18 
 
 
Tests of Within-Subjects Effects 
Repeated Measures Analysis of Variance: Pre-max Dominant Gluteus Medius (DC2-DC3) 
Source  Type III Sum 
of Squares  df  Mean Square  F  Sig. 
factor1  Sphericity Assumed  34523.498  1  34523.498  9.490  .007 
Greenhouse-Geisser  34523.498  1.000  34523.498  9.490  .007 
Huynh-Feldt  34523.498  1.000  34523.498  9.490  .007 
Lower-bound  34523.498  1.000  34523.498  9.490  .007 
Error(factor1)  Sphericity Assumed  61846.723  17  3638.043     
Greenhouse-Geisser  61846.723  17.000  3638.043     
Huynh-Feldt  61846.723  17.000  3638.043     
Lower-bound  61846.723  17.000  3638.043     
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Descriptive Statistics 
  Mean  Std. Deviation  N 
D2Rgmpostmean  92.1261  77.85249  18 
D3Rgmpostmean  53.1339  30.27252  18 
 
 
Tests of Within-Subjects Effects 
Repeated Measures Analysis of Variance: Post-mean Dominant Gluteus Medius (DC2-DC3) 
Source  Type III Sum 
of Squares  df  Mean Square  F  Sig. 
factor1  Sphericity Assumed  13683.541  1  13683.541  5.373  .033 
Greenhouse-Geisser  13683.541  1.000  13683.541  5.373  .033 
Huynh-Feldt  13683.541  1.000  13683.541  5.373  .033 
Lower-bound  13683.541  1.000  13683.541  5.373  .033 
Error(factor1)  Sphericity Assumed  43297.519  17  2546.913     
Greenhouse-Geisser  43297.519  17.000  2546.913     
Huynh-Feldt  43297.519  17.000  2546.913     
Lower-bound  43297.519  17.000  2546.913     
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Descriptive Statistics 
  Mean  Std. Deviation  N 
D2Rgmpostmax  190.2406  191.47567  18 
D3Rgmpostmax  101.4628  63.50088  18 
 
 
Tests of Within-Subjects Effects 
Repeated Measures Analysis of Variance: Post-max Dominant Gluteus Medius (DC2-DC3) 
Source  Type III Sum 
of Squares  df  Mean Square  F  Sig. 
factor1  Sphericity Assumed  70933.444  1  70933.444  4.678  .045 
Greenhouse-Geisser  70933.444  1.000  70933.444  4.678  .045 
Huynh-Feldt  70933.444  1.000  70933.444  4.678  .045 
Lower-bound  70933.444  1.000  70933.444  4.678  .045 
Error(factor1)  Sphericity Assumed  257755.244  17  15162.073     
Greenhouse-Geisser  257755.244  17.000  15162.073     
Huynh-Feldt  257755.244  17.000  15162.073     
Lower-bound  257755.244  17.000  15162.073     
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  Several limitations of the present study are apparent.  First, the current study included a 
small sample size of eighteen participants.  A study with a larger sample size may provide 
additional insight.  Also, a sample including participants from an injured population may reveal 
different results as well.  Thirdly, participants in our study completed a training protocol that has 
not been previously used or validated in the literature.  We made efforts to include exercises in 
the training protocol that have demonstrated through EMG amplitude to effectively activate the 
GM.  However, without the implementation of increasing resistance the training protocol may 
not have been strenuous enough to reveal comprehensive neuromuscular adaptations.  
Unfortunately, the analysis of muscle activation in the current study only included examining 
EMG amplitude.  Examining the timing of muscle activation combined with EMG amplitude 
may offer more comprehensive results to expand on.   
  Another limitation in the current study was the lack of observation at each training 
session.  Participants were only observed for one training session per week and instructed to 
complete the remaining two training sessions on their own.  We attempted to control for this by 
having participants complete a weekly exercise log, which recorded the training protocol and all 
other additional physical activity performed by each participant.  Our assumption is that 
participants completed the weekly exercise log honestly, and completed all three training 
sessions per week.  However, observing all three training sessions each week would strengthen 
validity of the study.  In addition, our protocol did not include increases in resistance but were 
completed only with body weight.  The idea behind this decision was to choose exercises that 
could be prescribed as a home exercise program or in settings where supplies may be limited.  
The 100% completion rate by all participants suggests that the current training protocol is a user 
friendly program.   162 
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SUBMISSION POLICIES 
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2. The following forms (available at www.journalofathletictraining.org) should be either scanned 
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a. Copyright form. A letter signed by each author must contain the following statements: 
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publication, and 3) will not be submitted elsewhere until a decision has been made 
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the suitability of the topic. 
 
15. Study design should be selected from the choices listed below (courtesy of the Centre for 
Evidence-Based Medicine [www.cebm.net] and the American Journal of Sports Medicine). 
Meta-Analysis: A systematic overview of studies that pools results of 2 or more studies to 
obtain an overall answer to a question or interest. Summarizes quantitatively the evidence 
regarding a treatment, procedure, or association.  
Systematic Review: An article that examines published material on a clearly described subject 
in a systematic way.  There must be a description of how the evidence on this topic was 
tracked down, from what sources, and with what inclusion and exclusion criteria.   
Randomized Controlled Clinical Trial: A group of patients is randomized into an experimental 
group and a control group.  These groups are followed up for the variables/outcomes of 
interest.   
Crossover Study Design: The administration of 2 or more experimental therapies, one after the 
other, in a specified or random order to the same group of patients.   
Cohort Study: Involves identification of 2 groups (cohorts) of patients, one which did receive 
the exposure of interest and one which did not, and following these cohorts forward for the 
outcome of interest.   
Case-Control Study: A study that involves identifying patients who have the outcome of 
interest (cases) and patients without the same outcome (controls) and looking back to see if 
they had the exposure of interest.   
Cross-Sectional Study: The observation of a defined population at a single point in time or time 
interval. Exposure and outcome are determined simultaneously.   
Case Series: Describes characteristics of a group of patients with a particular disease or who 
have undergone a particular procedure. Design may be prospective or retrospective. No 
control group is used in the study, although the Discussion may compare the results with 
others published in the literature.   
Case Report: Similar to the Case Series, except that only one or a small group of cases is 
reported.   
Descriptive Epidemiology Study: Observational study describing the injuries occurring in a 
particular sport.   
Controlled Laboratory Study: An in vitro or in vivo investigation in which 1 group receiving 
an experimental treatment is compared with 1 or more groups receiving no treatment or an 
alternate treatment.   
Descriptive Laboratory Study: An in vivo or in vitro study that describes characteristics such 
as anatomy, physiology, or kinesiology of a broad range of subjects or a specific group of 
interest.   167 
 
Qualitative Study: A study that utilizes qualitative methodology such as grounded theory, 
phenomenology, ethnography, or case-study approach to understand a phenomenon. Data-
collection methods may include participants describing their experiences orally or in writing 
or research observation of participants’behavior. 
 
16. Begin the text of the manuscript with an introductory paragraph or two in which the purpose 
or hypothesis of the article is clearly stated and developed. Tell why the study needed to be 
done or the article written, and end with a statement of the problem (or controversy). 
Highlights of the most prominent works of others as related to your subject are often 
appropriate for the introduction, but a detailed review of the literature should be reserved for 
the Discussion section. In a 1-to 2-paragraph review of the literature, identify and develop the 
magnitude and significance of the controversy, pointing out differences among others’ results, 
conclusions, and/or opinions. The Introduction is not the place for great detail; state the facts 
in brief, specific statements and reference them. The detail belongs in the Discussion. Also, an 
overview of the manuscript is part of the abstract, not the introduction. Writing should be in 
the active voice (for example, instead of ‘‘Participants were selected,’’ use ‘‘We selected 
participants’’) and in the first person (for example, instead of ‘‘The results of this study 
showed,’’ use ‘‘Our results showed’’). 
 
17. The body or main part of the manuscript varies according to the type of article (examples 
follow); however, the body should include a Discussion section in which the importance of 
the material presented is discussed and related to other pertinent literature. When appropriate, 
a subheading on the clinical relevance of the findings is recommended.  Liberal use of 
headings and subheadings, charts, graphs, and figures is recommended (see item 14 for 
exceptions regarding short reports and technical notes).  
a. The body of an Original Research or a Meta-Analysis or Systematic Review article consists 
of a Methods section, a presentation of the Results, and a Discussion of the results. The 
Methods section should contain sufficient detail concerning the methods, procedures, and 
apparatus employed so that others can reproduce the results.  The Results should be 
summarized using descriptive and inferential statistics and a few well-planned and 
carefully constructed illustrations.  For more information on preparing research 
manuscripts, authors are advised to consult the MOOSE and PRISMA statements, which 
are available through the JAT Web site. 
b. The body of a Case Report should include the following components: personal data (age 
and sex and, when relevant, race, marital status, and occupation but not name or initials), 
chief complaint, history of present complaint (including symptoms); results of physical 
examination (example:‘‘Physical findings relevant to the rehabilitation program were …’’); 
medical history (surgery, laboratory results, examination, etc); diagnosis, treatment and 
clinical course (rehabilitation until and after return to competition); criteria for return to 
competition; and deviation from expectations (what makes this case unique).   
c. The body of a Clinical Techniques article should include both the how and why of the 
technique: a step-bystep explanation of how to perform the technique, supplemented by 
photographs or illustrations, and an explanation of why the technique should be used. The 
Discussion concerning the why of the technique should review similar techniques, point out 
how the new technique differs, and explain the advantages and disadvantages of the 
technique in comparison with othertechniques.   168 
 
d. The body of an Evidence-Based Practice article provides a short review of current scientific 
literature and applies the findings to clinical athletic training practice. All articles submitted 
for this section should be concise reviews of published systematic reviews or  meta-
analyses on topics relevant to the 7 domains of athletic training 430 Volume 45 N Number 
4 N August 2010 (Prevention, Assessment/Evaluation, First Aid/Treatment, Rehabilitation, 
Organization/Administration, Counseling, and Education). Reviews of individual, large, 
controlled clinical trials will also be considered. The review must begin with the complete 
article title and reference and a statement of the clinical question the review addresses. The 
rest of the review consists of a summary of the article and must include the following 
sections: data sources and search terms used; study selection (inclusion and exclusion) 
criteria; the methods used to extract and review data, including a list of the primary 
outcome measures; results of the search strategy; and primary outcome measures and 
conclusions. A separate commentary section should address the application of the 
information to the clinical athletic training setting.  Authors may use supplementary 
scientific literature (up to a maximum of 5 references) to support the commentary.   
e. The body of a Short Report or Technical Note consists of sections appropriate to the theme 
of the paper.  For a Short Report, these sections will vary with the topic. Section headings 
should reflect the overall theme of the paper and should organize the material in a logical 
fashion. Data specific to the relevant findings should be provided if applicable. A summary 
providing a brief overview of the content should be included. For a Technical Note, the 
body consists of Introduction, Methods, Results or Key Findings, Commentary, and 
Conclusions. References should not exceed 10 for either a short report or technical note. 
 
18. Percentages should be accompanied by the numbers used to calculate them.  When reporting 
no difference among groups on a key outcome measure, include a power analysis to 
demonstrate that the study was adequate powered. The power analysis should quantify the 
smallest statistically significant difference that would have been detectable with the given 
sample size. (Additional information on power is available at 
http://www.stat.uiowa.edu/,rlenth/Power/ and 
http://www.sportsci.org/resource/stats/index.html.) Never report a single P value as an 
inequality (eg, P ..05) but instead report the exact value (eg, P 5 .06). If, however, the value 
would be reported as P 5 .00 because of the number of significant digits allowed, then it is 
acceptable to state P ,.001.When reporting groups of P values, it is permissible to provide an 
inequality (eg, ‘‘groups were similar on all demographic characteristics [P . .05]’’). 
 
19. Communications articles, including official Position Statements and Policy Statements from 
the NATA Pronouncements Committee; Technical Notes on such topics as research design 
and statistics; and articles on other professional issues of interest to the readership are 
solicited by the Journal. An author who has a suggestion for such a paper is advised to contact 
the Editorial Office for instructions. 
 
20. The manuscript should not have a separate summary section—the abstract serves as a 
summary. It is appropriate, however, to tie the article together with a list of conclusions at the 
end of the Discussion section or in a summary paragraph. 
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21. References should be numbered consecutively, using superscripted arabic numerals, in the 
order in which they are cited in the text. No more than 30 references should be cited in 
Original Research manuscripts. References should be used liberally. It is unethical to present 
others’ ideas as your own. Also, use references so that readers who desire further information 
on the topic can benefit from your scholarship. 
 
22. References to articles or books, published or accepted for publication, or to papers presented 
at professional meetings are listed in numerical order at the end of the manuscript. Journal 
title abbreviations conform to Index Medicus style. Examples of references are illustrated 
below. See the AMA Manual of Style for other examples. 
 
Journals: 
1. Boling MC, Padua DA, Creighton RA. Concentric and eccentric torque of the hip musculature 
in individuals with and without patellofemoral pain. J Athl Train. 2009;44(1):7–13. 
2. McDonough EB Jr, Wojtys EM. Multiligamentous injuries of the knee and associated vascular 
injuries. Am J Sports Med. 2009;37(1):156–159. 
 
Books: 
1. Ritter MA, Albohm MJ. Sports Injuries: Your Common Sense Guide. Traverse City, MI: 
Cooper Publishing Group; 2008:1–12. 
2. Massey-Stokes M. Body image and eating disturbances in children and adolescents. In: 
Robert-McComb JR, Norman R, Zumwalt M. The Active Female: Health Issues Throughout 
the Lifespan. Totowa, NJ: Humana Press; 2008: 57–80.  
 
Presentation: 
1. Ross SE, Linens SW, Arnold BL. Balance assessments for discriminating between functional 
ankle instability and stable ankles. Presented at:59th Annual Meeting & Clinical Symposia of 
the National Athletic Trainers’ Association; June 20, 2008; St Louis, MO.  
 
DVD: 
1. Athletic Taping and Bracing [DVD]. Champaign, IL: Human Kinetics; 2005.  
 
Software Manual: 
1. SPSS Base for Windows [computer program]. Version 13.0. Chicago, IL:SPSS Inc; 2005.  
 
Internet Sources: 
1. Cappaert TA, Stone JA, Castellani JW, Krause BA, Smith D, Stephens BA. National Athletic 
Trainers’ Association position statement: environmental cold injuries. 
http://www.nata.org/statements/position/environmentalcoldinjuries.pdf. J Athl Train. 
2008;43(6):640–658. Published December 2008. Accessed April 14, 2009. 
2. American College of Sports Medicine. Physical activity & public health guidelines. 
http://www.acsm.org/AM/Template.cfm?Section5General_Public&TEMPLATE5/CM/HTML
Display.cfm&CONTENTID511398. Published 2007. Accessed April 14, 2009.  
 
23. Personal communications are cited in the text as follows: ‘‘… (J.A. Smith, written 
communication, January 2005).’’ The written or oral nature of the communication is stated, 170 
 
and the communication does not appear in the reference list. Authors must provide written 
permission from each personal-communication source. A form is available on the JAT Web 
site and from the Editorial Office. 
 
24. Table Style: 1) Title is bold; body and column headings are roman type; 2) units are set 
above rules in parentheses; 3) numbers are aligned in columns by decimal; 4) footnotes are 
indicated by superscript letters; 5) capitalize the first letter of each major word in titles; for 
each column or row entry, capitalize the first word only. See a current issue of JAT for 
examples. 
 
25. Figures: Figures should use Arial (or another sans serif font), a white background, and no 
box. Minimum recommended resolution is 300 DPI. Multipart figures should be mounted 
together and use CAPITAL letter labels (A, B, C, etc).  Authors wishing color reproduction 
should request same in a cover letter with the submitted manuscript. Authors must pay for the 
additional cost of color reproduction ($750/figure) before their accepted article is typeset. For 
more details, consult the JAT Figure Guidelines at www.journalofathletictraining.org. 
 
26. Legends to figures are numbered with arabic numerals in order of appearance in the text. 
Legends should be printed on separate pages at the end of the manuscript. 
 
27. The Journal of Athletic Training follows the redundant publication guidelines of the Council 
of Science Editors, Inc (CBEViews. 1996; 19:76–77; also available on the JAT Web site). 
Authors in violation of redundant publication will have sanctions invoked by the Journal 
Committee of the National Athletic Trainers’ Association,Inc. 
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